fiera c & e c f , i m 8-11, 2017 program .srnt. · message from the program chair dear...

Firenze Fiera Congress & exhibition Center

FlorenCe, italy

MarCh 8-11, 2017

PrograM

www.srnt.org

1

SRNT 2017 · Florence, Italy

TABLE OF CONTENTS

Abstract Reviewers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8

Badges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16

Board of Directors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17

Conference Safety Rules and Guidelines . . . . . . . . . . . . . . . . . 18

Continuing Education Credits . . . . . . . . . . . . . . . . . . . . . . . . . . 14

Educational Objectives. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13

Exhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24

Evaluation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16

Future Meetings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18

Meeting Room Floor Plans . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25

Index–Author . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93

Internet Access . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13

Lunches . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14

Meet-the-Editor Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17

Message from the Program Chair . . . . . . . . . . . . . . . . . . . . . . . . 3

Members Meetings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16

Network Advisory Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7

Past Presidents and Program Chairs . . . . . . . . . . . . . . . . . . . . 11

Poster Session Setup Schedule . . . . . . . . . . . . . . . . . . . . . . . . 15

Program Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6

Registration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13

Remembrances of Pioneers for Whom SRNT’s 2017 Awards Are Named . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19

Schedule-at-a-Glance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107

Session Summary:

Wednesday, March 8, 2017 . . . . . . . . . . . . . . . . . . . . . . . . . . 29

Thursday, March 9, 2017 . . . . . . . . . . . . . . . . . . . . . . . . . . . 41

Friday, March 10, 2017 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59

Saturday, March 11, 2017 . . . . . . . . . . . . . . . . . . . . . . . . . . . 77

Speaker Ready Room . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16

SRNT Supporters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13

Target Audience . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13


2

3


MESSAGE FROM THE PROGRAM CHAIR

Dear Colleagues,

On behalf of the SRNT Program Committee, we welcome you to the 23rd Annual Meeting of the Society for Research on Nicotine and Tobacco (SRNT), in the wonderful city of Florence!

As always the meeting offers you a transdisciplinary collection of cutting-edge science across the full spectrum of basic and applied research on nicotine and tobacco. This year there will be presen-tations on a number of pivotal clinical trials, plus hot topics in the field of tobacco use epidemiology, genomics, biomarkers, cue reactivity, e-cigarettes, cigar use, waterpipes, smokeless tobacco, secondhand exposure, and tobacco product regulation. However, you will notice this year that there is a strong focus on concurrent use of tobacco with other psychoactive substances and drugs. We will discuss findings from basic science, pre-clinical and clinical studies to understand complex interactions between nicotine and other substances. Whilst the overall prevalence of smoking is decreasing in many countries, a significant proportion of tobacco smokers also use various psychoactive substances. Also, smoking rates are high among those who are addicted to various legal and illegal drugs, including marijuana, alcohol, and opioids. These populations need to be a focus of tobacco control policies and interventions moving forward, so that “no man is left behind” in our efforts to reduce smoking prevalence. In this manner equity is the focus, not just equality.

Several key highlights for the meeting are:

Wednesday, March 8, 20175:00 p.m.-6:00 p.m.Keynote Presidential Symposium (Opening Session)Nicotine + Other Addictive Behaviors: Addressing the Added Complexities Across the Translational ContinuumSpeakers: Neal L. Benowitz MD, Chief, Division of Clinical Pharmacology, University of California San Francisco, USA; Ron Borland PhD, FASSA, Nigel Gray Distinguished Fellow in Cancer Prevention, The Cancer Council Victoria, Melbourne, Australia; Joanna E. Cohen, PhD, Director, Institute for Global Tobacco Con-trol, Johns Hopkins Bloomberg School of Public, Baltimore, USA; Judith J. Prochaska, PhD, MPH, Associate Professor of Medicine, Department of Medicine, Stanford University, USA; Robert West, PhD, Professor of Health Psychology, University College London, UK

Thursday, March 9, 20179:30 a.m.-10:30 a.m.Epidemiology and Public Health Themed Lecture and 2017 Doll-Wynder Award RecipientHow to Think—Not Feel—About Tobacco Harm ReductionKenneth E. Warner; Avedis Donabedian Distinguished University Professor of Public Health at the University of Michigan, USA.

Thursday, March 9, 20172:00 p.m.-3:00 p.m.Pre-Clinical Theme Lecture Genetic Overlap Between Cigarette Smoking and Other Sub-stance UseJacqueline Vink, Professor, Behavioral Science Institute, Devel-opmental Psychopathology, Radboud University Nijmegen, The Netherlands


4

Friday, March 10, 20179:00 a.m.-10:00 a.m.Clinical Theme LectureTreatment of Patients With Tobacco Addiction: Improving Current Practice and Future PerspectivesProfessor Serena Tonstad, Head Physician, Preventive Cardiol-ogy section, Department of Endocrinology, Obesity and Preventive Medicine at Oslo University Hospital, Oslo, Norway and a Profes-sor, School of Public Health, Loma Linda University, Loma Linda, California.

Friday, March 10, 2017 2:00 p.m.-3:00 p.m.Public Policy Theme Lecture Population Level Policies to Prevent Chronic Disease: Apply-ing Lessons From Nicotine and Tobacco ResearchProfessor Linda Bauld, Professor of Health Policy, University of Stirling and Chair in Behavioral Research for Cancer Prevention, Cancer Research UK. President-elect of SRNT-Europe.

Also, not to be missed:

● The Opening Reception on Wednesday, March 8, from 6:00 p.m.-7:30 p.m., which will include hors d’oeuvres. All attend-ees are welcome!

● The Opening Remarks and Awards Ceremony on Thursday, March 9, from 9:00 a.m.-9:30 a.m., with special recognition of SRNT awardees: Doll-Wynder Award Winner, Dr. Kenneth E. Warner; John Slade Award Winner, Dr. Martin Raw; and Jarvik-Russell Award Winner, Dr. Thomas Kirchner.

● The SRNT-Europe Members Meeting on Friday, March 10, 8:15 a.m.-8:45 a.m.

● The SRNT Members Meeting on Saturday, March 11, 8:15 a.m.-8:45 a.m.

● Gala Dinner hosted by the SRNT-Europe organization at the breathtaking Palazzo Borghese Florence on Friday, March 10, at 7:30 p.m. (available at an additional fee)

● New this year, SRNT is proud to announce ‘Meet-the-Editor’ sessions on Thursday, Friday, and Saturday during the Annual Meeting. We have created an opportunity for all participants to join editors of the leading tobacco and nicotine journals for conversation. Meet-the-Editor is a chance to put members of the editorial boards in the hotseat. Editor of each journal will host a face-to-face session with the participants of the meeting. The editor will be available to answer questions, hear ideas, and discuss any comments about the journals. All are welcome but graduate students and postdocs are particularly invited.

For meeting attendees arriving early, there are 10 pre-conference workshops that will be held on Wednesday, March 8 (available at an additional fee). These include:

● SRNT-E Satellite Symposium: Comparing Regulations on Tobacco and Nicotine Products

● Novel Approaches to Implementing Tobacco Treatment Within Health Systems

● Is Nicotine Reduction Really a Viable Policy Option for To-bacco Control?

● Developing Evidence-Based Control Policies Targeting Water-pipe Tobacco Smoking: Time for Action

5


● Working Globally to Support Rapid Learning for E-Cigarette Policy, Surveillance, and Policy Research

● Introduction to the Multiphase Optimization Strategy (Most) for Building More Effective, Efficient, Economical, and Scalable Behavioral and Biobehavioral Interventions

● FDA’s Population Health Standard: Balancing the Risks and Benefits in Regulatory Decision-Making

● Tobacco and Marijuana Co-Use in Adolescents and Young Adults

● Reducing the Impacts of Commercial Tobacco on Indig-enous Peoples: Best Practices for Engaging With Indigenous Peoples in Research

● What Does Our Tobacco Work Mean to Us? Translating Knowledge Through Art in Florence

To follow, and as part of the general registration, please join us for the highly interactive Transdisciplinary Topical Discussions on Wednesday afternoon from 3:30 p.m.-4:45 p.m.:

● E-Health Smoking Cessation Interventions: Do They Really Work?

● NRT Bought Over the Counter: Are Gums and Patches Pos-sibly Not Effective in the Real World?

● Polysubstance Abuse: How to Treat Tobacco Alongside Other Addictions?

● Financial Incentives for Quitting Tobacco: An Effective and Ethical Approach?

● Making the Delivery of Tobacco Cessation Treatment Routine in Health Care Systems: What Are the Challenges?

● Vape Shops: Just Another Tobacco Product Retailer or a Smoking Cessation Service?

● How Do We Reduce Children’s Exposure to Second-Hand Tobacco Smoke Globally?

For the first time in SRNT history, we have received over one thousand (!!!) abstracts submissions. Over the past six months, we have worked thoughtfully to create a timely and high-quality scientific program spanning the full breath of the nicotine and tobacco research field. Our early registration numbers indicate attendance may break another record, being even higher than last years’ meeting in Chicago. Back by popular demand, we are utiliz-ing nine consecutive rooms during podium presentations, so yes, we anticipate hearing it is hard to choose!

We encourage you to attend sessions that stretch and expand your expertise, that you engage the company of your colleagues and seek out new connections, and importantly, that you enjoy the meeting and the true spirit of Italy!

Kind Regards,

Maciej L. Goniewicz, PhD, PharmD Program Chair

Rachel Grana, PhD, MPH, and Daniel Kotz, PhD, MsC, MPHProgram Co-Chairs


6

PROGRAM COMMITTEE

Maciej L. Goniewicz, PhD, PharmD Roswell Park Cancer Institute, USAProgram ChairRachel Grana, PhD, MPHNational Cancer Institute, USAProgram Co-ChairDaniel Kotz, PhD, McS, MPHDusseldorf University Hospital, GermanyProgram Co-ChairAndrea Villanti, PhDLegacy Foundation, USA

Andrew Harris, PhDUniversity of Minnesota, USA

Angela Attwood, PhDUniversity of Bristol, UK

Bartosz Koszowki, PharmD, PhDBattelle, USA

Bernard Le Foll, MD, PhD, MCFPUniversity of Toronto, Canada

Christie Fowler, PhDThe Scripps Research Institute, USA

Christopher Kahler, PhDBrown University, USA

Dunja Przulj, PhDQueen Mary University of London, UK

Eden Evins, MD, MPHHarvard University USA

Gorkem Yarbara, MD, PhDEge University, Turkey

Guadalupe P. Rodriquez, PhDCiudad Universitaria, Mexico

Hua Yong, PhDCancer Council Victoria, Australia

Ivan Berlin, MD, PhDPitié-Salpêtrière University Hospital, France

James Thrasher, PhDUniversity of South Carolina, USA

Jamie Brown, PhDUniversity College of London, England

Jean-Francois Etter, PhDUniversity of Geneva, Switzerland

Kamran Siddiqi, MBB, MPH, PhDUniversity of York, UK

Karl Fagerström, MD, PhDFagerström Consulting, Sweden

Kelly Blake, ScDNational Cancer Institute, USA

Kelvin Choi, PhDNational Institutes of Health, USA

Kola Okuyemi, MDUniversity of Minnesota, USA

Mandeep Virk-Baker, PhDNational Cancer Institute, USA

Marc Willemsen, PhDMaastricht University, Netherlands

Mark Parascandola, PhDNational Cancer Institute, USA

Natalie Nardone, PhDUniversity of California San Francisco, USA

Natalie Walker, PhDUniversity of Auckland, New Zealand

Noah Gubner, PhDUniversity of California San Francisco, USA

Olivia Wackowski, PhDRutgers University, USA

Philip Tonnesen, MD, PhDGentofte Hospital, Denmark

Rachel Cassidy, PhDBrown University, USA

Ramzi Salloum, PhDUniversity of Florida, USA

Reiner Hanewinkel, PhDInstitute for Therapy & Health Research, Germany

Richard O’Connor, PhDRoswell Park Cancer Institute, USA

Ron Borland, PhDCancer Council Victoria, Canada

Serena Tonstad, MD, PhDOslo, University Hospital, Norway

Suzanne Gage, PhDUniversity of Bristol, UK

Tellervo Korhonen, PhDUniversity of Helsinki, Finland

Thomas Kirchner, PhDNew York University, USA

7


NETWORK ADVISORY COMMITTEE

Adolescent

Suzanne Colby, PhD, Brown University

Robin Mermelstein, PhD, Uni-versity of Illinois at Chicago.

Basic Science

Christie Fowler, PhD, Univer-sity of California, Irvine

Mariella De Biasi, PhD, Univer-sity of Pennsylvania

Genetics

Marissa Ehringer, PhD, Univer-sity of Colorado

Anu Loukala, PhD, University of Helsinki

Global Health

Scott McIntosh, PhD, Uni-versity of Rochester Medical Center

Carla Berg, PhD, Emory University

Health Disparities

Steven Fu, MD, MSCE, Univer-sity of Minnesota

Norval Hickman, PhD, MPH, University of California

Public Health Policy

Andrea Villanti, PhD, MPH, CHES, Truth Initiative

Sara Hitchman, PhD, King’s College London

Trainee

Erika Bloom, PhD, Brown University

Meg Fluharty, PhD, University of Bristol

Stephen Heishman, PhD, National Institutes of Health

Treatment

Lisa Fucito, PhD, Yale Uni-versity

Megan Piper, PhD, University of Wisconsin-Madison


8

ABSTRACT REVIEWERS

Adam Cole, MSc Adam Leventhal, PhD Alexandra Pankova, MD Alexey Mukhin, MD Allison Carroll, MS Allison Kurti, PHD Amanda Johnson, MHS Allison Glasser, MPH Amanda Mathew, PhD Amer Siddiq Amer Nordin, MBChC, MPM Amy Cohn, PhD Amy Endacott, BSc Amy Taylor, PhD Andre Der-Avakian, PhD André Szklo, PhD Andrew Anesetti-Rothermel, PhD Andrew Moriarty, MBcHB Andrew Waa, MPH, B. Soc, Sc Andy Skinner, PhD Angelo DiBello, PhD Anh Lê, PhD Anh Nguyen, PhD Anil Batra, MD, PhD Ann Post, PhD Anna Phillips, PhD Anne-Laurence La Faou, MD, PhD Annette Kaufman, PhD, MPH Arei Dijkstra, PhD Ashely Sanders-Jackson, PhD

Babalola Faseru, MD, MPH Ban Majeed, PhD Benjamin Toll, PhD Benoit Forget, PhD Bettina Hoepnner, PhD Billie Bonevski, PhD Brain Hitsman, PhD Brain King, PhD Brandon Henderson, PhD Brantley Jarvis, PhD Bryan Heckman, PhD

Camille Morgan, MS Carlijn van der Aalst, PhD Cassandra Gipson-Reichardt, PhD Charl Els, MD, PhD Charlotte Smith, PhD Chris Bullen, MBChC, PhD Christine Czoli, PhD Candidate Christopher Russell, PhD Cristina Martínez, PhD

Daisy Thompson-Lake, MSc Daniel Giovenco, PhD Daniel Thomas, MD Darren Mays, PhD, MPH Dave Hammond, PhD David J. Drobes, PhD David Nelson, MD David Portnoy, PhD, MPH David Thomas, PhD, FAFPHM

Deborah Robson, PhD Deborah Scharf, PhD Debra Bernat, PhD Dennis Thomas, M. Pharm Dennis Trinidad, PhD Donna Shelley, MD, MPH Doug Levy, PhD

Ed Stephens, PhD Elena Ratschen, PhD Eleni Vangeli, Dpsych, MSc Elias Klemperer, PhD Elisardo Becona, PhD Elizabeth Klein, PhD, MPH Elyse Park, PhD Emily Brennan, BSc Emily Herbert, PhD Emily Peterson, PhD Emma Beard, PhD Erika Bloom, PhD Erin L. Sutfin, PhD Erin Mead, PhD Eva Králíková, MD, PhD

F. Javier Ayesta, MD, PhD Farahnaz Islam, MSPH Felix Naughton, PhD Francine Schneider, PhD Frank Bandiera, PhD

Gary Giovino, PhD Gaurave Kumar, PhD Gemma Taylor, PhD Genevieve Sansone, PhD Gera Nagelhout, PhD Gérard Peiffer, MD Gideon St. Helen, PhD Glenda Lassi, PhD Goedele Louwagie, MBBS, MPH, PhD Greg Hartwell, MSc

Hadii M. Mamudu, PhD, MPA Hakan Kayir, MD, PhD Hayden McRobbie, PhD Heath Smith, PhD Heather D’Angelo, PhD, MHS Hedieh Mehrtash, MS

Imad Damaj, PhD Irina Stepanova, PhD Isabelle Boileau, MD, PhD

Jacques Le Houezec, PhD Jamie Hartmann-Boyce, PhD Janet Hoek, MA, PhD Jen Dahne, PhD Jennifer Cantrell, DrPH, MPA Jennifer Cornacchione, PhD Jennifer Pearson, PhD Jennifer Shearston, BS Jennifer Tiday, PhD Jenny Hatchard, PhD Jessica Cook, PhD Jessica Pepper, PhD Jin Kim, PhD

9


Jin Yoon, PhD João Mauricio Castaldelli Maia, MD Jodi Gilman, PhD Johannes Thrul, PhD John Hughes, MD Jonathan Bricker, PhD Jordan Braciszewski, PhD Jose Trigo, PhD Juan Miguel Re Pino, PhD Judith McCool, PhD Judith Prochaska, PhD Julie Blendy, PhD

Karen Kasza, PhD Karin Hummel, MSc Karine Gallopel-Marvan, PhD Karma McKelvey, PhD Katarzyna Cambell, PhD Katherine Clegg-Smith, PhD Kathleen Garrison, PhD Kathryn Ross, PhD Katie Smith, PhD Katy Ross, PhD Kelly Cosgrove, PhD Kelly Young-Wolf, PhD Ken Wassum, BA Kevin Welding, PHD Khalid Kheirallah, PhD Kim Goodyear, PHD Kim Lyngby Mikkleson, MD Kristi Gamarel, PhD Kristie Foley, PhD, MS Kristie Soar, PhD Kristina Patja, MD, PhD Kym Sterling, DrPH

Laura Gibson, PhD Laura Jones, PhD Lauren Dutra, ScD, MA Lauren Pacek, PhD Laurence Galanti, MD, PhD Lazaros Mbulo, PhD Lila Rutten, PhD, MPH Lin Li, PhD Lion Shahab, PhD Lisa Carter-Harris, PhD, RN Lisa Henrikson, PhD Louisa Holmes, PhD Lucía Pérez, MPsych Lucy Papova, PhD Luz Myriam Reynales, PhD Lynn Kozlowksi, PhD Lynne Dawkins, PhD

Maansi Bansal-Travers, PhD Marc Willemsen, PhD Marcel Pieterse, PhD Marewa Glover, PhD Margriet van Laar, PhD Maria Cooper, PhD Maria Duaso, PhD Maria Melchior, PhD Marian Shahid, MSc Mark LeSage, PhD Mary Brunette, MD Matthew Carpenter, PhD Matthew Farrelly, PhD

Matthew Ford, PhD Matthew Palmatier, PhD Matthew Powers, PhD Meg Fluharty, MSc Megan Moran, PhD Megan Passey, MD, PhD Megan Piper, PhD Melissa Blank, PhD Michael Dunbar, PhD Michael Farrell, PhD Michael Ussher, PhD Michael Weitzman, MD Michelle Manderski, PhD Michelle Scollo, PhD Mikael Ekblad, MD, PhD Mirte Kuipers,PhD Mitch Nides, PhD Mohammad Siahpush, PhD Mohammed Jawad, MBcHB, MPH Mollie Miller, PhD Morgane Bennett, MPH Muhammad Darawad, PhD Muhammad Irfan, MBBS, FCPS Muhammed Jami Husain, PhD

Nancy Fleischer, PhD, MPH Nancy Jao, MS Nancy Rigotti, MD Nasir Mushtaq, MBBS, PhD Nicola Lindson-Hawley, PhD Niveen Abu-Rmeileh, PhD

Olivia Maynard, PhD Ollie Ganz, MSPH Omar El Shahaway, PhD Omara Dogar, MD

Patricia Bunney, PhD Patricia Cioe, PhD Patricia Di Ciano, PhD Peter Hajek, PhD Peter Selby, PhD Philip Tönnessen, MD, PhD

Rachel Cassidy, PhD Rachel Denlinger-Apt, MPH Rachna Begh, PhD Raika Durusoy, MD Ralph Caraballo, PhD Randah Hamadeh, D.Phil Ray Niaura, PhD Raymond Boyle, PhD Rebecca Anderson, MSc Rebecca Ashare, PhD Renee Bittoun, PhD Renee O’Leary, PhD Reuven Dar, PhD Richard Brown, PhD Richard Edwards, MB, Bchir, MPH, MD Rick Bevins, PhD Rifat Haider, MBBS, MHE Rima Nakkash, DrPH Ritesh Mistry, PHD Robert Loddenkemper, MD, PhD


10

Roberta Ferrence, PhD Rumana Huque, PhD Ryan Courtney, PhD Ryan Kennedy, PhD Ryan Redner, PhD Ryan Vandrey, PhD

Sally Adams, PhD Samuel Tomczky, MSc Sara Hitchman, PhD Sarah Snuggs, MSc Sarrah Peerbux, MSc Sarwat Shah, MBBS, MPH Saul Shiffman, PhD Sean Barrett, PhD Serena Tonstad, MD, PhD Seth Noar, PhD Shahrdad Loftipour, PhD Shannon Gravely, PhD Shari Feirmand, PhD Sharon Allen, PhD, MD Sharon Cox, PhD Sharon Rabinovitz-Shenkar, PhD

Shelley Golden, PhD Shyanika Rose, PhD, MA Sophie Orton, PhD Stella Vlachou, PhD Stuart Feruson, PhD Sue Cooper, PhD Sven Schneider, MD, PhD

Tara Elton-Marshall, PhD Taru Kinnunen, PhD Tim Coleman, MD, PhD Timea Partos, PhD Tracey Barnett, PhD Tracy Smith, PhD

Ulrich John, PhD Ute Mons, PhD

Vanessa Ochoa, PhD Vaughan Rees, PhD Vinu Ilakkuvan, MPH

Zaheera Chatra, BSc Zuzana Justinova, MD, PhD

11


PAST PRESIDENTS AND PROGRAM CHAIR(S)

1995 President: Ovide Pomerleau, PhD Program Chair(s): Kenneth Perkins, PhD, Chair

1996 President: John Hughes, PhDProgram Chair(s): Steve Heishman, PhD, Chair

1997President: Neal Benowitz, MDProgram Chair(s): Steve Heishman, PhD, Chair

1998President: Maxine Stitzer, PhDProgram Chair(s): Scott J. Leischow, PhD, Chair

1999President: Jack Henningfield, PhDProgram Chair(s): Joy Schmitz, PhD, Chair

1999-2000President: Dorothy Hatsukami, PhDProgram Chair(s): David Wetter, PhD, Chair

2000-2001 President: William Corrigall, PhDProgram Chair(s): David Wetter, PhD, Chair

Thomas Eissenberg, PhD, Co-Chair

2001-2002 President: Kenneth Perkins, PhDProgram Chair(s): Thomas Eissenberg, PhD, Chair

2002-2003 President: Harry Lando, PhDProgram Chair(s): Thomas Eissenberg, PhD, Chair

Laura Cousino Klein, PhD, Co-Chair

2003-2004 President: Nancy Rigotti, MDProgram Chair(s): Laura Cousino Klein, PhD, Chair

David Drobes, PhD, Co-Chair

2004-2005 President: Ken Warner, PhDProgram Chair(s): David Drobes, PhD, Chair

Suzanne Colby, PhD, Co-Chair Robert West, PhD, Co-Chair

2005-2006 President: David Balfour, PhDProgram Chair(s): Suzanne Colby, PhD, Chair

Eric C. Donny, PhD, Co-Chair Jennifer Tidey, PhD, Co-Chair

2006-2007 President: Ellen R. Gritz, PhDProgram Chair(s): Eric C. Donny, PhD, Chair

Janet E. Audrain-McGovern, PhD, Co-Chair Cynthia A. Conklin, PhD, Co-Chair


12

2007-2008 President: Ray Niaura, PhDProgram Chair(s): Janet Audrain-McGovern, PhD, Chair

Bernard Le Foll, MD, PhD, Co-Chair Robert Scholl, PhD, Co-Chair

2008-2009 President: Scott J. Leischow, PhDProgram Chair(s): Bernard Le Foll, MD, PhD, Chair

Marcus Munafò, PhD, MSc, Chair Ann McNeill, BSc, PhD, Co-Chair Robert A. Schnoll, PhD, Co-Chair

2009-2010 President: Sue Curry, PhDProgram Chair(s): Robert A. Schnoll, PhD, Chair

Darlene Brunzell, PhD, Co-Chair Lisa Dierker, PhD, Co-Chair

2010-2011President: Caryn Lerman, PhDProgram Chair(s): Thomas Gould, PhD, Chair

Lisa Dierker, PhD, Co-Chair Megan Piper, PhD, Co-Chair

2011-2012 President: Robert West, PhDProgram Chair(s): Megan Piper, PhD, Chair

Joanna Cohen, PhD, Co-Chair Kelly Cosgrove, PhD, Co-Chair

2012-2013President: Gary Swan, PhDProgram Chair(s): Joanna Cohen, PhD, Chair

Cristiano Chiamulera, PharmD, Co-ChairSean P. David, MD, SM, DPhil, Co-Chair

2013-2014President: Anne Joseph, MD, MPHProgram Chair(s): Sean P. David, MD, SM, DPhil, Chair

Angela Attwood, PhD, Co-Chair Judith Prochaska, PhD, MPH, Co-Chair

2014-2015President: Thomas Gould, PhDProgram Chair(s): Judith Prochaska, PhD, MPH, Chair

Maciej L. Goniewicz, PhD, PharmD Natalie Walker, PhD

2015-2016President: Robin Mermelstein, PhDProgram Chair(s): Natalie Walker, PhD, Chair

Maciej L. Goniewicz, PhD, PharmD Rachel Grana, PhD, MPH

2016-2017President: Deborah Ossip, PhDProgram Chair(s): Maciej L. Goniewicz, PhD, PharmD

Rachel Grana, PhD, MPHDaniel Kotz, PhD, Msc, MPH

13


SRNT SUPPORTORS

SRNT would like to thank Battelle, BioVirtus Research Site and Pfizer for their financial support of the 2017 Annual Meeting, and SRNT’s mission to stimulate the generation and dissemination of new knowledge concerning nicotine in all its manifestations, from cellular to societal.

REGISTRATION

Conference registration will be open daily located in the PIAZZA ADUA Reception Area of the Firenze Fiera Congress & Exhibition Center during the Annual Meeting. Hours for the SRNT registra-tion desk during the conference are as follows:

Tuesday, March 7 . . . . . . . . . . . . . . . . . . . . . . .3:00 p.m.-5:00 p.m.

Wednesday, March 8 . . . . . . . . . . . . . . . . . . . .7:30 a.m.-5:00 p.m.

Thursday, March 9 . . . . . . . . . . . . . . . . . . . . . .8:00 a.m.-5:00 p.m.

Friday, March 10. . . . . . . . . . . . . . . . . . . . . . . .8:00 a.m.-5:00 p.m.

Saturday, March 11. . . . . . . . . . . . . . . . . . . . . 8:00 a.m.-11:00 a.m.

*SRNT‘s registration area is located at the street address: 1 Piazza Adua. The PIAZZA ADUA reception area is an entrance area located next to the Palazzo Degli Affari (PDA) Building dedi-cated for registration and also used as the Main Entrance to the Firenze Fiera Congress & Exhibition Center. Using this entrance gives SRNT attendees private and easy access to the two build-ings that will house the SRNT session meetings located near the reception desk, known as the Palazzo Degli Affari (PDA) and the Palazzo dei Congressi (PDC) buildings.

INTERNET ACCESS

Complimentary Internet access will be available in the Congress Center meeting space available to all SRNT attendees. We kindly request ONE device per person. Instructions will be given on site.

EDUCATIONAL OBJECTIVES

● Address nicotine and tobacco’s role in the changing health care environment

● Describe new research and clinical data on the effects of nicotine and tobacco

● Discuss recent advances in nicotine and tobacco research

● Highlight international research on tobacco control

● Through scientific exchange, integrate current research with implications for clinical practice

● Address clinical and public health implications of concurrent use of tobacco with other psychoactive substances and drugs.

TARGET AUDIENCE

The 23rd Annual Meeting of SRNT is geared toward individuals involved in the research of nicotine and tobacco. This includes basic, clinical, policy, and public health scientists from academia, government, and industry.

Please note: Symposia that take place in advance of the meeting, after the meeting’s conclusion, or during evening hours are not


14

part of the SRNT Official Program unless specifically noted. The Program Committee has not reviewed the scientific content of Satellite Symposia. Satellite Symposia presenters are responsible for providing disclosures during their session.

CONTINUING EDUCATION CREDIT FOR PSYCHOLOGISTS

Continuing education credits have been approved for licensed psychologists. Postgraduate Institute for Medicine (PIM) is ap-proved by the American Psychological Association to sponsor continuing education for psychologists. PIM maintains responsibil-ity for this program and its content. Full attendance at the sessions and evaluation of each individual session attended is required to receive CE credit for psychologists. Partial credit will not be awarded. Late arrivals or early departures will preclude awarding of CE credits.

CONTINUING EDUCATION CREDIT FOR PHYSICIANS

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accredita-tion Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine and the Society for Research on Nicotine and Tobacco. Penn State Col-lege of Medicine is accredited by the ACCME to provide continu-ing medical education for physicians.

Physicians who have completed an MD, DO, or equivalent medi-cal degree from another country, or who have obtained a Fifth Pathway certificate, are eligible to receive AMA PRA Category 1 Credit(s)TM.

REQUIREMENTS TO RECEIVE CREDIT (AMA OR APA)

Evaluation of the sessions is integral to the education process. To receive AMA PRA Category 1 credit(s)TM credit, participants are required to:

A. Complete the attendance form, indicating only those ses-sions attended in their entirety;

B. Complete the overall evaluation form and corresponding individual evaluation pages; and

C. Return the forms to the CME registration table to receive CME Certificate.

LUNCHES

Boxed lunches will be served on Wednesday, Thursday, and Friday (see below). Bring your badge with you, as it will serve as your ticket for lunch.

Wednesday, March 8, 2017 All Pre-Conference Workshop attendees are entitled to a boxed lunch. The lunches will be available for distribution in the Firenze Congress Center in the building Palazzo dei Congressi (PDC), meeting space: Passi Perduti starting at 11:45 a.m.

Thursday, March 9, 2017 Boxed lunches will be distributed in the Firenze Congress Center in the building Palazzo dei Congressi (PDC), meeting space: Passi Perduti starting at 12:15 p.m. Plan to attend Poster Ses-sion 1 while eating your boxed lunch!

15


Friday, March 10, 2017Boxed lunches will be distributed in the Firenze Congress Center in the building Palazzo dei Congressi (PDC), meeting space: Passi Perduti starting at 11:45 a.m. Plan to attend Poster Ses-sion 3 while eating your boxed lunch!

POSTER SESSION SETUP SCHEDULE

Poster sessions have specific times designated for the authors to be present to discuss their posters with attendees in the building Palazzo dei Congressi (PDC), meeting space: Passi Perduti. Have your SRNT badge at all times to gain access to this area. An attendant will be checking badges at all times. (Refer to the SRNT area maps for location of this building.) Building hours are 8:00 a.m.-6:30 p.m. daily, however, no SRNT attendee will have access to this space before 10:00 a.m. or after 6:30 p.m. All posters must be removed immediately during the designated dismantle time for each session.

The schedule for poster presentation assembly, authors present, and dismantle is as follows:

Thursday, March 9, 2017 Poster Session 110:00 a.m.-11:00 a.m.. . . . . . . . . . . . . . . Presenters set up posters

12:30 p.m.-2:00 p.m. . . . . . . . . . . . . . . . . . . . . . Poster Session 1Presenters available at their poster

2:00 p.m.-2:30 p.m. . . . . . . . . . . . .Presenters remove their poster

Poster Session 22:30 p.m.-3:30 p.m. . . . . . . . . . . . . . . . . Presenters set up posters

5:00 p.m.-6:00 p.m. . . . . . . . . . . . . . . . . . . . . . . Poster Session 2Presenters available at their poster


Friday, March 10, 2017Poster Session 310:00 a.m.-11:00 a.m.. . . . . . . . . . . . . . . Presenters set up posters



Poster Session 42:30 p.m.-3:30 p.m. . . . . . . . . . . . . . . . . Presenters set up posters

5:00 p.m.- 6:00 p.m. . . . . . . . . . . . . . . . . . . . . . Poster Session 4Presenters available at their poster


Saturday, March 11, 2017 Poster Session 510:00 a.m.-11:00 a.m.. . . . . . . . . . . . . . . Presenters set up posters




16

EVALUATION

Thank you again for attending the meeting! We hope you enjoy the sessions and Florence, Italy. An overall program evaluation will be emailed to all Annual Meeting participants following the conference. Your feedback is greatly appreciated!

BADGES

Your badge will admit you to all of the educational sessions, wel-come reception, and the poster sessions at the Annual Meeting. Wear your badge at all times. Thank you.

SPEAKER READY ROOM

Important Information for All Oral Presentations:

The Speaker Ready Room is located in the meeting room Retropresidenza, in the PASSI PERDUTI area. The Speaker Ready Room is on the Lowest Level of the Palazzo dei Congressi (PDC) building, located behind the General Session Auditorium. Each speaker using computerized audio-visual equipment for their presentation at the 2017 Annual Meeting MUST report to the Speaker Ready Room to load their presentation (or verify online upload) on the laptop computer that will be used in their session room. Please review the following schedule and make note of these important times:

If Your Presentation Date/Time is…..

Then Your Time to Load Your Presentation is….

Thursday, March 9 between 8:00 a.m.-12:00 noon

Report to the Speaker Ready Room between 1:00 p.m.-6:30 p.m. on Wednesday, March 8

Thursday, March 9 between 1:00 p.m.-5:00 p.m.

Report to the Speaker Ready Room no later than 11:00 a.m. on Thursday, March 9

Friday, March 10 between 8:00 a.m.-12:00 noon

Report to the Speaker Ready Room no later than 3:00 p.m. on Thursday, March 9

Friday, March 10 between 1:00 p.m.-5:00 p.m.

Report to the Speaker Ready Room no later than 11:00 a.m. on Friday, March 10

Saturday, March 11 between 8:00 a.m.-12:30 p.m.

Report to the Speaker Ready Room no later than 3:00 p.m. on Friday, March 10

A technician from our audio-visual company will be available in the Speaker Ready Room to assist you. The Speaker Ready Room will be open at the following times:

Wednesday, March 8 . . . . . . . . . . . . . . . . . . . .1:00 p.m.-6:30 p.m.

Thursday, March 9 . . . . . . . . . . . . . . . . . . . . . .8:00 a.m.-5:00 p.m.

Friday, March 10. . . . . . . . . . . . . . . . . . . . . . . .8:00 a.m.-5:00 p.m.

Saturday, March 11. . . . . . . . . . . . . . . . . . . . . 8:00 a.m.-11:00 a.m.

MEMBERS MEETINGS

● The E-SRNT will be holding its Members Meeting on Friday, March 10, from 8:15 a.m.-8:45 a.m. in the building Palazzo dei

17


Congressi (PDC), meeting room: Sala Verde (located on the second floor). All E-SRNT members are encouraged to attend.

● The SRNT will be holding its Members Meeting on Saturday, March 11, from 8:15 a.m.-8:45 a.m. in the building Palazzo dei Congressi (PDC), meeting room: Sala Verde (located on the second floor). All SRNT members are encouraged to attend.

MEET-THE-EDITOR SESSIONS

SRNT is proud to announce Meet-the-Editor sessions. During the 2017 SRNT meeting we have created an opportunity for all partici-pants to join editors of the leading tobacco and nicotine journals for conversation. Meet-the-Editor is a chance to put members of the editorial boards in the “hot seat.” Editor of each journal will host a face-to-face session with the participants of the meeting. After a presentation by the editor, the session opens up to ques-tions from the floor, giving you the opportunity to get an insight into the review process and clear up any submissions queries you may have. The editor will be available to answer questions, hear ideas, and discuss any comments about the journals. All are welcome but graduate students and postdocs are particularly invited.

Editor Journal Time

Joanna Cohen, Deputy Editor

Tobacco Control Thursday, March 9, 2017; 12:45 p.m.-1:45 p.m.

Marcus Munafo, Editor-in-Chief

Nicotine and Tobacco Research

Thursday, March 9, 5:00 p.m.-6:00 p.m.

Robert West, Editor-in-Chief

Addiction Friday, March 10, 12:15 p.m.- 1:15 p.m.

Scott Leischow, Editor-in-Chief

Tobacco Regulatory Science

Friday, March 10, 5:00 p.m.-6:00 p.m.

Renee Bittoun, Editor-in-Chief

Journal of Smoking Cessation

Saturday, March 11, 10:30 a.m.-11:30 a.m.

Adam Leventhal, Associate Editor for Nicotine and Tobacco

Drug and Alcohol Dependence

Saturday, March 11, 12:30 p.m.- 1:30 p.m.

2016-2017 SRNT BOARD OF DIRECTORS

President Deborah Ossip, PhD, MS, BA

President-Elect Jodi Prochaska

Immediate Past-President Robin Mermelstein, PhD

Secretary/Treasurer Megan Piper, PhD


18

Journal Editor-in-Chief Marcus Munafo, PhD

Member Delegate At-Large 2016-2019 Jennifer McClure, PhD

Member Delegate, Europe 2015-2018 Tellervo Korhonen, PhD

Member Delegate, AAOLA 2014-2017 Naoruart Charoenca, PhD

Member Delegate, North America 2016-2019 Jasjit Ahluwalia, MD, MPH

FUTURE SRNT MEETINGS

SRNT 24th Annual Meeting February 21-24, 2018 Hilton Baltimore, Baltimore, Maryland

SRNT 25th Annual Meeting February 20-24, 2019 Hilton San Francisco, San Francisco, California

SRNT 26th Annual Meeting March 11-14, 2020 Hilton New Orleans Riverside, New Orleans, Louisiana

SRNT 27th Annual Meeting February 24-27, 2021 Hilton Baltimore, Baltimore, Maryland

CONFERENCE SAFETY RULES AND GUIDELINES

To ensure the safety and security of our attendees and guests, we have composed the following list of safety rules and guidelines for this conference.

1. When inside the conference venue, nametags should be worn and visibly displayed at all times. For security reasons, we recommend that you DO NOT wear your badge outside of the conference venue. If you lose your badge, please notify registration immediately.

2. If you witness a disruption or security issue, please contact any member of the SRNT staff or security. The Congress center reception desk number: 055 49721.

3. In the event of a medical or other emergency, the Italian medical emergency number dial 118. You may also notify any SRNT staff, &/or Congress Center security/staff person.

4. Please do not leave any bags or articles unsecured in any display area, meeting room, or public area of the Congress Center.

5. If you note any suspicious articles, packages, persons, or ac-tivity please contact the SRNT staff, or security immediately.

6. Do not give your lodging information to any person. You should not open your room door or grant access to any per-son claiming to be with the event or hotel staff without proper identification. If you have any doubt, do not open your room door and contact the front desk or security.

19


7. When leaving the hotel, you should take care to secure your identification, cash and credit cards. Valuables in your hotel room should be secured in the room safe or a lock box at the hotel.

8. When venturing outside of the conference facility, take rea-sonable care to protect yourself. Whenever possible, travel with another person. Remove any conference ID badges and make sure that someone knows where you are going and when you expect to return.

9. Take precautions to protect your personal information. Do not discard your conference materials, receipts, or other personal information without destroying it first. Any documents contain-ing account numbers, social security numbers, or other non-public personal information should not be discarded in public trash receptacles.

10. Attendees at this conference are expected to maintain a level of decorum appropriate to the nature and purpose of our meeting. While exchange and debate is welcome where appropriate, any person who is disruptive or abusive in language or manner will be removed and barred from further conference proceedings.

11. Individual photography is not permitted at the conference. SRNT reserves the right to inspect any and all packages or bags. (Photo Release: By attending the SRNT Annual Meet-ing all attendees should acknowledge that SRNT may take professional photos and those photos may be placed on the SRNT website without formal consent. Thank you.)

REMEMBRANCES OF PIONEERS FOR WHOM SRNT’S 2017 AWARDS ARE NAMED

SRNT’s annual awards presentation will be Thursday, March 9, at 9:00 a.m. in the building Palazzo dei Congressi (PDC), meeting room: Auditorium. Our awards are named after pioneers in the field of nicotine and tobacco research, and we are pleased to remember those pioneers.

THE JOHN SLADE AWARD

The John Slade Award honors individuals who have made out-standing contributions to public health and tobacco control through science-based public policy and public advocacy.

2017 Award Recipient:

Martin Raw, PhDDirector, International Centre for Tobacco CessationVisiting Scholar, New York University School of Medicine, USAHonorary Associate Professor, UK Centre for Tobacco and Alcohol Studies, School of Medicine, University of Nottingham, UK

JOHN SLADE

Dr. John Slade was an expert on the treatment of alcohol, tobac-co, and drug addiction, and one of America’s pioneer advocates for tobacco control.

He was a member of the team that conducted the first scholarly analysis of previously secret documents from the Brown and Williamson Tobacco Company, which formed the basis for the film “The Insider.” John›s analysis led to a landmark series of articles in the Journal of the American Medical Association in 1995, as well as a book, “The Cigarette Papers.” His groundbreaking


20

research to prove that cigarettes are nicotine delivery devices helped make it possible for the Food and Drug Administration to claim regulatory authority over tobacco products under then-FDA Commissioner Dr. David Kessler.

John was appointed Professor of Medicine, Robert Wood Johnson Medical School of the UMDNJ, in 1998. He emerged as a leader in substance abuse prevention and tobacco control for the state of New Jersey through his teaching and clinical work as well as through his active involvement with the Medical Society of New Jersey and the New Jersey Public Health Association. John played a major role in helping New Jersey develop its tobacco prevention and treatment program, funded as part of the 1998 $206 billion settlement with tobacco companies.

He co-edited the first major clinical textbook on nicotine addic-tion and founded the Committee on Nicotine Dependence of the American Society of Addiction Medicine (ASAM).

THE JARVIK-RUSSELL NEW INVESTIGATOR AWARD

The Jarvik-Russell Young Investigator Award, named after Murray Jarvik and Michael Russell, recognizes scientists early in their careers who have made extraordinary contributions to the field of nicotine and tobacco research.


Thomas R. Kirchner, PhD Clinical Associate Professor of Public Health, Medicine, and Urban Science NYU College of Global Public Health New York, USA

MURRAY E. JARVIK

Dr. Murray Jarvik was born in New York City in 1923. Following medical school, Murray worked at the Yerkes Laboratory in Flor-ida. It was here that he serendipitously witnessed a monkey that would smoke cigarettes. A Fellowship at Mount Sinai Hospital in New York followed, where Murray became one of the pre-eminent researchers studying a newly discovered substance: LSD.

LSD research pivoted Murray into the emerging field of psycho-pharmacology in the mid-1950’s and to a professorial position at the newly created Albert Einstein School of Medicine. It was here that Murray established himself as a premier researcher on effects of drugs on learning and behavior.

Murray’s interests in the mid-1960s turned toward tobacco smok-ing. Although Murray continued, initially, to study the effects of other drugs and memory, he eventually shifted his focus to smok-ing and nicotine addiction almost entirely.

One of the first projects he attempted, spurred by the very memo-rable observation at Yerkes, was to attempt to get monkeys to smoke. This was partially successful and led to experiments with humans and rats so that by 1970 Murray had collected sufficient data to suggest that nicotine was key in the reinforcement of smoking. His work was included in subsequent Surgeon General Reports on smoking and nicotine addiction.

Perhaps Murray Jarvik’s most notable achievement was work done with Jed Rose in the 1980’s investigating the possibility of delivering nicotine through the skin in sufficient quantities to

21


affect smoking behavior. At first, their approach was quite simple, a basic poultice of nicotine. After much development, they were able to patent the concept of a nicotine transdermal patch, which they turned over to UCLA. It soon made it into production as the second FDA-approved pharmacologic treatment for smoking ces-sation after nicotine gum. With both established efficacy and ease of use, it was highly successful, for several years among the top three most profitable patents for the University of California.

MICHAEL RUSSELL

By the 1960s, the emerging evidence of the danger of cigarette smoking was clear, but there was very little understanding of why people smoked. Cigarette smoking was generally thought of as a habit, with pharmacological factors receiving little or no attention.

Michael Russell was the man who did most to revolutionize our understanding. His research led to the 1988 report of the US Sur-geon General, Nicotine Addiction, which finally brought recognition that cigarette smoking is a classic drug dependence. Russell was a psychiatrist in training at the Maudsley hospital, in south Lon-don, when he chose the topic of cigarette smoking for his research thesis in 1967. Based on his review of what was then fragmentary research literature, he concluded in a 1971 paper that the drug nicotine was the motivating force underlying smoking behavior. He made the study of the interacting pharmacological and psychologi-cal determinants of tobacco dependence his life’s work.

Mike is regarded by many as the father of effective treatment to help smokers quit. But he is probably best known in the cessation field for a non-pharmacological intervention. In 1979 he published a trial examining the effectiveness of brief advice to quit smoking given by GPs in the course of routine consultations. The one-year success rate was 5%, compared with less than 1% in controls. A successful trial of nicotine chewing gum combined with brief ad-vice in primary care followed. Mike Russell moved toward the con-cept of an integrated district smoking cessation service, in which routine delivery of advice and pharmacological therapy in primary care was combined with intensive clinic support. That vision has now been realized in Great Britain’s National Health Service.

THE DOLL-WYNDER AWARD

The Doll-Wynder Award honors scientists who have made ground-breaking advances in public health, public policy or epidemiologi-cal research.


Kenneth E. Warner Avedis Donabedian Distinguished University Professor of Public Health at the University of Michigan, USA.

RICHARD DOLL

Sir William Richard Shaboe Doll was a British physiologist who became the foremost epidemiologist of the 20th century, turning the subject into a rigorous science. He was a pioneer in research linking smoking to health problems. With Ernst Wynder, Bradford Hill and Evarts Graham, he was credited with being the first to prove that smoking caused lung cancer and increased the risk of heart disease.

In 1948 he joined a research team under Dr. Francis Avery-Jones at the Central Middlesex Hospital, run under the auspices of the


22

statistical research unit of the Medical Research Council. Over a 21-year career in the unit, Doll rose to become its director. In 1950, he undertook with Austin Bradford Hill a study of lung cancer patients in 20 London hospitals, at first under the belief that it was due to the new material tarmac, or motor car fumes, but rapidly discovering that tobacco smoking was the only factor they had in common. Doll himself stopped smoking as a result of his findings, published in the British Medical Journal in 1950, which concluded; “The risk of developing the disease increases in proportion to the amount smoked. It may be 50 times as great among those who smoke 25 or more cigarettes a day as among non-smokers.”

Four years later, in 1954 the British doctors study, a study of some 40,000 doctors over 20 years, confirmed the suggestion, based on which the government issued advice that smoking and lung cancer rates were related.

In 1966 Doll was elected to the Royal Society. The citation stated: Doll is distinguished for his researches in epidemiology, and par-ticularly the epidemiology of cancer where in the last 10 years he has played a prominent part in (a) elucidating the causes of lung cancer in industry (asbestos, nickel & coal tar workers) and more generally, in relation to cigarette smoking, and (b) in the investiga-tion of leukaemia particularly in relation to radiation, where using the mortality of patients treated with radiotherapy he has reached a quantitative estimate of the leukaemogenic effects of such radia-tion. In clinical medicine he has made carefully controlled trials of treatments for gastric ulcer. He has been awarded the United Nations prize for outstanding research into the causes and control of cancer and the Bisset Hawkins medal of the Royal College of Physicians for his contributions to preventative medicine.

Doll was made a Fellow of the Royal Society in 1966, Knighted in 1971, and awarded the Edward Jenner Medal of the Royal Society of Medicine in 1981. In 1996 he was made a Companion of Honour for “services of national importance”. International honours included the Presidential Award of the New York Academy of Sci-ences as well as a UN Award for his research into cancer. In April 2005, he was awarded the Saudi Arabian King Faisal International Prize for medicine jointly with Richard Peto for their work on dis-eases related to smoking. In 2004, he was awarded the inaugural Shaw Prize for Life Sciences and Medicine for his contribution to modern cancer epidemiology. He was also awarded honorary degrees by thirteen different universities.

ERNST WYNDER

Ernst Ludwig Wynder was an American epidemiology and public health researcher who studied the risk factors of smoking tobacco. His 1950 coauthored publication of “Tobacco Smoking as a Pos-sible Etiologic Factor in Bronchiogenic Carcinoma: A Study of 684 Proved Cases” appeared in the Journal of the American Medical Association. It was one of the first major scientific publications identifying smoking as a contributory cause of lung cancer.

Wynder began collaborating with his coauthor on the article, Evarts Ambrose Graham, as a medical student at Washington University in St. Louis in 1947. The previous summer he had conducted epidemiological studies of smoking behavior among 146 lung cancer patients in New York City. The project was funded by the American Cancer Society. Now, with Graham, Wynder col-lected extensive data on 604 patients with lung cancer at hospitals across the United States. Departing from a tradition of using an-ecdotal evidence (e.g., clinical interviews) to develop explanations

23


of disease causation, Wynder and Graham applied rudimentary statistical methods to their study. They divided patients into crude categories of “moderate” or “heavy” smokers, based on retrospec-tive interviews of each patient’s smoking behavior over a twenty-year period. They also measured and controlled for important confounding factors (e.g., age, types of tobacco use, inhalation level). Most importantly, with regard to an ability to demonstrate causation, Wynder and Graham also studied a control group of cancer-free individuals in hospitals. They used this control group to systematically compare their lung cancer patients.

On May 27, 1950 the Journal of the American Medical Associa-tion published the resulting scientific report. Wynder and Graham found that lung cancer could develop among nonsmokers, such that smoking is not the single factor in the induction of disease. But they identified smoking’s role as a significant risk factor for lung cancer, providing four reasons to support this argument: 1) lung cancer prevalence was found to be rare in nonsmokers; 2) among patients with lung cancer, cigarette use tended to be high; 3) lung cancer prevalence among men and women matched patterns of smoking behavior in men and women; and, lastly, 4) “the enormous increase in the sale of cigarettes in this country approximately parallels the increase in [lung cancer].” As further scientific evidence of smoking’s role in causing lung cancer began to mount in the United States and Great Britain, Wynder and Graham investigated the biological plausibility of the association between smoking and lung disease. In 1950, they initiated a study of the impact of tars from tobacco smoke on mice. After a year of exposure to tar, 44 percent of the mice developed cancers. Wynder also discovered specific carcinogens in tar (e.g., benzo-pyrenes, arsenic), but was unable to identify the contributions of these chemicals to cancer.

2017 SRNT TRAVEL AWARD WINNERS

• Monika Arora, Bangladesh

• Oana Blaga, Romania

• Sandra Braun, Argentina

• Deepa Camenga, USA

• Richard Holliday, United Kingdom

• Munir Gunes Kutlu, USA

• Ming Li, China

• Nigar Nargis, India

• Eeva-Liisa Tuovinen, Finland

• Emily Stockings, Australia

• Erikas Simonavicius, United Kingdom

• Raydel Valdes Salgado, USA


24

2017 SRNT SPONSORS & EXHIBITORS

Plan time in your schedule to visit with the SRNT sponsors and exhibitors. They will be located in the building Palazzo dei Congressi (PDC), Salone Club (lower level). Located in the pre-function space of the Auditorium. Thanks to all the companies exhibiting this year.SRNT appreciates their financial support!

Exhibit Hours:

Wednesday, March 8, 2017 . . . . . . . . . . . . . . 5:00 p.m.-7:00 p.m.

Thursday, March 9, 2017 . . . . . . . . . . . . . . . . 9:00 a.m.-3:30 p.m.

Friday, March 10, 2017. . . . . . . . . . . . . . . . . . 9:30 a.m.-3:30 p.m.

25


MEETING ROOM FLOOR PLANS

SRNT 2017 Area Maps

VIALE FILIPPO STROZZI

AUDITORIUM

VILLAVITTORIA

VIA

FAEN

ZA

VIA

VALFO

ND

A

VIA CENNINI

PALAZZODEGLIAFFARI(PDA)

PALAZZODEICONGRESSI(PDC)

STAZIONE DISANTA MARIA NOVELLA(TRAIN STATION)

LIMONAIA

1

2

3

PDC ENTRANCE

PDA ENTRANCES

* See the following pages for detailed information on the numbered buildings in this diagram.

PIAZZA ADUA(SRNT REGISTRATION)

Main Entrance

4

Overview: Firenze Fiera Congress & Exhibition CenterFlorence, Italy


26

MEETING ROOM FLOOR PLANSSRNT 2017 Area Maps

VILLAVITTORIA

AUDITORIUM

1. VILLA VITTORIA - PIANO TERRA - GROUND FLOOR SRNT will be using SALA 4, SALA 5, SALA 6, SALA 9, and SALA Onice on this floor. (SALA translates to “Room” in English.)

2. VILLA VITTORIA - PIANO PRIMO - FIRST FLOOR SRNT will be using SALA 101, SALA 104, SALA 105, and SALA 106 on this floor.

3. VILLA VITTORIA - PIANO SECONDO - SECOND FLOOR SRNT will be using SALA Verde on this floor.

4. VILLA VITTORIA - BELVEDERE SRNT will not be using this floor.

5. ANFITEATRO - AMPHITHEATRE (Located Outside) SRNT will not be using this space.

6. AUDITORIUM - LOWER LEVEL SRNT will be using the Auditorium on this floor, as the General Session. (Use the main entrance to the Villa Vittoria to access the Auditorium via stairs or elevator.)

7. SALONE CLUB - LOWER LEVEL SRNT’s Exhibit Area will be held in this space.

8. PASSI PERDUTI - BASEMENT - LOWEST LEVEL SRNT will be using the Passi Perduti. Boxed Lunch pick-up area. Poster Sessions will be located in this space and on the Balcony. Refreshment Break area.

9. RETROPRESIDENZA - LOWEST LEVEL SRNT’s Speaker Ready Room is located on this level. * Refer to the SRNT Program-at-a-Glance for when SRNT meeting space is in use in this building.

SRNT Floor Usage*

Building One:Palazzo Dei Congressi (PDC)

Building Two:Limonaia (Lemon House)

LIMONAIA

Located inside the centuries-old park of Villa Vittoria, between Palazzo dei Congressi and Palazzo degli Affari, the Limonaia (Lemon House) represents the meeting point of the two venues, in the garden-area between the two buildings. This building will not be used by SRNT.

1

2

3

45

68

1. VILLA VITTORIA - PIANO TERRA - GROUND FLOOR2. VILLA VITTORIA - PIANO PRIMO - FIRST FLOOR3. VILLA VITTORIA - PIANO SECONDO - SECOND FLOOR4. VILLA VITTORIA - BELVEDERE5. ANFITEATRO - AMPHITHEATRE6. AUDITORIUM - LOWER LEVEL7. SALONE CLUB - LOWER LEVEL8. PASSI PERDUTI - BASEMENT - LOWEST LEVEL9. RETROPRESIDENZA - LOWEST LEVEL

7

9

27


MEETING ROOM FLOOR PLANSSRNT 2017 Area Maps

1

2

3

4

5

6

1. PIANO INFERIORE - BASEMENT

2. PIANO TERRA - GROUND FLOOR

3. PRIMO PIANO - FIRST FLOOR

4. SECONDO PIANO - SECOND FLOOR

5. TERZO PIANO - THIRD FLOOR

6. QUARTO PIANO - FOURTH FLOOR

1. PIANO INFERIORE - BASEMENT SRNT will be using the Basement Level.

2. PIANO TERRA - GROUND FLOOR SRNT will be using the Ground Floor.

3. PRIMO PIANO - FIRST FLOOR SRNT will be using the First Floor, also known as Sala Centrale (Main Hall). SRNT will also be using SALA ADUA 1

4. SECONDO PIANO - SECOND FLOOR SRNT will be using the Second Floor, also known as Sala Centrale (Main Hall). SRNT will also be using SALA ADUA 2.

5. TERZO PIANO - THIRD FLOOR SRNT will not be using this floor.

6. QUARTO PIANO - FOURTH FLOOR SRNT will be using this floor. * Refer to the SRNT Program-at-a-Glance for when SRNT meeting space is in use in this building.

Building Four:Palazzo Degli Affari (PDA)

SRNT Floor Usage*

PALAZZODEGLIAFFARI

PIAZZA ADUA(REGISTRATION)

Main Entrance

Building Three:Piazza Adua (Reception Area)

Located next to the PDA building, , but not directly connected, is a reception area dedicated as the SRNT Registration Area. It is located at 1 Piazza Adua, and is the Main Entrance to the Congress Center to easily access the PDA, and PDC buildings.

Be sure to have your SRNT badge at all times, in order to gain access to all sessions and events. An attendant will be checking badges at all times.

4


28


29

Wed

nesd

ay, M

arch

8, 2

017

SESSION SUMMARY WEDNESDAY

MARCH 8, 2017

30



31

Wed

nesd

ay, M

arch

8, 2

017

WEDNESDAY, MARCH 8, 2017

8:00 a.m.-5:00 p.m.Piazza Adua Reception Area(The Reception area is the main entrance area to the Firenze Fiera Congress & Exhibition Center located next to the Palazzo Degli Affari (PDA) Building.) Registration

8:30 a.m.-12:00 noonPre-Conference Workshops(Available at an additional fee)

9:00 a.m.-12:00 noonSala Auda 1 – Primo Piano (1st Floor)PDA Building (Palazzo Degli Affari Building)Pre-Conference Workshop #1Novel Approaches to Implementing Tobacco Treatment Within Health SystemsSpeaker(s): Peter Selby, MBSS, CCFP MHSc FASAM, Centre for Addiction and Mental Health, Canada; Ben Toll, PhD, Medical University of South Carolina, US; Nancy Rigotti, MD, Massachusetts General Hospital/Harvard Medical School, US; Kamran Siddiqi, PhD, University of York, UK; Amanda Baker, PhD, University of Newcastle, Australia; Harry Lando, PhD, University of Minnesota School of Public Health, US; Robert West, PhD, University College London, UKModerator(s): Lisa Fucito, PhD, Yale University, US; Megan Piper, PhD, University of Wisconsin, Madison, USSponsored by the SRNT Treatment Network

9:00 a.m.-12:00 noonSala Affari: Room 2 – Primo Piano (1st Floor)PDA BuildingPre-Conference Workshop #2Is Nicotine Reduction Really a Viable Policy Option for Tobacco Control?Speaker(s): Karl Fagerstrom, MD, PhD, Fagerström Consulting, Sweden; Tracy Smith, PhD, University of Pittsburgh, US; Eric Donny, PhD, University of Pittsburgh, US; Ann McNeill, BSc, PGCE, PhD, King’s College London, UK; Neal Benowitz, MD, Center for Tobacco Control, US; Dorothy Hatsukami, PhD, University of Minnesota, US; Natalie Walker, PhD, University of Auckland, New ZealandModerator(s): Scott Leischow, PhD, Mayo Clinic, US; Natalie Walker, PhD, University of Auckland, New Zealand

9:00 a.m.-12:00 noonSala Affari: Room 1 – Secondo Piano (2nd Floor)PDA BuildingPre-Conference Workshop #3Developing Evidence-Based Control Policies Targeting Waterpipe Tobacco Smoking: Time for Action.Speaker(s): Kenneth D. Ward, PhD, University of Memphis School of Public Health, U.S.; Rima Afifi, PhD, MPH, Faculty of Health Sciences, American University of Beirut, Lebanon; Alan Shihadeh, DrPH, Faculty of Engineering and Architecture, American University of Beirut, Lebanon; Scott Sherman, MD, MPH, New York University School of Medicine, US; Ramzi Salloum, PhD, Department of Health Outcomes and Policy, Uni-versity of Florida, US; Taghrid Asfar, MD, MSPH, Scientist, Uni-versity of Miami Miller School of Medicine, US; Wasim Maziak, MD, PhD, Department of Epidemiology, Florida International University, US, Syrian Center for Tobacco Studies, Syria.Moderator(s): Rima Afifi, PhD, American University of Beirut, Lebanon; Fouad Fouad, MD, American University of Beirut, LebanonSponsored by NIDA, TBC

Program · Wednesday, March 8, 2017

32

9:00 a.m.-12:00 noonSala Affari: Piano Terra (Ground Floor)PDA BuildingPre-Conference Workshop #4Working Globally to Support Rapid Learning for E-Cigarette Policy, Surveillance and Policy Research

Speaker(s): Linda Bauld, PhD, University of Stirling and Cancer Research UK; Alison Cox, BA, Cancer Research UK; Susan J. Curry, PhD, University of Iowa College of Public Health, US; Allison Glasser, MPH, Schroeder Institute for Tobacco Research and Policy Studies at Truth Initiative, US; Thomas J. Glynn, PhD, Stanford Prevention Research Center, US; Cheryl Healton, DrPH, College of Global Public Health at New York University, US; Ryan Kennedy, PhD, Johns Hopkins Bloomberg School of Public Health, US; Matt Myers, JD, Campaign for Tobacco-Free Kids, US; Raymond Niaura, PhD, Schroeder Institute for Tobacco Research and Policy Stud-ies at Truth Initiative, US; Tracy Orleans PhD, Robert Wood Johnson Foundation, US; Jennifer Pearson, PhD, Schroeder Institute for Tobacco Research and Policy Studies at Truth Initiative, US; Andrea Villanti, PhD, Schroeder Institute for To-bacco Research and Policy Studies at the Truth Initiative, USModerator(s): Joanna Cohen, PhD; Institute for Global Tobacco Control, Johns Hopkins Bloomberg School of Public Health, USSponsored by Johns Hopkins Bloomberg School of Public Health, Truth Initiative, Robert Wood Johnson Foundation, Cancer Research UK

9:00 a.m.-12:00 noonSala Affari: Room 2 – Secondo Piano (2nd Floor)PDA BuildingPre-Conference Workshop #5Introduction to the Multiphase Optimization Strategy (MOST) for Building More Effective, Efficient, Economical, And Scalable Behavioral and Biobehavioral InterventionsSpeakers: Linda M. Collins, The Methodology Center and Department of Human Development & Family Studies, Penn StateModerator(s): Linda M. Collins, The Methodology Center and Department of Human Development & Family Studies, Penn State

8:30 a.m.-12:00 noonVilla Vittoria: Sala Verde (2nd Floor)PDC BuildingPre-Conference Workshop #6FDA’s Population Health Standard: Balancing the Risks and Benefits in Regulatory Decision-makingSpeaker(s): Mitchell Zeller, JD, Center for Tobacco Products; David L. Ashley, PhD, Center for Tobacco Products; Ii-Lun Chen, MD, Center for Tobacco Products; Cathy L. Backinger, PhD, MPH, Center for Tobacco Products; Jamie Hartmann-Boyce, MA, University of Oxford; Eric K. Soule, PhD, MPH, Virginia Commonwealth University; Bridget Ambrose, PhD, MPH, Center for Tobacco ProductsPanelist(s): Geoffrey T. Fong, PhD, University of Waterloo, Canada; Dorothy K. Hatsukami, PhD, University of Minnesota, U.S.; Andrew Hyland, PhD, Roswell Park Cancer Institute, US, Peter Hajek, PhD, Queen Mary University of London, UKModerator(s): Mitchell Zeller, JD and Cathy L. Backinger, PhD, MPH, Center for Tobacco Products, U.S. Food and Drug Administration, USSponsored by the Center for Tobacco Products, FDA


33

Wed

nesd

ay, M

arch

8, 2

017

9:00 a.m.-12:00 noonSala Affari: Room 1 – Primo Piano (1st Floor)PDA BuildingPre-Conference Workshop #7Tobacco and Marijunana Co-use in Adolescents and Young AdultsSpeaker(s): Amy M. Cohn, PhD, Schroeder Institute for To-bacco Research and Policy Studies, Washington, DC, USA; Grace Kong, PhD, Yale University, New Haven, CT, USA; Erin A. McClure, PhD, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA; Erica N. Peters, PhD, Battelle Public Health Center for Tobacco Research, Baltimore, MD, USA; Sherry Emery, PhD, NORC at the University of Chicago, Chicago, IL USA Discussant: Robin Mermelstein, PhD, Institute for Health Research and Policy and Psychology Department, University of Illinois at ChicagoModerator(s): Suzanne Colby, PhD, Brown University Center for Alcohol & Addiction Studies, and Alexandra Loukas, PhD, Department of Kinesiology & Health Education, University of Texas at AustinSponsored by the SRNT Adolescent Network

8:30 a.m.-12:00 noonSala Affari: Auda 2 – Secondo Piano (2nd Floor)PDA BuildingPre-Conference Workshop #8Reducing The Impacts of Commercial Tobacco on Indigenous Peoples: Best Practices For Engaging with Indigenous Peoples in ResearchSpeaker(s): Rob Schwartz, PhD, Canada; Ray Lovett, PHD, Australia National University, Australia; Patricia Nez Hender-son, MD, MPH, USA; David Thomas, PhD, Australia; Raglan Maddox, PhD, Australia; El-Shadan Tautolo, PhD, New Zealand; Heather Gifford, PhD, New Zealand; Andrew Waa, MPH, New ZealandModerator(s): Andrew Waa, MPH, New Zealand

9:00 a.m.-12:00 noonSala Affari: Quarto Piano – Top Floor (4th Floor)PDA BuildingPre-Conference Workshop #9What Does Our Tobacco Work Mean to Us? Translating Knowledge Through Art in FlorenceSpeaker(s): Gillian S Gould, PhD, MA (Arts Therapy), MBChB, Grad Dip Experiential and Creative Arts Therapy, Dip Drama. National Health and Medical Research Council and Cancer Institute New South Wales Research Fellow, University of Newcastle, AustraliaModerator(s): Gillian S Gould, PhD, MA (Arts Therapy), MB-ChB, Grad Dip Experiential and Creative Arts Therapy, Dip Drama; National Health and Medical Research Council and Cancer Institute New South Wales Research Fellow, Univer-sity of Newcastle, Australia; Cheryl Gould, BA (Hons) Fine Art Sculpture, Member of Royal Society of British Sculptures, Life Drawing Tutor, Harrow Arts Centre, Middlesex, London, UKSponsored by Faculty of Health and Medicine, University of Newcastle, Australia


34

8:30 a.m.-12:00 noonVilla Vittoria: Sala Onice (Ground Floor)PDC BuildingSRNT-E Satellite Symposium: Comparing Regulations on Tobacco and Nicotine Products Speaker(s): Anna-Eva Ampelas, LL.M., DG SANTE, European Commission, Brussels, Belgium; Deborah Arnott, MBA FRCP (Hon), Action on Smoking and Health, UK; Natalie Walker, PhD, National Institute for Health Innovation, University of Auckland, New Zealand; Quan Gan, PhD, The International Union Against Tuberculosis and Lung Disease (Tobacco Control Depart-ment), China; Ron Borland, PhD, Cancer Council Victoria, Melbourne, AustraliaDiscussant(s): Jaakko Kaprio, MD, PhD, University of Helsinki, Helsinki, Finland; Maciej Goniewicz, PhD, PharmD, Roswell Park Cancer Institute, USAModerator(s): Michael Cummings, PhD, Medical University of South Carolina, Charleston, SC, USA; Tellervo Korhonen, PhD, University of Helsinki, Helsinki, Finland Sponsored by SRNT-Europe

1:00 p.m.-6:30 p.m.Retropresidenza (Passi Perduti - Lowest Level)PDC BuildingSpeaker Ready Room

1:00 p.m.-3:15 p.mNetwork MeetingsPlan to join your colleagues and attend the Network meeting of interest. All meetings will be located in the PDC Building.

1:00 p.m.-2:00 p.mAdolescent Network Meeting: Villa Vittoria: Sala 101 - Primo Piano (1st Floor) Genetics Network Meeting: Villa Vittoria: Sala Onice - Terra Piano (Ground Floor)Global Health Network Meeting: Villa Vittoria: Sala 9 - Terra Piano (Ground Floor)Health Disparities Network Meeting: Villa Vittoria: Sala Verde – Secondo Piano (2nd Floor)

2:15 p.m.-3:15 p.m.Basic Science Network Meeting: Villa Vittoria: Sala Onice - Terra Piano (Ground Floor)Public Health Policy Network Meeting: Villa Vittoria: Sala 4 - Terra Piano (Ground Floor)Treatment Network Meeting: Villa Vittoria: Sala Verde - Secondo Piano (2nd Floor)

3:30 p.m.-4:45 p.mTransdisciplinary Topical Discussions #1-#7 are held concurrentlyThese roundtable sessions have been selected to address a diverse array of pressing questions in our field. They will be moderated by world leading experts who will stimulate and encourage group discussion. These sessions are designed to be transdisciplinary–covering preclinical and clinical research and diverse methodologies. You do not need to be an expert in the subject area to attend a session. In fact, we encourage that you cross boundaries and take the opportunity to participate in new topical discussions that will develop novel ideas and viewpoints.

TTD #1Sala Affari: Room 1 – Primo Piano (1st Floor)PDA Building E-Health Smoking Cessation Interventions: Do They Re-ally Work?Electronic health (e-health) interventions for smoking cessation have become increasingly popular during recent


35

Wed

nesd

ay, M

arch

8, 2

017

years due to technological advances and facilitation by the Internet. Such interventions can potentially reach large numbers of smokers at low cost, and their flexibility enables personalised tailored support. On the other hand, many e-health interventions are anonymous by nature and less obliging than face-to-face behavioural support, leading to lower adherence. As they can be developed and maintained at relatively low cost, there is an excess supply of interventions available, in particular regarding smartphone apps. Moreover, evidence of their effectiveness is often lacking and also difficult to obtain due to methodological challenges. Moderator(s): Saul Shiffman, PhD, University of Pittsburgh, USA

TTD #2Sala Auda 1 – Primo Piano (1st Floor)PDA Building NRT Bought Over the Counter: Are Gums and Patches Possibly Not Effective in the Real World? Evidence from over 150 randomised controlled trials clearly demonstrates the efficacy of nicotine replacement therapy (NRT) for smoking cessation. NRT in its various forms of delivery (gum, patch etc.) are the most frequently used pharmacotherapy for smoking cessation. In many countries, NRT is also available over the counter (i.e., without prescription and behavioural support from a health professional). Due to the efficacy of NRT, proven by clinical trials, and its popularity as and aid to cessation, NRT bought over the counter seems to be a powerful method to improve the population’s health. However, recent studies have raised concerns about the effectiveness of NRT bought over the counter in the real world, outside of clinical trials. Moderator(s): Ann McNeill, PhD, King’s College, London, United Kingdom

TTD #3Sala Affari: Auda 2 – Secondo Piano (2nd Floor)PDA Building Polysubstance Abuse: How to Treat Tobacco Alongside Other Addictions Tobacco addiction is strongly associated with other addictions, in particular alcohol use disorders. The health risks of single addictions are many and may be amplified by polysubstance abuse, highlighting the need for effective cessation treatments. Currently each addiction is usually treated independently, but it may be advantageous to treat multiple co-occurring addictions simultaneously. However, there are challenges to this approach, which include insufficient knowledge on how to develop new, effective, multi-target treatments with interacting treatment components and how to implement these in patient care. Moderator(s): Carla Berg, PhD, Emory University Woodruff Health Sciences Center, Atlanta, USA

TTD #4Sala Affari: Room 2–Primo Piano (1st Floor)PDA BuildingFinancial Incentives for Quitting Tobacco: An Effective and Ethical Approach?Quitting tobacco is vital to reduce health risks, but also very difficult due to the addictive nature of nicotine. There are evidence-based behavioural and pharmacological treatments for smoking cessation, but their success rates are limited. Recent studies have investigated whether providing financial incentives might increase smoking cessation rates, particularly in specific subgroups of the smoking population such as pregnant smokers and smokers with low socioeconomic status. There are concerns, however, about the long-term


36

effectiveness beyond the period of reward and the ethics of paying people to change their behaviour, as well as who should defray associated costs. Moderator(s): Stephen Higgins, PhD, University of Vermont, USA

TTD #5Sala Affari: Room 1 –Secondo Piano (2nd Floor)PDA BuildingMaking the Delivery of Tobacco Cessation Treatment Rou-tine in Health Care Systems: What Are the Challenges? Tobacco use remains a leading preventable cause of morbidity and mortality. During the past decades, various effective and cost-effective behavioural and pharmacological smoking cessation treatments have been developed and tested. Clinical guidelines recommend clinicians to offer evidence-based treatment to every smoking patient. Yet, far too few smoking patients receive competent smoking cessation advice and the offer of evidence-based treatment when consulting their health care provider. It seems that, despite the necessity to routinely deliver evidence-based treatment, implementation in our health care systems remains challenging. Moderator(s): Nancy Rigotti, PhD, Massachusetts General Hospital and Harvard Medical School, Boston, USA

TTD #6Sala Affari: Piano Terra (Ground Floor)PDA Building Vape Shops: Just Another Tobacco Product Retailer or a Smoking Cessation Service?Stores that sell electronic nicotine delivery systems (ENDS) as their primary product are an emerging phenomenon. Such “vape shops” provide consumers a place to purchase and discuss e-cigarettes and offer an environment that serves as a place of recreation with customers lounging once inside. Their growing presence and marketing raise important questions about how these shops might potentially affect the public’s health. They may attract novice ENDS users and non-smokers alike, and may influence social norms around ENDS use, particularly around acceptability for use indoors. On the other hand, vape shop owners are in a unique position to serve as frontline consumer educators regarding the benefits and risks of ENDS. This unique context highlights the importance of understanding the interactions between vape shop owners, workers and customers.Moderator(s): Maciej L. Goniewicz, PhD, Pharm D, Roswell Park Cancer Institute, Buffalo, USA

TTD #7Sala Affari: Quarto Piano–Top Floor (4th Floor)PDA Building How Do We Reduce Children’s Exposure to Second-Hand Tobacco Smoke Globally?Exposure to secondhand tobacco smoke (SHS) has been causally linked with mortality and morbidity in non-smokers and disproportionately affects the health of children. Globally, hundreds of millions of children are regularly exposed to SHS, especially in their home. New evidence is emerging on how to reduce children’s exposure to SHS, but there are still significant gaps in the knowledge and there is discussion about future directions in research and policy. Moderator(s): Megan Passey, PhD, University of Sydney, Australia


37

Wed

nesd

ay, M

arch

8, 2

017

5:00 p.m.-6:00 p.m.Auditorium-General Session RoomPDC BuildingKeynote Presidential Symposium (Opening Session)Nicotine + Other Addictive Behaviors: Addressing the Added Complexities Across the Translational ContinuumChairs: Maciej L. Goniewicz, PhD, Roswell Park Cancer Institute, USA and Rachel Grana Mayne, PhD, National Cancer Institute, USA

Title of presentationThe Global Epidemiology of Polysubstance UseSpeaker: Joanna E. Cohen, PhD, Director, Institute for Global Tobacco Control, Johns Hopkins Bloomberg School of Public, Baltimore, USAPharmacokinetic and Pharmacodynamic Interactions Between Nicotine and Other Drugs of AbuseSpeaker: Neal L. Benowitz MD, Chief, Division of Clinical Phar-macology, University of California San Francisco, USAUnderstanding Propensity to AddictionSpeaker: Robert West, PhD, Professor of Health Psychology, University College London, UKPublic Health Implications of Polysubstance UseSpeaker: Ron Borland PhD, FASSA, Nigel Gray Distinguished Fellow in Cancer Prevention, The Cancer Council Victoria, Melbourne, AustraliaTreating Tobacco Addiction in Smokers With Co-occur-ring DisordersSpeaker: Judith J. Prochaska, PhD, MPH, Associate Professor of Medicine, Department of Medicine, Stanford University, USA

Whilst the overall prevalence of smoking is decreasing in many countries, a significant proportion of tobacco smokers also use various psychoactive substances. Smoking rates are high among those who are addicted to various legal and illegal drugs, includ-ing marijuana, alcohol, and opioids. These populations need to be a focus of tobacco control policies and interventions moving forward, so that ‘no man is left behind’ in our efforts to reduce smoking prevalence. During this symposium, we will address the added complexities of nicotine and other addictive behaviors across the translational continuum. First, Dr. Cohen will present the scope of use of other drugs by tobacco users, and use of tobacco by users of other drugs. Dr. Benowitz will review phar-macokinetic and pharmacodynamics interactions between nico-tine and alcohol, cannabis, opiates and stimulants. Dr. West will show how a general model of behavior can provide a framework for understanding patterns of association with addictive disorders and how this can be used to guide interventions to combat ciga-rette addiction in people who also suffer from other addictions. The public health challenge is to develop a framework that leads to the least harmful use of the least harmful products or mix of products. Dr. Borland will discuss how tobacco smoking and nicotine fit into that agenda. Dr. Prochaska will present new data and review the literature on treating tobacco addiction in smok-ers with co-occurring alcohol and other drug use disorders.

6:00 p.m.-7:30 p.m.Passi Perduti (Basement - Lowest Level)PDC Building Opening Reception(All attendees are welcome! Cash bar and hors d’oeuvres)

38



39

40



Thur

sday

, Mar

ch 9

, 201

7

41

SESSION SUMMARY THURSDAY

MARCH 9, 2017

42



Thur

sday

, Mar

ch 9

, 201

7

Audience Key: BS: Basic Science; PC: Pre-Clinical; C: Clinical; PH/E: Public Health/Epidemiology; P: Policy; HD: Health Disparities; I: International; LMIC: Lower-Middle Income Countries; T=Treatment

43

THURSDAY, MARCH 9, 2017

8:00 a.m.-5:00 p.m.Piazza Adua (Reception Area)Registration

8:00 a.m.-5:00 p.m.Retropresidenza (Passi Perduti - Lowest Level)PDC BuildingSpeaker Ready Room

9:00 a.m.-3:30 p.m.Salone Club (Lower level)PDC BuildingExhibits Open

9:00 a.m.-10:30 a.m.Sala Auditorium (Lower Level)PDC BuildingWelcome/Awards/Plenary

9:00 a.m. Welcome & Opening Remarks by the Presidents of SRNT-E & SRNT

Ivan Berlin, PhDDeborah Ossip, PhD

9:10 a.m. Awards

Tom Glynn, PhD Chair, Awards Sub-Committee

John Slade AwardMartin Raw, PhDDirector, International Centre for Tobacco CessationHonorary Associate Professor, UK Centre for Tobacco and Alcohol Studies, School of Medicine, University of Not-tingham, UKVisiting Professor, National Institute of Alcohol and Drug Policies, Federal University of Sao Paulo, Brazil

Jarvik-Russell New Investigator AwardThomas R. Kirchner, PhDClinical Associate Professor of Public Health, Medicine, and Urban Science at NYU College of Global Public Health, USA

Doll-Wynder Award Kenneth E. Warner, PhDAvedis Donabedian Distinguished University Professor of Public Health at the University of Michigan, USA

9:30 a.m. Plenary

Epidemiology and Public Health Themed Lecture and 2017 Doll-Wynder Award Winner“How to Think - Not Feel - About Tobacco Harm Reduction”Kenneth E. Warner; Avedis Donabedian Distinguished University Professor

10:30 a.m.-11:00 a.m.Salone Club (Lower level)PDC BuildingExhibitor Time

Refreshment Break - Passi Perduti (Basement - Lowest Level)

Program · Thursday, March 9, 2017

44

11:00 a.m.-12:30 p.m.Affari (2nd Floor) - Auda 2Podium Presentation 1Symposium 1HEALTH COMMUNICATION FOR NON-CIGARETTE TOBACCO PRODUCTSChair: Erin L. Sutfin, PhD, USADiscussant: Seth M. Noar, PhD

Audience: P, I, LMIC

SYM1A: DEVELOPING A POINT-OF-SALE HEALTH COMMUNICATION CAMPAIGN FOR CIGARILLOS AND WATERPIPE TOBACCOPresenters: Erin L. Sutfin, PhD; Jennifer Cornacchione, PhD; Allison Lazard, PhD; Elizabeth Orlan; Cynthia Suerken, MS; Kimberly D. Wiseman, MS; Beth A. Reboussin, PhD; Mark Wolfson, PhD; Seth M. Noar, PhD

SYM1B: THE FIRST NATIONAL SMOKELESS TOBACCO PREVENTION CAMPAIGN: PRESENTATION OF FORMATIVE RESEARCH LEADING TO DEVELOP HEALTH MESSAGINGPresenters: Tesfa Alexander, PhD; Matthew W. Walker, DrPh, MPH

SYM1C: IDENTIFYING PROMISING CAMPAIGN THEMES FOR A MASS MEDIA CAMPAIGN TO PREVENT YOUTH INITIATION OF VAPING AND E-CIGARETTE USEPresenters: Angeline Sangalang, PhD; Allyson C. Volinsky, MA; Qinghua Yang, PhD; Jiaying Liu, MA; Stella Lee, MA; Laura A. Gibson, PhD; Robert C. Hornik, PhD

SYM1D: DEVELOPING AND EVALUATING HEALTH COMMUNICATION MESSAGES ABOUT ENDS FOR CURRENT SMOKERSPresenters: Scott R. Weaver, PhD; Lucy Popova, PhD; Mi-chael P. Eriksen, ScD

11:00 a.m.-12:30 p.m.Affari (1st Floor) - Room 1Podium Presentation 1Symposium 2EXPLORING MARIJUANA AND TOBACCO CO-USE: A PROBLEMATIC RELATIONSHIP THAT CAN NO LONGER BE IGNOREDChair: Erin A McClure, PhD, USADiscussant: Kimber P Richter, PhD, MPH

Audience: PH/E, PC, HD, I

SYM2A: COMBUSTED PRODUCT USE AMONG A SAMPLE OF US ADULTS WHO CO-USE TOBACCO AND MARIJUANAPresenters: Erica N Peters, PhD; Zachary R Rosenberry, BS; Gillian L Schauer, PhD, MPH

SYM2B: DIMENSIONS OF PERCEIVED HARM OF TOBACCO, MARIJUANA, AND ELECTRONIC VAPORIZERS AMONG YOUNG ADULTS IN COLORADO: A QUALITATIVE STUDYPresenters: Lucy Popova, PhD; Emily A McDonald, PhD; Sohrab Sidhu, MD, MPH; Rachel A Barry, MS; Tracey A Richers Maruyama, MA; Nicolas M Sheon, PhD; Pamela M Ling, MD, MPH

SYM2C: EXPLORING PATTERNS OF TOBACCO AND CANNABIS CO-USE IN PATIENTS WITH SCHIZOPHRENIA VERSUS CONTROLS: THE EFFECTS OF CANNABIS ABSTINENCEPresenters: Rachel A Rabin, PhD; Tony P George, MD


Thur

sday

, Mar

ch 9

, 201

7


45

SYM2D: A RANDOMIZED CONTROLLED TRIAL TARGETING TOBACCO USE DURING TREATMENT FOR CANNABIS USE DISORDERPresenters: Dustin C Lee, PhD; Alan J Budney, PhD; Denise D Walker, PhD; Mary F Brunette, MD; John R Hughes, MD; Jean-Francois Etter, PhD; Samantha Auty; Catherine Stanger, PhD

SYM2E: ASSESSING REGULATORY SYSTEMS FOR RETAIL MARIJUANA WITHIN A TOBACCO CONTROL FRAMEWORK: EVIDENCE FROM URUGUAY AND THE UNITED STATESPresenters: Rachel A Barry, MA

11:00 a.m.-12:30 p.m.Affari (1st Floor) - Room 2Podium Presentation 1Symposium 3IN MEMORY OF ATHINA MARKOU: A LEGACY OF TRANSITIONAL SCIENCE ON NICOTINE WITHDRAWAL AND REWARDChair: Jason A Oliver, PhD, USACo-Chair: Andre Der-Avakian, PhD, USADiscussant: Eric C Donny, PhD

Audience: BS, PC, T

SYM3A: EFFECTS OF KETAMINE ON NICOTINE WITHDRAWAL- AND STRESS-INDUCED DEFICITS IN BRAIN REWARD FUNCTION IN RATSPresenters: Andre Der-Avakian, PhD

SYM3B: MOVING BEYOND IMMEDIATE REWARD: DOES NICOTINE WITHDRAWAL IMPACT REINFORCEMENT LEARNING?Presenters: Jason A Oliver, PhD; Nicolette Sullivan, PhD; Merideth A Addicott, PhD; Francis J McClernon, PhD; David E Evans, PhD; Thomas H Brandon, PhD; David J Drobes, PhD

SYM3C: CLINICAL MANIFESTATIONS OF ANHEDONIA IN TOBACCO WITHDRAWALPresenters: Adam M Leventhal, PhD

SYM3D: DEPRESSION AND NICOTINE WITHDRAWAL AT THE POPULATION LEVELPresenters: Michele L Pergadia, PhD; John W Newcomer, MD; David G Gilbert, PhD

1:00 a.m.-12:30 p.m.Affari (2nd Floor)Podium Presentation 1Symposium 4EXPLORING DIMENSIONS OF FLAVORS: TOXICITY, PREFERENCE, AND USEChair: Cathy L Backinger, PhD, MPH, USADiscussant: Suchitra Krishnan-Sarin, PhD

Audience: BS, PC, PH/E, I

SYM4A: A REVIEW OF AGE-RELATED DIFFERENCES IN FLAVOR PREFERENCESPresenters: Allison C Hoffman, PhD; Raydel Valdes Salgado, PhD, MPH, MS; Carolyn Dresler, MD, MPA; Rachel Williams Faller, MPH; Christopher Bartlett, PhD

SYM4B: INHALATION TOXICITY OF FLAVORINGS IN ELECTRONIC NICOTINE DELIVERY SYSTEMS (ENDS)Presenters: Maciej L Goniewicz, PhD, PharmD


46

SYM4C: ANALYSIS AND BEHAVIORAL EFFECTS OF HIGH-INTENSITY SWEETENERS IN ALTERNATIVE TOBACCO PRODUCTSPresenters: Sairam Jabba, DVM, PhD; Cheenu Tiwari; Pamela Bonner, MBS; Tamara deWinter, PhD; Shida Miao, PhD; Evan S Beach, PhD; Toby J Sommer, PhD; Julie B Zimmerman, PhD; Sven-Eric Jordt, PhD

SYM4D: ARE YOUTH AND YOUNG ADULTS WHO FIRST TRY A FLAVORED TOBACCO PRODUCT MORE LIKELY TO CONTINUE USING TOBACCO? FINDINGS FROM THE PATH STUDYPresenters: Andrea C Villanti, PhD, MPH

11:00 a.m.-12:30 p.m.Palazzo dei Congressi: VerdePodium Presentation 1Symposium 5THE ECONOMICS OF TOBACCO CONTROL: KEY FINDINGS FROM THE NCI & WHO TOBACCO CONTROL MONOGRAPHChair: Mark Parascandola, PhD, USACo-Chair: Geoffrey Fong, PhD, CanadaDiscussant: Hana Ross, PhD


SYM5A: BEST PRACTICES IN TOBACCO TAXATIONPresenters: Frank J Chaloupka, PhD

SYM5B: GLOBALIZATION OF THE TOBACCO INDUSTRY AND IMPLICATIONS FOR TOBACCO CONTROLPresenters: Ayda Yurekli, PhD

SYM5C: THE ECONOMIC IMPACT OF TOBACCO USE AND TOBACCO CONTROLPresenters: Evan Blecher, PhD

11:00 a.m.-12:30 p.m.Affari (4th Floor)Podium Presentation 1Symposium 6THE CHRNA5-A3-B4 GENE CLUSTER: FROM DISCOVERY TO CAUSALITY, MECHANISM, AND THERAPEUTICSChair: Glenda Lassi, PhD, UKDiscussant: Mariella De Biasi, PhD

Audience: BS, PC, I

SYM6A: FROM GENETICS TO CAUSALITYPresenters: Marcus R Munafò, PhD

SYM6B: THE CHRNA5-A3-B4 GENE CLUSTER: FROM GENOTYPE TO PHENOTYPEPresenters: Glenda Lassi, PhD; Tim Eisen, PhD

SYM6C: NICOTINIC RECEPTOR CIRCUITS MEDIATING REINFORCEMENT AND AVERSIONPresenters: Christie Fowler, PhD

SYM6D: IN VIVO PHARMACOLOGICAL PROFILE OF THE SELECTIVE A3B4 NACHR PARTIAL AGONIST AT-1001, IN NICOTINE SELF-ADMINISTRATION, REINSTATEMENT AND WITHDRAWAL: ROLE OF A3B4 NACHR AS A TARGET FOR SMOKING CESSATION PHARMACOTHERAPYPresenters: Nurulain T Zaveri, PhD


Thur

sday

, Mar

ch 9

, 201

7


47

11:00 a.m.-12:30 p.m.Auditorium-General Session RoomPDC BuildingPodium Presentation 1Paper Session 1NOVEL FINDINGS FROM CLINICAL TRIALSChair: Sue Curry, PhD, USA

Audience: C,T,I

11:00 a.m. - 11:15 a.m.EFFECTIVENESS OF INTENSIVE PRACTICE NURSE COUNSELLING VERSUS BRIEF GENERAL PRACTITIONER ADVICE IN COMBINATION WITH VARENICLINE FOR SMOKING CESSATION: A RANDOMISED PRAGMATIC TRIAL IN PRIMARY CAREDaniel Kotz, PhD*; Carolien van Rossem, MSc; Mark Spigt, PhD; Wolfgang Viechtbauer, PhD; Annelies Lucas, MD; Onno C.P. van Schayck, PhD

11:15 a.m. - 11:30 a.m.REAL WORLD EFFECTIVENESS OF VARENICLINE AND BUPROPION FOR SMOKING CESSATION: AN INTERNET-BASED RANDOMIZED CONTROLLED TRIAL (MATCH)Helena Zhang, BSc*; Bernard Le Foll, MD, PhD; Peter Selby, MBBS; Laurie Zawertailo, PhD

11:30 a.m. - 11:45 a.m.CARDIOVASCULAR SAFETY OF VARENICLINE, BUPROPION AND NICOTINE PATCH: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIALNeal L Benowitz, M.D.*; Robert West, Ph D.; Andrew Pipe, CM, BA, MD, LLD (Hons), DSc (Hons); Taylor Hays, M.D.; Lisa St. Aubin, Ph D.; Thomas McRae, Ph D.; Robert An-thenelli, M.D.

11:45 a.m. - 12:00 noonASSOCIATION OF ELECTRONIC CIGARETTE USE WITH SMOKING CESSATION AMONG SMOKERS WHO PLAN TO QUIT AFTER HOSPITAL DISCHARGE: A LONGITUDINAL ANALYSISNancy A Rigotti, MD*; Yuchiao Chang, PhD; Hilary A Tindle, MD, MPH; Susan Regan, PhD; Sara M Kalkhoran, MD, MAS; Jennifer H Kelley, RN, MA; Elyse R Park, PhD, MPH; Thomas Ylioja, MSW; Daniel E Singer, MD

12:00 noon - 12:15 p.m.THE NATURALISTIC UPTAKE AND IMPACT OF E-CIGARETTES: RESULTS FROM A PILOT RANDOMIZED TRIALMatthew J Carpenter, PhD*; Bryan W Heckman, PhD; Amy E Wahlquist, MS; Amy Boatright; Brett Froeliger, PhD; Kevin M Gray, MD; K. Michael Cummings, PhD, MPH

12:15 p.m. - 12:30 p.m.YOGA AS A COMPLEMENTARY THERAPY IN COGNITIVE BEHAVIORAL SMOKING CESSATION: A RANDOMIZED CLINICAL TRIALBeth C Bock, PhD*; Shira Dunsiger, PhD; Ernestine Jennings, PhD; Rochelle Rosen, PhD; Bess H Marcus, PHD

11:00 a.m.-12:30 p.m.Affari (1st Floor) - Auda 1Podium Presentation 1Paper Session 2SECONDHAND EXPOSURE ASSESSMENTChair: Yi Nam Suen, PhD, Hong KongCo-Chair: Luk Tzu Tsun Kevin, PhD, Hong Kong

Audience: PC, PH/E, I, LMIC


48

11:00 a.m. - 11:15 a.m.SECONDHAND SMOKE EXPOSURE AMONG THOSE WHO SHOULD NOT BE EXPOSED: A U.S. NATIONAL ESTIMATETaghrid Asfar, MD, MSPH.*; Kristopher Arheart; Tulay Koru-Sengul; David Lee

11:15 a.m. - 11:30 a.m.SECONDHAND SMOKE EXPOSURE AMONG A VULNERABLE POPULATION OF ADOLESCENTSNatalie Nardone, PhD*; Shonul Jain, MD; Delia Dempsey, MD; Peyton Jacob, PhD; Neal L Benowitz

11:30 a.m. - 11:45 a.m.SECOND HAND SMOKE EXPOSURE AMONG PREGNANT WOMEN IN ARGENTINA. ROLE OF HEALTH CARE PROFESSIONALSPaola Morello, MD MPH*; Mabel Berrueta, MD; Luz Gibbons, PhD; Jose Belizan, MD; Fernando Althabe, MD

11:45 a.m. - 12:00 noonUSING AIR-QUALITY FEEDBACK TO FACILITATE SMOKE-FREE HOMESAmanda Amos, BA, MSc, PhD*; Steve Turner, MBBS, FR-CPCH, MD; Rachel O’Donnell, BSc, PhD; Susan Lyttle, BSc, MPH; Tracey Henderson; Lynn Adams, BSc; Sean Semple, BSc, MSC, PhD

12:00 noon - 12:15 p.m.EFFECTS OF HOOKAH SMOKING ON INDOOR AIR QUALITY IN HOMESLily Lee, *; Michael Weitzman, MD; Afzal Hussein Yusufali, PhD; Fatma Bali, MD; MJ Ruzmyn Vilcassim, MS; Shashank Ghandhi, MS; Richard Peltier, PhD; Arthur Nadas, PhD; Scott E Sherman, MD; Zhang Hong, MS; Jenni A Shearston, BA; Su Hyun Park, PhD; Terry Gordon, PhD

12:15 p.m. - 12:30 p.m.SECONDHAND AND THIRDHAND EXPOSURE TO NICOTINE FROM ELECTRONIC CIGARETTESLisa M Vogl, MPH*; Zachary Dunbar, BS; Eric Jensen; Mark Travers, PhD; Maciej L Goniewicz, PhD, PharmD

11:00 a.m.-12:30 p.m.Affari (Ground Floor)Podium Presentation 1Paper Session 3CORRELATES OF NOVEL PRODUCT USEChair: Rachel Grana, PhD, MPH, USA

Audience: PH/E, P, HD, I, LMIC

11:00 a.m. - 11:15 a.m.WHAT FACTORS ARE ASSOCIATED WITH SMOKERS USING OR STOPPING E-CIGARETTE USE?Leonie S Brose, PhD*; Erikas Simonavicius, MSc; Deborah Arnott, MBA; Ann McNeill, PhD

11:15 a.m. - 11:30 a.m.THE SOCIAL ENVIRONMENT AND FUTURE USE OF CIGARETTES AND E-CIGARETTESRobert Urman, PhD*; Jessica L Barrington-Trimis, PhD, MA, MS; Rob McConnell, MD

11:30 a.m. - 11:45 a.m.WHY DO YOUTH AND YOUNG ADULTS USE E-CIGARETTES? MOTIVATIONS AND EXPECTANCIESJessica M Rath, PhD, MPH*; Morgane A Bennett, MPH; Lyubov Teplitskaya, MS; Elizabeth C Hair, PhD; Jennifer Cantrell, DrPH, MPA; Jennifer L Pearson, PhD, MPH; Donna M Vallone, PhD, MPH


Thur

sday

, Mar

ch 9

, 201

7


49

11:45 a.m. - 12:00 noonPREDICTING CIGARETTE INITIATION AMONG YOUNG ADULTS: A SURVIVAL ANALYSIS EXAMINING THE INFLUENCE OF E-CIGARETTE USEAlexandra Loukas, PhD*; C. Nathan Marti, PhD; Maria R. Cooper, PhD; Keryn E. Pasch, PhD; Cheryl L. Perry, PhD

12:00 noon - 12:15 p.m.RESULTS FROM AN E-CIGARETTE PREVENTION PILOT TEST IN 25 USA MIDDLE SCHOOLS WITH 1371 STUDENTS: CATCH MY BREATH PROGRAMSteven H Kelder, PhD, MPH*; Duncan Van Dusen, MPH; Megan M Grayless, MPH

12:15 p.m. - 12:30 p.m.SUSCEPTIBILITY MEDIATES THE ASSOCIATION BETWEEN PSYCHOSOCIAL FACTORS AND YOUTHS’ SUBSEQUENT HOOKAH INITIATIONMeLisa Creamer, PhD, MPH*; Maria Cooper, PhD; Christina Ly, PhD, MPH; Brittani Crook, PhD; Melissa B Harrell, PhD, MPH; Cheryl L Perry, PhD

12:30 p.m.-2:00 p.m.Passi PerdutiPDC BuildingPoster Session 1: Clinical

12:30 p.m.-2:00 p.m.Passi Perduti (Basement - Lowest Level)Lunch Break

Pick up your complimentary boxed lunch, starting at 12:15 p.m.

12:45 p.m.-2:00 p.m.Villa Vittoria: Sala 101 - Primo Piano (1st Floor)Past Presidents Luncheon

(by invitation only)

12:45 p.m.-1:45 p.m.Villa Vittoria: Sala 4 – Terra Piano (Ground Floor) Meet-the-Editor

Joanna Cohen, Deputy Editor Tobacco Control Journal

2:00 p.m.- 3:00 p.m.Auditorium-General Session RoomPDC BuildingPre-Clinical/Basic Science Plenary Themed Lecture

Genetic Overlap Between Cigarette Smoking and Other Substance UseJacqueline Vink, Professor, Behavioral Science Institute, Radboud University, Nijmegen, The Netherlands

3:00 p.m.- 3:30 p.m.Salone Club (Lower level)PDC BuildingExhibitor Time


3:30 p.m.-5:00 p.m.Affari (4th Floor)Podium Presentation 2Symposium 7ENDOCANNABINOID MODULATION OF NICOTINE DEPENDENCE: SYMPOSIUM IN MEMORIAM OF DR. LARRY PARSONSChair: Christie D Fowler, PhD, USACo-Chair: Matthew W Buczynski, PhD, USADiscussant: Christie D Fowler, PhD

Audience: BS, PC, I


50

SYM7A: DIACYLGLYCEROL LIPASE DISINHIBITS VTA DOPAMINE NEURONS FOLLOWING CHRONIC NICOTINE EXPOSUREPresenters: Matthew W Buczynski, PhD; Melissa A Herman; Ku-Lung Hsu; Ilham Y Polis; Benjamin F Cravatt; Marisa Roberto; Loren H Parsons

SYM7B: ROLE OF N-ACYLETHANOLAMINES IN NICOTINE EFFECTS ON MIDBRAIN DOPAMINE NEURONSPresenters: Miriam Melis, PhD; Marco Pistis, MD

SYM7C: ROLE OF TRANSIENT RECEPTOR POTENTIAL VANILLOID 1 IN THE CONTROL OF BOTH NICOTINE-RELATED BEHAVIORS AND NICOTINE-INDUCED DOPAMINE NEURONAL ACTIVITY IN MICEPresenters: Anne-Emilie Alain; Marie-Line Fournier; Oceane Aribo; Martine Cador; Sandrine S Bertrand; Stéphanie Caillé-Garnier, PhD

SYM7D: ROLE OF THE ENDOCANNABINOID SYSTEM IN NICOTINE ADDICTIONPresenters: Jose M Trigo, PhD; Bernard Le Foll, MD, PhD, MCFP

3:30 p.m.-5:00 p.m.Affari (1st Floor) - Room 2Podium Presentation 2Symposium 8GLOBAL TOBACCO CONTROL DISPARITIES: WHERE ARE WE? WHERE ARE WE GOING?Chair: Jennifer Cantrell, DrPH, MPA, USACo-Chair: Carla Berg, PhD, USADiscussant: Joanna Cohen, PhD, MHSc ; Jim F Thrasher, PhD, MA, MS

Audience: P, HD, I, LMIC

SYM8A: SOCIODEMOGRAPHIC PATTERNING OF CESSATION BEHAVIOR ACROSS LOW AND MIDDLE- INCOME COUNTRIES: EMERGING EVIDENCE FROM THE GLOBAL ADULT TOBACCO SURVEYS AND INTERNATIONAL TOBACCO CONTROL SURVEYSPresenters: Nigar Nargis, PhD; Hua-Hie Yong, PhD, MPsych; Pete Driezen, PhD Candidate, MSc; Lazarous Mbulo, PhD; Geoffrey Fong, PhD; Mary Thompson, PhD; Ron Borland, PhD, MAPS; Krishna Palipudi, PhD; Gary Giovino, PhD, MS; Jim F Thrasher, PhD, MA, MS

SYM8B: TOBACCO CONTROL POLICY IMPLEMENTATION AND EVALUATION: A PROPOSED FRAMEWORK FOR LOW- AND MIDDLE-INCOME COUNTRIESPresenters: Ryan D Kennedy, PhD; Stephen A Tamplin, MSE; Lisa P Lagasse, PhD; Joanna E Cohen, PhD

SYM8C: LINKING GLOBAL TOBACCO CONTROL AND THE SUSTAINABLE DEVELOPMENT GOALS: OPPORTUNITIES AND CHALLENGES FOR RESEARCH AND ADVOCACYPresenters: Monika Arora, PhD, MSc, MSc; Shikha Bhasin, MPH, BDS; Amit Yadav, LLM, MPhil; Alice Grainger-Gasser, BSN

3:30 p.m.-5:00 p.m.Affari (2nd Floor)Podium Presentation 2Symposium 9CONTRIBUTIONS OF BASIC SCIENCE TO PUBLIC POLICYChair: Tracy T Smith, PhD, USADiscussant: Jonathan Foulds, PhD

Audience: BS, P, I


Thur

sday

, Mar

ch 9

, 201

7


51

SYM9A: TESTING INHALATION TOXICITY OF NOVEL TOBACCO PRODUCTS USING IN VITRO MODELS - IMPLICATIONS FOR REGULATORY SCIENCE AND POLICYPresenters: Maciej L Goniewicz, PhD, PharmD

SYM9B: INTRAORAL FLAVORANTS ENHANCE DOPAMINE SIGNALING AND NICOTINE-TAKING IN A PRECLINICAL RAT MODELPresenters: Nii A Addy, PhD; Robert J Wickham, PhD; Eric J Nunes, PhD; Phillip R Silva, BS; Jinwoo Park, PhD

SYM9C: BEHAVIORAL ECONOMIC ASSESSMENTS OF THE IMPACT OF NICOTINE REDUCTION ON RAT SELF-ADMINISTRATION AND HUMAN SMOKINGPresenters: Tracy T Smith, PhD; Rachel N Cassidy, PhD; Joseph S Koopmeiners, PhD; Xianghua Luo, PhD; Laura E Rupprecht, BS; Alan F Sved, PhD; Jennifer W Tidey, PhD; Dorothy K Hatsukami, PhD; Eric C Donny, PhD

SYM9D: EXAMINING TOBACCO CONTROL AND REGULATORY SCIENCE QUESTIONS IN THE CLINICAL LABORATORY SETTINGPresenters: Stephen T Higgins, PhD

3:30 p.m.-5:00 p.m.Affari (Ground Floor)Podium Presentation 2Symposium 10UNDERSTANDING NON-ADHERENCE TO SMOKING INTERVENTIONS: DETECTION, REASONS, INDIVIDUAL DIFFERENCES, AND CONSEQUENCESChair: Sarah S Dermody, PhD, CanadaDiscussant: Neal Benowitz, PhD

Audience: C, T, I

SYM10A: REASONS FOR NON-COMPLIANCE IN A CIGARETTE NICOTINE REDUCTION CLINICAL TRIALPresenters: Natalie Nardone, PhD; Neal Benowitz, MD; Tracy Smith, PhD; Joseph Koopmeiners, PhD; Dorothy Hatsukami, PhD; Eric C Donny, PhD

SYM10B: COMPENSATORY SMOKING OF REDUCED NICOTINE CONTENT CIGARETTES IN CONFINED SMOKERSPresenters: Neal Benowitz, MD; Natalie Nardone, PhD; Tracy Smith, PhD; Rachel Denlinger, MPH; Joseph S. Koop-meiners, PhD; Dorothy Hatsukami, PhD; Eric C Donny, PhD

SYM10C: ESTIMATING THE IMPACT OF MANDATED REDUCTIONS IN THE NICOTINE CONTENT OF CIGARETTES FROM DATA COLLECTED IN AN UNREGULATED WORLDPresenters: Joseph S Koopmeiners, PhD; Jeffery A Boatman; David M Vock, PhD; Eric C Donny, PhD

SYM10D: THE EFFECTS OF ADHERENCE WITH EXCLUSIVELY SMOKING VERY LOW NICOTINE CONTENT CIGARETTES ON WITHDRAWAL SYMPTOMSPresenters: Sarah S Dermody, PhD; F. Joseph McClernon, PhD; Neal Benowitz, MD; Joseph Koopmeiners, PhD; Xianghua Luo, PhD; Jennifer Tidey, PhD; Ryan Vandry, PhD; Dorothy Hatsukami, PhD; Eric C Donny, PhD


52

SYM10E: MEASURES AND PREDICTORS OF VARENICLINE ADHERENCE IN THE TREATMENT OF NICOTINE DEPENDENCEPresenters: Mark Morales, BA; Annie R Peng, BSc; E. Paul Wileyto, PhD; Ning Chen, PhD; Larry W Hawk Jr., PhD; Paul Cinciripini, PhD, MD; Tony P George, MD; Neal Benow-itz, MD; Nikka L Nollen, PhD; Caryn Lerman, PhD; Rachel F Tyndale, PhD; Robert Schnoll, PhD

3:30 p.m.-5:00 p.m.Affari (1st Floor) - Auda 1Podium Presentation 2Symposium 11DEVELOPMENT AND TESTING OF SMARTPHONE APPS FOR SMOKING CESSATIONChair: Kathleen A Garrison, PhD, USACo-Chair: Reuven Dar, PhD, IsraelDiscussant: Saul M Shiffman, PhD

Audience: PC, C, T, I

SYM11A: A NOVEL SMOKING CESSATION APP UTILIZING BIG DATA OVER WEARABLES: A PILOT STUDYPresenters: Reuven Dar, PhD

SYM11B: UX DESIGN AND N-OF-1 TRIALS OF LEARN TO QUIT, A NOVEL SMOKING CESSATION APP FOR CHRONIC MENTAL ILLNESSPresenters: Roger Vilardaga, PhD; Javier Rizo, BA; Arpita Bhattacharya, BS; Emily Y Zeng, BS; Brain Marr, BA; Julie Kientz, PhD; Richard Ries, MD

SYM11C: USING OUR SMARTPHONES TO LEARN TO PAY ATTENTION AND QUIT SMOKING: SMARTPHONE APP-BASED MINDFULNESS TRAINING FOR SMOKING CESSATIONPresenters: Kathleen A Garrison, PhD; Prasanta Pal, PhD; Stephanie S O’Malley, PhD; Judson A Brewer, MD, PhD

3:30 p.m.-5:00 p.m.Affari (1st Floor) - Room 1Podium Presentation 2Symposium 12TIME-VARYING EFFECT MODELING TO SHED NEW LIGHT ON THE DEVELOPMENTAL COURSE OF NICOTINE PRODUCT USE IN THE USChair: Stephanie T Lanza, PhD, USADiscussant: Megan E Piper, PhD

Audience: PH/E, P

SYM12A: AGE-VARYING RATES OF NICOTINE PRODUCT USE THROUGHOUT ADOLESCENCEPresenters: Jessica L Braymiller, MS; Stephanie T Lanza, PhD

SYM12B: LOW FAMILY SES AND SMOKING: AGE-VARYING ASSOCIATIONS FROM ADOLESCENCE TO YOUNG ADULTHOODPresenters: Michael A Russell, PhD; Sara A Vasilenko, PhD; Stephanie T Lanza, PhD

SYM12C: AGE-VARYING RISK FOR INITIATION AND ESCALATION ACROSS MAJOR SMOKING MILESTONES DURING ADOLESCENCEPresenters: Lisa Dierker, PhD; Jennifer S Rose, PhD; Arielle S Selya, PhD


Thur

sday

, Mar

ch 9

, 201

7


53

3:30 p.m.-5:00 p.m.Auditorium-General Session RoomPDC BuildingPodium Presentation 2Symposium 13THE POTENTIAL OF ELECTRONIC CIGARETTES FOR REDUCING THE HARM OF TOBACCO IN PRIORITY POPULATIONS: PEOPLE, PLACES, POLICIES, PROMOTION, AND PRACTICESChair: Billie Bonevski, BA(Hons), PhD, AustraliaDiscussant: Amanda Baker, PhD


SYM13A: SOCIOECONOMIC DIFFERENCES IN USE OF VAPORIZED NICOTINE: FINDINGS FROM THE ITC FOUR COUNTRY SURVEYSPresenters: Ron Borland, PhD; Hua-Hie Yong, PhD; Michael K Cummings, PhD; Geoffrey Fong, PhD; Ann McNeill, PhD

SYM13B: USE OF ELECTRONIC CIGARETTES BY AUSTRALIAN SMOKERS IN SUBSTANCE ABUSE TREATMENT: REASONS FOR USE, AND PLACE OF PURCHASEPresenters: Billie Bonevski, PhD; Ashleigh Guillaumier, PhD; Eliza Skelton, BA(Hons); Anthony Shakeshaft, PhD; Michael Farrell, PhD; Flora Tzelepis, PhD; Adrian Dunlop, PhD; Chris Paul, PhD; Catherine D’Este, PhD

SYM13C: “VAPING NOT ONLY SAVED MY LIFE, BUT FREED ME FROM A CAGE”: A QUALITATIVE ANALYSIS OF SOCIAL MEDIA DISCUSSIONS ABOUT MOTIVATIONS FOR AND BARRIERS TO SMOKERS WITH MENTAL ILLNESS SWITCHING TO E-CIGARETTESPresenters: Ratika Sharma, M.DenSurg; Britta Wigginton, PhD; Carla Meurk, PhD; Pauline Ford, PhD; Coral Gartner, PhD

SYM13D: HEALTH PRACTITIONERS’ ATTITUDES TOWARD TOBACCO HARM REDUCTION APPROACHES FOR SMOKERS FROM PRIORITY POPULATIONS WITH CO-MORBIDITIES.Presenters: Coral Gartner, PhD; Stephanie Bell, BSc; Ratika Sharma, M.DenSurg; Carla Meurk, PhD; Judith Dean, PhD; Charles F Gilks, PhD; Mark Boyd, PhD

SYM13E: WHAT ROLE DO E-CIGARETTES HAVE IN A COUNTRY WITH A SMOKEFREE GOAL?Presenters: Chris Bullen, MBChB, PhD; Natalie Walker, PhD

3:30 p.m.-5:00 p.m.Palazzo dei Congressi: VerdePodium Presentation 2Paper Session 4TREATMENT IN SMOKERS WITH COMORBIDITIESChair: Peter Selby, PhD, Canada

Audience: C, HD, I, T

3:30 p.m. - 3:45 p.m.A SMOKING CESSATION TRIAL IN PEOPLE LIVING WITH HIV (PLWH) IN SOUTH AFRICAJonathan E Golub, PhD, MPH*; Limakatso Lebina; Katlego Motlhaoleng; Sandy Chon; Nikhil Gupte; Ray Niaura; David Abrams; Ebrahim Variava; Neil Martinson


54

3:45 p.m. - 4:00 p.m.EFFECTIVENESS OF A CLINICAL PRACTICE CHANGE INTERVENTION IN INCREASING THE PROVISION OF TREATMENT FOR SMOKING IN INPATIENT PSYCHIATRIC FACILITIES: AN IMPLEMENTATION TRIALEmily A Stockings, PhD*; Paula M Wye, PhD; Jenny A Bow-man, PhD; Christopher Oldmeadow, PhD; John H Wiggers, PhD

4:00 p.m. - 4:15 p.m.HELPING CANCER PATIENTS QUIT SMOKING BY IMPROVING THEIR RISK COMMUNICATION: A RANDOMIZED CONTROLLED TRIALHo Cheung, William Li, PhD, RN*; Tsz Yan, Yannes Cheung, PhD; Siu Chee, Sophia Chan, PhD; Tai-Hing Lam, MBBS, MD(HK), MSc(Occupational Medicine)(Lond), FAFOM RACP, FFPH, FFOM(Lond), Hon.FHKCCM, FHKAM(Community Medicine), FRCP(Edin)

4:15 p.m. - 4:30 p.m.BRIEF INTERVENTION TO PROMOTE SMOKING CESSATION AND IMPROVE GLYCEMIC CONTROL IN SMOKERS WITH TYPE 2 DIABETES: A RANDOMIZED CONTROLLED TRIALYannes Tsz-Yan Cheung, *; William Ho-Cheung Li; Sophia Siu Chee Chan; Tai-Hing Lam

4:30 p.m. - 4:45 p.m.CARDIOVASCULAR AND NEUROPSYCHIATRIC RISKS OF VARENICLINE IN SMOKERS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A RETROSPECTIVE COHORT STUDY USING A NATIONAL GENERAL PRACTICE DATABASEDaniel Kotz, PhD*; Wolfgang Viechtbauer, PhD; Colin Simp-son, PhD; Onno C.P. van Schayck, PhD; Robert West, PhD; Aziz Sheikh, PhD

4:45 p.m. - 5:00 p.m.DOES DISEASE PROGRESSION POTENTIATE THE EFFECTS OF POLYTOBACCO USE? A CHARACTERIZATION OF INTENTION TO QUIT AMONG NEWLY DIAGNOSED HIV SEROPOSITIVE SMOKERSMicah J Savin, *; Ellen R Gritz, PhD; Summer Frank; Roberto C Adruino, MD; Damon J Vidrine, DrPH, MS

3:30 p.m.-5:00 p.m.Affari (2nd Floor) - Auda 2Podium Presentation 2Paper Session 5TAX AND PRICE POLICYChair: Frank Chaloupka, PhD, USA


3:30 p.m. - 3:45 p.m.6 YEARS, 15 COUNTRIES, 30 MILLION LIVES: LESSONS ON TOBACCO TAXATION FROM THE BLOOMBERG INITIATIVERajeev Cherukupalli, PhD*

3:45 p.m. - 4:00 p.m.TAXATION, DISPARITIES, AND REDUCTIONS IN SMOKING IN THE U.S., 2001-2011Lucie Kalousova, *; Nancy L Fleischer, PhD, MPH; David T Levy, PhD; James F Thrasher, PhD, MA, MS; Paula M Lantz, PhD, MS, MA; Rafael Meza, PhD


Thur

sday

, Mar

ch 9

, 201

7


55

4:00 p.m. - 4:15 p.m.UNDERSTANDING TOBACCO INDUSTRY PRICING AND WHETHER IT UNDERMINES TOBACCO TAX POLICIESRosemary Hiscock, PhD*; Anna B Gilmore, MBBS (hons), DTM&H MSc (dist) PhD FFPH; Robert Branston, PhD; Sara C Hitchman, PhD; Timea Partos, PhD; Ann McNeill, PhD

4:15 p.m. - 4:30 p.m.EVALUATION OF NEW YORK CITY’S CIGAR PRICING AND PACKAGING LAWTodd Rogers, PhD*; Elizabeth Brown, MPH; Matthew Eggers, MPH; Doris Gammon, MS; James Nonnemaker; Tarsha Mc-Crae

4:30 p.m. - 4:45 p.m.E-CIGARETTE USE AMONG ADULTS IN THE UNITED STATES: SHOULD WE ENCOURAGE E-CIGARETTES TAXATION?Omar El Shahawy, MD, MPH, PhD*; Su Park, PhD, MPH; Lily Lee; Dustin T. Duncan, ScD; Kosuke Tamura, PhD; Jenni A. Shearston, BA; Scott E. Sherman, MD, MPH; Michael Weitzman, MD\r

4:45 p.m. - 5:00 p.m.ESTIMATED COST PER QUITTER FOR SMOKERS USING A SMOKING CESSATION SERVICE IN ENGLANDVasiliki Kiparoglou, PhD*

5:00 p.m.-6:00 p.m.Villa Vittoria: Sala Onice – Terra Piano (Ground Floor) Meet-the-Editor

Marcus Munafo, Deputy Editor Nicotine and Tobacco Re-search Journal

5:00 p.m.-6:00 p.m.Passi PerdutiPDC BuildingPoster Session 2: Policy, Pre-Clinical

56



57

58



Frid

ay, M

arch

10,

201

7

59

SESSION SUMMARY FRIDAY

MARCH 10, 2017

60



Frid

ay, M

arch

10,

201

7


61

FRIDAY, MARCH 10, 2017



8:15 a.m.-8:45 a.m.Villa Vittoria: Sala Verde – Secondo Piano (2nd Floor)PDC BuildingSRNT-Europe Members Meeting

(All members are welcome to attend.)

9:00 a.m.-10:00 a.m.Auditorium-General Session RoomPDC BuildingClinical Plenary Themed Lecture

Treatment of Patients With Tobacco Addiction: Improving Cur-rent Practice and Future PerspectivesSerena Tonstad, MD, MPH, PhD, Head Physician, Preventive Cardiology section, Department of Endocrinology, Obesity and Preventive Medicine at Oslo University Hospital, Oslo, Norway and a Professor, School of Public Health, Loma Linda University, Loma Linda, California


10:00 a.m.- 10:30 a.m.Salone Club (Lower level)PDC BuildingExhibitor Time


10:30 a.m.-12:00 noonAffari (2nd Floor) - Auda 2Podium Presentation 3Symposium 14NATURAL, ORGANIC, ADDITIVE-FREE, AND ECO-FRIENDLY THEMES IN CIGARETTE PACKAGING AND ADVERTISING: THE NEW “LIGHT,” “LOW,” AND “MILD”?Chair: David Hammond, PhD, MSc, CanadaDiscussant: Robin Koval, CEO

Audience: PH/E, P, I

SYM14A: MISPERCEPTIONS OF HARM AMONG AMERICAN SPIRIT SMOKERS: RESULTS FROM WAVE 1 OF THE POPULATION ASSESSMENT OF TOBACCO AND HEALTH (PATH) STUDY (2013-2014)Presenters: Jennifer L. Pearson, MPH, PhD; Amanda John-son, MHS; Andrea Villanti, MPH, PhD; Allison M. Glasser, MPH; Lauren Collins, MPH; Amy Cohn, PhD; Shyanika W. Rose, MA, PhD; Raymond Niaura, PhD; Cassandra A. Stanton, PhD

SYM14B: THE USE OF IMAGERY AND TEXT THAT COULD CONVEY REDUCED HARM IN AMERICAN SPIRIT ADVERTISEMENTSPresenters: Meghan B. Moran, PhD; John P Pierce, PhD; Caitlin Weiger, BA; Mary C. Cunningham, BA; James D. Sargent, MD

Program · Friday, March 10, 2017

62

SYM14C: AMERICAN SPIRIT DIRECT MAIL: BUILDING RELATIONSHIPS WITH CONSUMERS AND REINFORCING BRAND POSITIONINGPresenters: M. Jane Lewis, DrPH; Mia Zimmerman, MPH; Chris Ackerman, MPH; Eugene Talbot, MPH

SYM14D: THE USE OF NATURAL, ORGANIC, AND NATURE APPEALS ON TOBACCO PACKS IN 14 LOW AND MIDDLE INCOME COUNTRIESPresenters: RD Kennedy, PhD; Kevin Welding, PhD; Meghan B. Moran, PhD; Katherine Clegg Smith, PhD; Jo-anna E. Cohen, PhD

10:30 a.m.-12:00 noonAuditorium-General Session RoomPDC BuildingPodium Presentation 3Symposium 15E-CIGARETTE USE AMONG YOUTH AND YOUNG ADULTS: FINDINGS FROM THE U.S. SURGEON GENERAL’S REPORTChair: Brian A King, PhD, MPH, USADiscussant: Jonathan M Samet, MD, MS

Audience: PH/E, P, I

SYM15A: FINDINGS FROM THE SURGEON GENERAL’S REPORT ON E-CIGARETTE USE AMONG YOUTH AND YOUNG ADULTS: HISTORICAL BACKGROUND AND PATTERNS OF USEPresenters: Melissa B Harrell, PhD, MPH; MeLisa Creamer, PhD, MPH; Steven Kelder, PhD; Leslie Norman, MBA; Brian A King, PhD, MPH; Cheryl Perry, PhD

SYM15B: FINDINGS FROM THE SURGEON GENERAL’S REPORT ON E-CIGARETTE USE AMONG YOUTH AND YOUNG ADULTS: HEALTH EFFECTSPresenters: Steven Kelder, PhD; Leslie Norman, MBA; Cher-yl Perry, PhD; Melissa Harrell, PhD, MPH; MeLisa Creamer, PhD, MPH; Brian A King, PhD, MPH

SYM15C: FINDINGS FROM THE SURGEON GENERAL’S REPORT ON E-CIGARETTE USE AMONG YOUTH AND YOUNG ADULTS: ACTIVITIES OF THE E-CIGARETTE COMPANIESPresenters: MeLisa Creamer, PhD, MPH; Cheryl Perry, PhD; Steven Kelder, PhD; Melissa B Harrell, PhD, MPH; Brian A King, PhD, MPH; Leslie Norman, MBA

SYM15D: FINDINGS FROM THE SURGEON GENERAL’S REPORT ON E-CIGARETTE USE AMONG YOUTH AND YOUNG ADULTS: E-CIGARETTE POLICY AND PRACTICE IMPLICATIONSPresenters: Brian A King, PhD, MPH; Melissa B Harrell, PhD, MPH; Leslie Norman, MBA; MeLisa Creamer, PhD, MPH; Cheryl Perry, PhD; Steven Kelder, PhDAudience: PH/E, P, I

10:30 a.m.-12:00 noonAffari (Ground Floor)Podium Presentation 3Symposium 16CYTISINE UPDATE: MOVING RESEARCH FORWARD TOWARD A GLOBALLY AFFORDABLE TOBACCO CESSATION MEDICAITONChair: Nancy A Rigotti, MD, USADiscussant: Hayden McRobbie, MB, ChB, PhD

Audience: C, T, I


Frid

ay, M

arch

10,

201

7


63

SYM16A: MEASURING PLASMA CYTISINE CONCENTRATIONS, CIGARETTE CRAVING, WITHDRAWAL, SMOKING SATISFACTION AND MOOD TO INVESTIGATE THE CONCENTRATION-EFFECT RELATIONSHIP IN SMOKERSPresenters: SooHee Jeong, PhD; David Newcombe, PhD; Janie Sheridan, PhD; Malcolm Tingle, PhD

SYM16B: CYTISINE FOR SMOKING CESSATION IN TB PATIENTS: A MULTI-COUNTRY RANDOMIZED CONTROLLED TRIAL IN SOUTH ASIAPresenters: Kamran Siddiqi, PhD; Omara Dogar, MBBS, MPH

SYM16C: CYTISINE VERSUS VARENICLINE FOR SMOKING CESSATION: TWO CLINICAL TRIALS FROM THE AUSTRALASIAN CYTISINE TRIALIST GROUPPresenters: Ryan Courtney, PhD; Natalie Walker, PhD

SYM16D: THE REGULATORY SCIENCE OF CYTISINE: RESULTS FROM PRE-CLINICAL GLP-REGULATED SAFETY ASSESSMENTPresenters: David Shurtleff, PhD; Craig Hopp, PhD; Hanna Ng, PhD; Gary W Wolfe, PhD

SYM16E: THE CHALLENGE TO GETTING CYTISINE LICENSED FOR USE WORLD-WIDE: POLICY CONSIDERATIONSPresenters: Natalie Walker, PhD, MSc, DPH

10:30 a.m.-12:00 noonAffari (1st Floor) - Room 1Podium Presentation 3Symposium 17EXAMINING LINKS BETWEEN MENTHOL USE AND SMOKING PERSISTENCE IN VULNERABLE POPULATIONSChair: Jennifer W Tidey, PhD, USACo-Chair: Laura R Stroud, PhD, USADiscussant: Raymond Niaura, PhD

Audience: PC, PH/E, HD, I, LMIC

SYM17A: MENTHOL TOBACCO USERS’ RESPONSE TO RESTRICTIONS ON MENTHOL CIGARETTES: RESULTS AMONG US YOUNG ADULTSPresenters: Shyanika W Rose, PhD; Amy C Cohn, PhD; Jen-nifer L Pearson, PhD; Ashley Mayo, MPH; Andrea C Villanti, PhD

SYM17B: HIGH RATES OF MENTHOL USE IN PREGNANT SMOKERS: PRELIMINARY REPORT FROM TWO PREGNANCY COHORTSPresenters: Laura Stroud, PhD; Chrystal Vergara-Lopez, PhD; Allison Gaffey, PhD; Margaret Bublitz, PhD; Raymond Niaura, PhD

SYM17C: MENTHOL EFFECTS ON WITHDRAWAL AND CRAVING IN SMOKERS WITH SCHIZOPHRENIAPresenters: Jennifer W Tidey, PhD; Mollie E Miller, PhD; Rachel L Denlinger, MPH

10:30 a.m.-12:00 noonAffari (1st Floor) - Room 2Podium Presentation 3Symposium 18BEYOND PLAIN PACKAGING: PACK INSERTS AND DISSUASIVE CIGARETTESChair: David Hammond, PhD, CanadaDiscussant: Linda Bauld, PhD

Audience: P, PC, I, LMIC


64

SYM18A: ADULT SMOKERS’ PERCEPTIONS OF CIGARETTE PACK INSERTS WITH CESSATION MESSAGES: A FOCUS GROUP STUDYPresenters: Crawford Moodie, PhD

SYM18B: CAN CIGARETTE PACKAGE INSERTS PROMOTE CESSATION-RELATED BELIEFS? AN EXPERIMENT WITH ADULT SMOKERS IN THE USPresenters: James F Thrasher, PhD; Dien Ashari; Farah Islami; David Hammond, PhD; Ramzi Salloum, PhD

SYM18C: CONSUMER PERCEPTIONS OF CIGARETTE DESIGN IN FRANCEPresenters: Karine Gallopel-Morvan, PhD; Romain Guignard, PhD; Crawford Moodie, PhD; Figen Eker; Emmanuelle Beguinot; Viet Nguyen-Thanh

SYM18D: ADOLESCENT PERCEPTIONS OF DISSUASIVE STICKS: A WEB SURVEY AMONG 16-20 YEAR OLDS IN NORWAYPresenters: Ingeborg Lund; Janne Scheffels, PhD

10:30 a.m.-12:00 noonPalazzo dei Congressi: VerdePodium Presentation 3Symposium 19THE BRIGHTER SIDE OF NICOTINE: BEYOND NICOTINE ADDICTION AND TOWARDS DEVELOPMENT OF BENEFICIAL NICOTINIC DRUGS.Chair: Jill Turner, PhD, USACo-Chair: Kenneth Kellar, PhD, USADiscussant: Mariella DeBiasi, PHD

Audience: PC, C, T, I

SYM19A: NICOTINIC INVOLVEMENT IN ATTENTION, LEARNING, AND MEMORY: BASIC DISCOVERIES AND THERAPEUTIC DEVELOPMENT.Presenters: Edward Levin, PHD

SYM19B: DIVERGENT RESPONSES TO NICOTINE IN MODELS OF ANXIETY MAY REPRESENT DIFFERING CIRCUITRY EFFECTS IN THE HIPPOCAMPUS AND ORBITOFRONTAL CORTEX.Presenters: Jill R Turner, PHD

SYM19C: TRANSGENERATIONAL EFFECTS OF NICOTINE AND STRESS: INTERACTIONS ACROSS GENERATIONS.Presenters: Nicole Yohn, PHD; Julie A Blendy, PHD

SYM19D: DESENSITIZATION OF NICOTINIC RECEPTORS: THERAPEUTIC IMPLICATIONS FOR OBESITY PHARMACOTHERAPYPresenters: Ghazaul Dezfuli, PHD; Kenneth J Kellar, PHD

10:30 a.m.-12:00 noonAffari (4th Floor)Podium Presentation 3Paper Session 6Nicotine and Animal ModelsChair: Marina Picciotto, PhD, USA

Audience: BS, PC

10:30 a.m. - 10:45 a.m.DEVELOPMENTAL NICOTINE EXPOSURE INDUCES PERSISTENT ALTERATIONS IN ACCUMBENS GLUTAMATERGIC CIRCUITRYGregory L Powell, PhD*; Julianna Goenaga; Armani Del Franco; Michael C Holter; Raul Garcia; Annika Vannan; Janet L Neisewander, PhD; Cassandra D Gipson, PhD


Frid

ay, M

arch

10,

201

7


65

10:45 a.m. - 11:00 a.m.TRANSGENERATIONAL EFFECTS OF PATERNAL NICOTINE EXPOSURE ON FEAR RESPONSE AND CHOLINERGIC FUNCTIONMunir Gunes Kutlu, PhD.*; Rob Cole; Jessica M Tumolo; Vinay Parikh, PhD; Thomas J Gould, PhD

11:00 a.m. - 11:15 a.m.CHRONIC INTERACTIONS OF SEROTONERGIC AND DOPAMINERGIC TREATMENTS WITH NICOTINE INFUSIONS FOR DECREASING NICOTINE SELF-ADMINISTRATION IN RATSEdward D Levin, PhD*; Devon DiPalma; Blair Willette; Corinne Wells; Susan Slade; Brandon J Hall, PhD; Amir H Rezvani, PhD

11:15 a.m. - 11:30 a.m.NICOTINE WITHDRAWAL-INDUCED ANXIETY AND DEPRESSION-LIKE BEHAVIOR IN C57BL6 MICE: AN ANIMAL MODEL FOR NICOTINE PHYSICAL DEPENDENCERanjithkumar Chellian*, M.Pharm*; Vijayapandi Pandy, PhD; Zahurin Mohamed, PhD

11:30 a.m. - 11:45 a.m.EXAMINING SELF-MEDICATION OF NICOTINE IN SCHIZOPHRENIA USING RODENT MODELS OF NICOTINE SELF-ADMINISTRATION FOLLOWING SUB CHRONIC KETAMINE EXPOSUREMohammed Shoaib, PhD, BSc*

11:45 a.m. - 12:00 noonMENTHOL DECREASES ORAL NICOTINE AVERSION IN C57BL/6 MICE THROUGH A TRPM8-DEPENDENT MECHANISMSairam V Jabba, DVM, PhD*; Lu Fan, MD, PhD; Shrilatha Balakrishna, PhD; Pamela E Bonner, MS; Seth R Taylor, PhD; Marina R Picciotto, PhD; Sven-Eric Jordt, PhD

10:30 a.m.-12:00 noonAffari (1st Floor) - Auda 1Podium Presentation 3Paper Session 7Smoking in Low and Medium Income CountriesChair: Pal-Istvan Kikeli, PhD, Romania

Audience: PH/E, P, LMIC

10:30 a.m. - 10:45 a.m.VERY UNSUCCESSFUL ATTEMPTS TO QUIT: EXAMINING CORRELATES IN THE 13 COUNTRIES WHERE ALMOST 2/3 OF SMOKERS LIVEJoão Mauricio Castaldelli-Maia, MD*

10:45 a.m. - 11:00 a.m.COMPARING PACK DESIGN AND BRANDING APPEALS BETWEEN THE MOST EXPENSIVE AND THE CHEAPEST CIGARETTE PACKS FROM 14 LOW AND MIDDLE INCOME COUNTRIESKatherine C Smith, PhD*; Kevin Welding, PhD; Joanna E Cohen, PhD

11:00 a.m. - 11:15 a.m.SMOKERS’ REACTIONS TO TEXT AND GRAPHIC WARNINGS ON CIGARETTE PACKAGES: FINDINGS FROM ITC AFRICAN COUNTRIESSusan C Kaai, PhD*; Geoffrey T Fong, PhD; Gang Meng, PhD; Anne C.K Quah, PhD; Annika C Green, MPH; Fastone Goma, MD, PHD; Premduth Burhoo, MRes; Jane Ong’ang’o, MD


66

11:15 a.m. - 11:30 a.m.SALE OF SINGLE CIGARETTES NEAR PRIMARY AND SECONDARY SCHOOLS IN 10 COUNTRIESJennifer L Brown, MPH*; Ashley Grant, MPH; Caitlin Weiger; Joanna Cohen, PhD

11:30 a.m. - 11:45 a.m.WATERPIPE SMOKING AMONG EAST-AFRICANS: A COMMUNITY-BASED PARTICIPATORY RESEARCH TRIAL INVESTIGATING THE POTENTIAL ROLE OF RELIGION IN CESSATIONPrashasti Bhatnagar, *; Abdi Jibril, MS; Abdullahi Sheikh, MS; Kamran Siddiqi, MBBS,MRCP, MPH, FFPH, PhD; Hemen Muleta, BA; Janet Thomas, PhD, LP

11:45 a.m. - 12:00 noonTHE ECONOMICS OF TOBACCO FARMING IN LOW- AND MIDDLE-INCOME COUNTRIESJeffrey Drope, PhD*; Raphael Lencucha, PhD

10:30 a.m.-12:00 noonAffari (2nd Floor)Podium Presentation 3Paper Session 8Smoking and E-Cigarette Use in PregnancyChair: Gillian Gould, PhD, AustraliaCo-Chair: Yael Bar-Zeev, PhD, Australia

Audience: PH/E, C, HD, I

10:30 a.m. - 10:45 a.m.SMOKING DURING PREGNANCY IN THE UNITED STATES, 2005-2014: THE ROLE OF PSYCHOLOGICAL DISTRESS AND DEPRESSIONRenee D Goodwin, PhD, MPH*; Keely Cheslack-Postava, PhD; Melanie M Wall, PhD; Deborah Hasin, PhD; Deborah Nelson, PhD; Philip Smith, PhD

10:45 a.m. - 11:00 a.m.PREVALENCE OF E-CIGARETTE USE AND CHARACTERISTICS IN A U.S. NATIONALLY REPRESENTATIVE SAMPLE OF PREGNANT WOMENAllison N Kurti, PhD*; Janice Y Bunn, PhD; Stephen T Hig-gins, PhD; Ryan Redner, PhD; Alexa A. Lopez, PhD; Diana R Keith, PhD; Cassandra A. Stanton, PhD; Diann E. Gaalema, PhD; Nathan J. Doogan, PhD; Antonio Cepeda-Benito, PhD; Megan E. Roberts, PhD

11:00 a.m. - 11:15 a.m.POSTPARTUM CHANGES IN MOOD AND SMOKING-RELATED SYMPTOMATOLOGY: AN INVESTIGATION USING ECOLOGICAL MOMENTARY ASSESSMENTAlicia M Allen, PhD, MPH*; Nicole Tosun, MS; Samantha Carlson, MPH; Sharon Allen, MD, PhD

11:15 a.m. - 11:30 a.m.PREDICTORS OF POSTPARTUM SMOKING RELAPSE INTENT IN A SAMPLE OF ROMANIAN WOMENOana M Blaga, MA*; Alexandra Brinzaniuc, MA; Razvan M Chereches, MD, PhD; Cristian I Meghea, PhD

11:30 a.m. - 11:45 a.m.HOW INCENTIVE PROGRAMS FOR PREGNANT INDIGENOUS WOMEN TO QUIT CHANGE IN PRACTICE.Marewa Glover, PhD*; Anette Kira, PhD; Keriata Paterson, PhD


Frid

ay, M

arch

10,

201

7


67

11:45 a.m. - 12:00 noonTHE INFLUENCE OF PARTNER’S SMOKING ON FACTORS ASSOCIATED WITH INTENTION TO QUIT SMOKING AMONG PREGNANT SMOKERS ENROLLED IN A CESSATION INTERVENTION TRIALJonathan T Macy, PhD, MPH*; Rachel M Dowty, RN, MPH; Susan E Middlestadt, PhD; Alejandro Arrieta, PhD; Joan Duwve, MD, MPH; Stephen J Jay, MD

12:00 noon-1:30 p.m.Passi PerdutiPDC BuildingPoster Session 3: Public Health

12:00 noon-1:30 p.m.Passi Perduti (Basement - Lowest Level)Lunch Break

Pick up your complimentary boxed lunch, starting at 11:45 a.m.

12:00 noon-1:30 p.m.Villa Vittoria: Sala 9 – Terra Piano (Ground Floor)PDC BuildingTrainee Network Senior Investigator Roundtables

12:15 p.m.-1:15 p.m.Villa Vittoria: Sala 101 – Primo Piano (1st Floor)Meet-the-Editor

Robert West, Deputy Editor Addiction Journal

1:30 p.m.-2:00 p.m.Auditorium-General Session RoomPDC BuildingJarvik-Russell New Investigator Awards Paper Session

Ecological Momentary Tobacco ControlThomas R. Kirchner, PhD, Clinical Associate Professor of Public Health, Medicine, and Urban Science at NYU College of Global Public Health, USA

2:00 p.m.- 3:00 p.m.

Policy Theme Plenary LecturePopulation Level Policies to Prevent Chronic Disease: Apply-ing Lessons From Nicotine and Tobacco ResearchLinda Bauld, Professor of Health Policy, University of Stirling and Chair in Behavioural Research for Cancer Prevention, Cancer Research UK. President-elect of SRNT-Europe

3:00 p.m.-3:30 p.m.Salone Club (Lower level)PDC BuildingExhibitor Time (Last time to visit)


3:30 p.m.-5:00 p.m.Affari (1st Floor) - Room 2Podium Presentation 4Symposium 20INCREASING REACH WITHIN AND BEYOND HEALTH CARE SETTINGS TO IMPROVE ACCESS TO TOBACCO USE TREATMENT: LEVERAGING COMMUNITY AND TREATMENT SETTINGS IN ASIA, AUSTRALIA AND THE UNITED STATESChair: Christine L Paul, PhD, AustraliaDiscussant: Amanda Baker, PhD

Audience: C, T, I


68

SYM20A: EFFECTIVENESS OF STRATEGIES FOR IMPLEMENTING TOBACCO USE TREATMENT GUIDELINES IN COMMUNITY CENTERS IN VIETNAMPresenters: Nina Siman, MSEd, MA; Nam Truong Nguyen, MD, DrPH; Charles M Cleland, PHD; Nancy VanDevanter, DrPH, RN, EdM, FAAN; Trang Thi Nguyen; Linh Thi Nguyen; Donna Shelley, MD, MPH

SYM20B: ADDRESSING TOBACCO USE IN KOREAN AND VIETNAMESE SMOKING PATIENTS IN COMMUNITY HEALTH PRIMARY CARE SETTINGS IN CALIFORNIA, UNITED STATESPresenters: Janice Y Tsoh, PhD; Thu Quach, PhD; Thomas B Duong, BS; Emily (Sa Nan) Park, BS; Ching Wong, BS; Hy Lam, BS; Susan Huang, MS MD; Tung T Nguyen, MD

SYM20C: AN ORGANISATIONAL CHANGE INTERVENTION FOR INCREASING THE DELIVERY OF SMOKING CESSATION SUPPORT IN ADDICTION TREATMENT CENTRESPresenters: Billie Bonevski, PhD; Ashleigh Guillaumier, PhD; Anthony Shakeshaft, PhD; Flora Tzelepis, PhD; Catherine D’Este, PhD; Michael Farrell, PhD; Christine L Paul, PhD; Adrian Dunlop; Scott Walsberger; Pete Kelly, PhD; Christo-pher Oldmeadow, PhD; Andrew Searles, PhD

SYM20D: EMBEDDING SMOKING CESSATION SUPPORT IN CANCER CARE CLINICS IN NEW SOUTH WALES AUSTRALIAPresenters: Christine L Paul, PhD; Emma Sherwood; Megan Freund, PhD; Ann Dadich, PhD; Bettina Meiser, PhD; Nata-lie Taylor, PhD; Tim Shaw, PhD; Fiona Day, PhD; Megan Varlow; Sanchia Aranda, PhD

3:30 p.m.-5:00 p.m.Affari (2nd Floor)Podium Presentation 4Symposium 21E-CIGARETTES AND OTHER GLOBAL TOBACCO EXPOSURES DURING PREGNANCY.Chair: Gillian S Gould, PhD, MA, MBChB, AustraliaDiscussant: Marewa Glover, PhD

Audience: PH/E, HD, I

SYM21A: ELECTRONIC CIGARETTES IN PREGNANCY: WHAT DO WE KNOW?Presenters: Linda Bauld, PhD

SYM21B: ASSESSMENT OF EXCLUSIVE AND DUAL CIGARETTE AND HOOKAH SMOKING AMONG A SAMPLE OF PREGNANT WOMEN IN EGYPT.Presenters: Omar El Shahawy, MD, MPH, PhD; Kareem Labib, MD, MSc; Erin Mead, PhD, MHS; Ahmed Nagib, MD, MSc; Scott Sherman, MD, MPH; Cheryl Oncken, MD, MPH

SYM21C: USING SIMULATION MODELING TO EXAMINE PERINATAL HEALTH CONSEQUENCES OF SMOKELESS TOBACCO USE AMONG PREGNANT INDIAN WOMEN.Presenters: Jean J Schensul, PhD; Saritha Nair, PhD; David Lounsbury, PhD

SYM21D: ARE AUSTRALIAN CLINICIANS ASKING ABOUT CONTEMPORARY EXPOSURES TO TOBACCO, SMOKING AND NICOTINE DURING PREGNANCY IN AUSTRALIA? A NATIONAL CROSS-SECTIONAL SURVEY.Presenters: Gillian S Gould, PhD, MA, MBChB; Yael Bar-Zeev, MD, MPH; Laura Twyman, PhD; Christopher Old-meadow, PhD; Billie Bonevski, PhD


Frid

ay, M

arch

10,

201

7


69

3:30 p.m.-5:00 p.m.Auditorium-General Session RoomPDC BuildingPodium Presentation 4Symposium 22TOBACCO USE TRANSITIONS AMONG YOUTH AND ADULTS: DESCRIPTIVE LONGITUDINAL DATA FROM WAVES 1 AND 2 OF THE PATH STUDYChair: Kevin Conway, PhD, USACo-Chair: Nicolette Borek, PhD, USADiscussant: Gary Giovino, PhD

Audience: PH/E

SYM22A: TOBACCO USE TRANSITIONS AMONG YOUTH AND ADULTS: DESCRIPTIVE LONGITUDINAL DATA FROM WAVES 1 AND 2 OF THE PATH STUDYPresenters: The PATH Study Team

SYM22B: TOBACCO USE TRANSITIONS AMONG YOUTH AND ADULTS: DESCRIPTIVE LONGITUDINAL DATA FROM WAVES 1 AND 2 OF THE PATH STUDYPresenters: The PATH Study Team

SYM22C: TOBACCO USE TRANSITIONS AMONG YOUTH AND ADULTS: DESCRIPTIVE LONGITUDINAL DATA FROM WAVES 1 AND 2 OF THE PATH STUDYPresenters: The PATH Study Team

3:30 p.m.-5:00 p.m.Affari (Ground Floor)Podium Presentation 4Symposium 23NICOTINE PRELOADING: EFFECTIVENESS AND MECHANISMSChair: Stuart G Ferguson, PhD, AustraliaCo-Chair: Paul Aveyard, FRCGP PhD, UKDiscussant: Larry Hawk, PhD

Audience: C, T, I

SYM23A: NICOTINE PRELOADING: A RANDOMISED TRIALPresenters: Paul Aveyard, FRCGP PhD

SYM23B: NICOTINE PRELOADING TRIAL: MEDIATION ANALYSISPresenters: Peter Hajek, PhD

SYM23C: SATISFACTION WITH SMOKING, AND SMOKING REDUCTION, DURING PRE-QUIT TREATMENT WITH NICOTINE PATCH OR VARENICLINE.Presenters: Stuart Ferguson, PhD

SYM23D: DOES SMOKING REDUCTION WHILE ON NICOTINE PRELOADING PREDICT CESSATION? FINDINGS FROM THE PRELOADING TRIALPresenters: Paul Aveyard, FRCGP PhD

3:30 p.m.-5:00 p.m.Affari (4th Floor)Podium Presentation 4Symposium 24ADVANCES IN UNDERSTANDING NICOTINE DEPENDENCE IN AFRICAN AMERICAN SMOKERS: A TRANSDISCIPLINARY PERSPECTIVEChair: Lisa Sanderson Cox, PhD, USADiscussant: Jasjit S. Ahluwalia, MD

Audience: PC, C, HD, I, LMIC


70

SYM24A: VARENICLINE IS LESS EFFECTIVE IN AFRICAN AMERICAN COMPARED TO CAUCASIAN AMERICAN SMOKERS: RESULTS FROM A PROSPECTIVE STRATIFIED CLINICAL TRIALPresenters: Nikki L. Nollen, PhD; Lisa Sanderson Cox, PhD; Matthew S. Mayo, PhD; Edward F. Ellerbeck, MD; Taneisha S. Scheuermann, PhD; Rachel F. Tyndale, PhD; Neal L. Benowitz, MD; Jasjit S. Ahluwalia, MD

SYM24B: VARIATION IN NICOTINE METABOLISM AND RENAL TRANSPORT ALTER VARENICLINE TREATMENT IN AFRICAN AND CAUCASIAN SMOKERSPresenters: Rachel F. Tyndale, PhD; Annie R. Peng, BSc; Andy ZX. Zhu, PhD; Caryn Lerman, PhD

SYM24C: SOCIOPHARMACOLOGICAL PREDICTORS OF TOBACCO WITHDRAWAL AMONGST AFRICAN AMERICANSPresenters: Adam M. Leventhal, PhD; Mariel S. Bello, BS; Mollie S. Pester, BA; Claudia Aguirre, BA; Madalyn M. Liautaud, BA; Matthew D. Stone, BA; Nicolas I. Goldenson, BA; Raina D. Pang, PhD; Matthew G. Kirkpatrick, PhD; Lara A. Ray, PhD

3:30 p.m.-5:00 p.m.Affari (1st Floor) - Auda 1Podium Presentation 4Symposium 25THE ROLE OF RESEARCH IN MEETING FCTC COMMITMENTS TO INDIGNEOUS PEOPLES: WHAT PROGRESS HAVE WE MADE?Chair: Andrew M Waa, MPH, DPH, BSco.Sc, New ZealandDiscussant: Patricia N Henderson, MD, MPH


SYM25A: FRAMEWORK CONVENTION ON TOBACCO CONTROL COMMITMENTS TO PEOPLES: HOW ARE WE DOING?Presenters: Andrew M Waa, MPH, DPH, B.Soc.Sc; Raglan Maddox, Ph.D, MPH, BSc

SYM25B: UNDERSTANDING CAUSES OF DISPARITIES FOR INDIGENOUS PEOPLES: THE EXAMPLE OF THE ABORIGINAL AND TORRES STRAIT ISLANDER AUSTRALIANS AND THE TALKING ABOUT THE SMOKES PROJECTPresenters: David Thomas, PhD, MSc, DTM&H, MBBS

SYM25C: THE TRIBAL TOBACCO EDUCATION AND POLICY INITIATIVE: FINDINGS FROM A COLLABORATIVE, PARTICIPATORY EVALUATIONPresenters: Joanne D’Silva, MPH; Sheryl Scott, MPH; Bar-bara A Schillo, PhD; Nicole Villaluz, BA; Jaime L Martinez, MEd; Carol Hernandez, BA; Chris M Matter, BM

SYM25D: INDIGENOUS ENGAGEMENT IN TOBACCO CONTROL RESEARCH: MAORI AND PACIFIC YOUNG ADULT VIEWS ON SMOKING AS AN INFORMED CHOICEPresenters: Heather Gifford, PhD, MPH, DPH; El-Shadan Tautolo, PhD, MHSc, PGDip Forensics, BSc


Frid

ay, M

arch

10,

201

7


71

3:30 p.m.-5:00 p.m.Affari (2nd Floor) - Auda 2Podium Presentation 4Symposium 26NEW MECHANISTIC AND TRANSLATIONAL VIEWS OF THE HIPPOCAMPUS IN NICOTINE DEPENDENCE AND RELAPSE: EVIDENCE BRIDGING MOUSE AND HUMAN.Chair: Jill R Turner, PhD, USADiscussant: Brett Froeliger, PhD

Audience: BS, PC, T

SYM26A: ADOLESCENT NICOTINE EXPOSURE DISRUPTS ADULT HIPPOCAMPUS-DEPENDENT LEARNING AND ALTERS METHYLATION OF CHROMATIN-RELATED GENES IN THE DORSAL HIPPOCAMPUS.Presenters: Munir Kutlu; Miri Gitik; Erica Holiday; Yuan Qiaoping; Leung Ming; David Goldman; Thomas Gould, PhD

SYM26B: A TRANSLATIONAL VIEW OF THE HIPPOCAMPUS IN NICOTINE DEPENDENCE AND RELAPSE: FROM ANIMAL MODELS TO HUMAN NEUROIMAGING TO CLINICAL INTERVENION.Presenters: F. Joseph McClernon, PHD

SYM26C: CORTICOLIMBIC CIRCUITRY FUNCTION MEDIATING NEGATIVE EMOTION REGULATION IS ASSOCIATED WITH LAPSE VULNERABILITY.Presenters: Brett Froeliger, PHD; Christie Eichberg; Spencer Bell; Kevin Gray

SYM26D: NICOTINE WITHDRAWAL INDUCED BEHAVIORS ARE DIFFERENTIALLY REGULATED BY CREB ACTIVITY WITHIN THE VENTRAL AND DORSAL HIPPOCAMPUS: POSSIBLE ROLE FOR NRG3 SIGNALING.Presenters: Miranda Fisher; Jill R Turner, PHD

3:30 p.m.-5:00 p.m.Affari (1st Floor) - Room 1Podium Presentation 4Paper Session 9Tobacco Product Health WarningsChair: Sara Hitchman, PhD, UK

Audience: PC, P, I, LMIC

3:30 p.m. - 3:45 p.m.OVER-TIME IMPACTS OF NOVEL PICTORIAL HEALTH WARNING LABELS AND THEIR DIFFERENCES ACROSS SMOKER SUBGROUPS: RESULTS FROM SMOKERS IN AUSTRALIA AND CANADAFarahnaz Islam, MSPH*; James F Thrasher, PhD; Kamala Swayampakala, PhD; Hua Yong, PhD; Ron Borland, PhD; James W Hardin, PhD; Lin Li, PhD; David Hammond, PhD

3:45 p.m. - 4:00 p.m.MONITORING COMPLIANCE OF CIGARETTE PACK GRAPHIC HEALTH WARNING LABELS THREE MONTHS AFTER IMPLEMENTATION OF INDIA’S NEW HEALTH WARNING LABELS LAWErnesto M Sebrie, MD, MPH*; Teresa E DeAtley, MPH; Van-dana Shah, LLM; Seema Gupta, MSW; Bhavna B Mukhopad-hyay, MS; Karoline Walter; Deirdre L Kittner, PhD, MPH

4:00 p.m. - 4:15 p.m.CHARACTERIZING SOCIAL INTERACTIONS ABOUT PICTORIAL WARNINGS ON CIGARETTE PACKSJennifer C Morgan, MPH*; Seth M Noar, PhD; Kurt M Ribisl, PhD; Noel T Brewer, PhD


72

4:15 p.m. - 4:30 p.m.LONGITUDINAL EFFECT OF EMOTIONAL GRAPHIC WARNING LABELS ON THE BRAINAn-Li Wang, Ph.D.*; Zhenhao Shi, Ph.D.; Victoria Fairchild; Catherine Aronowitz; Daniel Langleben

4:30 p.m. - 4:45 p.m.CHARACTERISTICS OF WARNING STATEMENTS PRINTED ON ELECTRONIC CIGARETTE LIQUID BOTTLES MANUFACTURED AND DISTRIBUTED IN THE UNITED STATESPebbles Fagan, PhD, MPH*; Pallav Pokhrel, PhD, MPH; Thaddeus A Herzog, PhD; Mignonne C Guy, PhD; Kari-Lyn K Sakuma, PhD, MPH; Dennis R Trinidad, PhD, MPH; Kevin D Cassel, DrPH, MPH; Dorothy Jorgensen, MPH; Tania Lynch, MSN, MPH; Jamie Q Felicitas-Perkins, MPH; Sherilyn Palafox, BS;Faith Hamamura, BS;Sarah Maloney, BA; Kaylah Degree, BA;Thomas Eissenberg, PhD

4:45 p.m. - 5:00 p.m.EVALUATION OF WAYS TO COMMUNICATE HARMFUL AND POTENTIALLY HARMFUL CONSTITUENTS (HPHC) INFORMATION ON PRODUCT INSERTS: A DISCRETE CHOICE EXPERIMENTRamzi G Salloum, PhD*; Jordan Louviere, PhD; Kayla R Getz, MPH; Farahnaz Islam; David Hammond, PhD; Richard J O’Connor, PhD; James F Thrasher, PhD

3:30 p.m.-5:00 p.m.Palazzo dei Congressi: VerdePodium Presentation 4Paper Session 10Attitudes Toward SH Exposure PoliciesChair: Monica Tarcea, MD, PhD, Romania

Audience: OH/E, P, I, LMIC

3:30 p.m. - 3:45 p.m.HOUSEHOLD SMOKING BANS AND YOUTH SMOKING BEHAVIOUR IN ITALY: FINDINGS FROM THE SIDRIAT LONGITUDINAL STUDYGiuseppe Gorini, MD*; Giulia Carreras, PhD; Barbara Cortini, BSc; Simona Verdi, BSc; Maria Grazia Petronio, MD; Pier-sante Sestini, MD; Elisabetta Chellini, MD

3:45 p.m. - 4:00 p.m.VALIDITY OF REPORTED MEASURES OF SECONDHAND SMOKE EXPOSURE IN INDIAN HOUSEHOLDS: MISHRI PREPARATION A POTENTIALLY OVERLOOKED SOURCE IN LOW-INCOME INDIAN COMMUNITIESJessica L Elf, PhD MPH*; Aarti Kinikar; Sandhya Khadse; Vidya Mave; Nikhil Gupte; Nishi Suryavanshi; Priyanka Rai-chur; Joanna Cohen; Patrick Breysse; Amita Gupta; Jonathan Golub

4:00 p.m. - 4:15 p.m.KIDS SAFE AND SMOKEFREE: PARENTS’ SELF-EFFICACY, NOT COPING SKILLS OR HOME SMOKING RESTRICTIONS, MEDIATES COUNSELING TREATMENT EFFECTS ON LOW-INCOME PARENTS’ SMOKING CESSATIONBradley N. Collins, PhD*; Stephen J. Lepore, PhD; Donna L. Coffman, PhD

4:15 p.m. - 4:30 p.m.PREDICTORS OF AFFORDABLE HOUSING RESIDENTS’ SUPPORT FOR A SMOKING BAN, PRE- AND POST-ADOPTIONVaughan W. Rees, PhD*


Frid

ay, M

arch

10,

201

7


73

4:30 p.m. - 4:45 p.m.THE EFFECT OF A SMOKING BAN IN CASINOS ON ADMISSIONS AND REVENUEJohn A Tauras, PhD*; Frank J. Chaloupka, PhD

4:45 p.m. - 5:00 p.m.RESTRICTIONS ON THE USE OF E-CIGARETTES IN PUBLIC AND PRIVATE PLACES - CURRENT PRACTICE AND SUPPORT AMONG ADULTS IN GREAT BRITAINLeonie S Brose, PhD*; Ann McNeill, PhD; Deborah Arnott, MBA; Hazel Cheeseman, MSc

5:00 p.m.-6:00 p.m.Villa Vittoria: Sala Onice – Ground FloorMeet-the-Editor

Scott Leischow, Editor-in-Chief Tobacco Regulatory Science Journal

5:00 p.m.-6:00 p.m.Passi PerdutiPDC BuildingPoster Session 4: Public Health

7:30 p.m.-10:30 p.m.

SRNT-E Gala Dinner(RSVP and additional fee required)

74



75

76



Satu

rday

, Mar

ch 1

1, 2

017

77

SESSION SUMMARY SATURDAY

MARCH 11, 2017

78



Satu

rday

, Mar

ch 1

1, 2

017


79

SATURDAY, MARCH 11, 2017

8:00 a.m.-11:00 a.m.Piazza Adua (Reception Area) Registration

8:00 a.m.-11:00 a.m.Retropresidenza (Passi Perduti - Lowest Level)PDC BuildingSpeaker Ready Room

8:15 a.m.- 8:45 a.m.Villa Vittoria: Sala Verde – Secondo Piano (2nd Floor)PDC BuildingSRNT Members Meeting

9:00 a.m.-10:30 a.m.Affari (2nd Floor) - Auda 2Podium Presentation 5Symposium 27UNDERSTANDING DIVERSE PATTERNS OF POLY-TOBACCO AND CANNABIS PRODUCT USE AMONG YOUTH AND YOUNG ADULTS: LONGITUDINAL DATA FROM FOUR TOBACCO CENTERS FOR REGULATORY SCIENCEChair: Suchitra Krishnan-Sarin, PhD, USACo-Chair: Adam M Leventhal, PhD, USADiscussant: Robin J Mermelstein, PhD

Audience: PH/E, HD

SYM27A: CIGAR USE AND SUBSEQUENT CIGARETTE INITIATIONPresenters: Grace Kong, PhD; Jessica L Barrington-Trimis, PhD; Margaret Mayer, MPH; Rob McConnell, MD; Adam M Leventhal, PhD; Suchitra Krishnan-Sarin, PhD

SYM27B: E-CIGARETTE USE AND PROGRESSION TO CIGARETTE SMOKING AND DUAL PRODUCT USEPresenters: Jessica L Barrington-Trimis, PhD; Grace Kong, PhD; Adam M Leventhal, PhD; Tess Boley Cruz, PhD; Suchitra Krishnan-Sarin, PhD; Rob McConnell, MD

SYM27C: E-CIGARETTE AND COMBUSTIBLE TOBACCO PRODUCT USE AMONG YOUTH: WHICH COMES FIRST?Presenters: Melissa B Harrell, PhD; Christian D Jackson, MS; Joanne E Delk, MS; MeLisa Creamer, PhD; Cheryl L Perry, PhD

SYM27D: ADOLESCENT MARIJUANA AND TOBACCO USE: OLD AND NEW CO-MORBIDITIESPresenters: Janet Audrain-McGovern, PhD; Jessica L Barrington-Trimis, PhD; Adam M Leventhal, PhD

9:00 a.m.-10:30 a.m.Affari (1st Floor) - Auda 1Podium Presentation 5Symposium 28PRODUCT STANDARDS FOR CIGARETTES: MODELS TO ACHIEVE MAXIMUM PUBLIC HEALTH BENEFITChair: Irina Stepanov, PhD, USACo-Chair: Dorothy Hatsukami, PhD, USADiscussant: Jack E Henningfield, PhD

Audience: PC, P, I

SYM28A: ESTABLISHING LIMITS FOR CIGARETTE SMOKE CONSTITUENT LEVELS PER MILLIGRAM NICOTINEPresenters: Irina Stepanov, PhD; Dorothy Hatsukami, PhD

Program · Saturday, March 11, 2017

80

SYM28B: REDUCING THE NICOTINE CONTENT TO MAKE CIGARETTES LESS ADDICTIVEPresenters: Neal L. Benowitz, MD

SYM28C: CIGARETTE PHYSICAL DESIGN FEATURES THAT INCREASE PRODUCT ELASTICITYPresenters: Reinskje Talhout, PhD; Patricia Richter, PhD; Irina Stepanov, PhD; Christina Watson; Clifford Watson, PhD

SYM28D: PROMISES AND PERILS OF POTENTIAL REGULATORY OPTIONS FOR CIGARETTESPresenters: Jack E. Hennigfield, PhD

9:00 a.m.-10:30 a.m.Auditorium-General Session RoomPDC BuildingPodium Presentation 5Symposium 29E-CIGARETTES AND E-LIQUIDS: EVALUATING THE EFFECTS OF CONSTITUENTSChair: Andrea King, PhD, USACo-Chair: Suchitra Krishnan-Sarin, PhD, USADiscussant: Stephanie O’Malley, PhD

Audience: PC, P, I

SYM29A: IMPACT OF VARIOUS PRODUCT CHARACTERISTICS ON POTENTIAL INHALATION TOXICITY OF ELECTRONIC NICOTINE DELIVERY DEVICES (ENDS)Presenters: Maciej L Goniewicz, PhD

SYM29B: CUE EXPOSURE EFFECTS OF 2ND AND 3RD GENERATION E-CIGARETTES AND ROLE OF E-LIQUID VEGETABLE GLYCERIN CONCENTRATIONSPresenters: Andrea King, PhD; Megan Howe, BS; Luke Newell; Patrick Mcnamara; Dingcai Cao

SYM29C: IMPACT OF E-LIQUID FLAVORS ON NICOTINE INTAKE AND PHARMACOLOGY OF ELECTRONIC CIGARETTESPresenters: Neal Benowitz, MD; Gideon St.Helen, PhD

SYM29D: INTERACTIVE EFFECTS OF MENTHOL AND NICTOINE AMONG YOUTH; AN EXAMINATION USING E-CIGARETTESPresenters: Suchitra Krishnan-Sarin, PhD; Stephanie O’Malley, PhD; Grace Kong, PhD; Dana Cavallo, PhD; Ral-itza Gueorguieva, PhD

9:00 a.m.-10:30 a.m.Affari (2nd Floor)Podium Presentation 5Symposium 30IS SMOKING CESSATION CLINICAL PRACTICE HAMPERED BY OUTDATED REGULATION OF PHARMACOTHERAPIES?Chair: Renee Bittoun, , AustraliaDiscussant: Karl-Olov Fagerstrom, PhD

Audience: C, T, P, I

SYM30A: THE CONTROVERSY BETWEEN IMPLEMENTATION OF EVIDENCE BASED KNOWLEDGE AND MEDICATION LABELING IN THE EUROPEAN UNION.Presenters: Ivan Berlin

SYM30B: REGULATORY CONSTRAINTS ON NRT IN THE USPresenters: Saul Shiffman, PhD

SYM30C: IMPLEMENTING CHANGES IN PATIENT INFORMATION: THE AUSTRALIAN EXPERIENCEPresenters: Renee Bittoun


Satu

rday

, Mar

ch 1

1, 2

017


81

9:00 a.m.-10:30 a.m.Palazzo dei Congressi: VerdePodium Presentation 5Paper Session 11Public Education CampaignsChair: Richard Edwards, PhD, New ZealandCo-Chair: Leon Kosmider, PhD, Poland

Audience: PH/E. P, HD, I

9:00 a.m. - 9:15 a.m.OUTCOME EVALUATION RESULTS FOR FDA’S THE REAL COST CAMPAIGN: IMPACT ON YOUTH’S RISK PERCEPTIONS, BELIEFS ABOUT SMOKING AND SMOKING BEHAVIORSTesfa Alexander, PhD*; Jennifer Duke, PhD; Matthew Farrelly; Anna MacMonegle; James Nonnemaker, PhD; Xiaoquan Zhao, PhD; Pamela Rao, PhD; Janine Delahanty, PhD

9:00 a.m. - 9:15 a.m.DIGITAL EXPOSURE TO ANTI-SMOKING MESSAGING AND SMOKING-RELATED ATTITUDES AND INTENTIONS TO SMOKEDonna M Vallone, PhD, MPH*; Jennifer Cantrell, DrPH, MPA; Michael J Halenar, MPH; Haijun Xiao, MS; Jessica M Rath, PhD, MPH, CHES; Elizabeth C Hair, PhD, MA

9:15 a.m. - 9:30 a.m.CAN TV MASS MEDIA CAMPAIGNS LEAD TO CHANGES IN SMOKING BEHAVIOUR IN SCOTLAND? A STRUCTURAL VECTOR AUTOREGRESSION ANALYSISHoura Haghpanahan, PhD*; Daniel Mackay; Jill Pell; David Bell; Tessa Langley; Sally Haw

9:30 a.m. - 9:45 a.m.A COST-EFFECTIVENESS ANALYSIS OF INCREASING THE DOSE OF TELEVISION ADVERTISING IN A NATIONAL ANTISMOKING MEDIA CAMPAIGN: RESULTS FROM A RANDOMIZED FIELD TRIALXin Xu, PhD*; Sean Simpson, MA; Deesha Patel, MPH; James Nonnemaker, PhD; Shanna Cox, MSPH; Kevin Davis, MA; Tim McAfee, MD

10:00 a.m. - 10:15 a.m.ASSOCIATION BETWEEN MEDIA DOSES OF THE TIPS FROM FORMER SMOKERS™ CAMPAIGN AND CESSATION BEHAVIORS AND INTENTIONS TO QUIT AMONG CIGARETTE SMOKERS, 2012–2015Kevin Davis, MA*; Deesha Patel, MPH; Shanna Cox, MSPH; Rebecca Glover-Kudon, PhD, MSPH; Paul Shafer, MA; Wil-liam Ridgeway, MA; Jennifer Duke, PhD

10:15 a.m. - 10:30 a.m.BRAIN PROCESSES INVOLVED IN SELF-RELATED PROCESSING DURING MESSAGE EXPOSURE ALSO USED DURING RECALL OF “THE REAL COST“ ANTI-SMOKING CAMPAIGNElissa C Kranzler, MA, MSEd*; Ralf Schmaelzle, PhD; Rui Pei; Matthew B O’Donnell, PhD; Emily B Falk, PhD

9:00 a.m.-10:30 a.m.Affari (Ground Floor)Podium Presentation 5Paper Session 12Prenatal Exposure to Tobacco, E-Cigarettes and MarijuanaChair: Cheryl Oncken, PhD, USA

Audience: BS, PC, HD


82

9:00 a.m. - 9:18 a.m.PRENATAL SMOKING EXPOSURE AND THE RISK FOR PSYCHIATRIC MORBIDITY IN SINGLETON SIBLING PAIRSMikael Ekblad, MD, PhD*; Liisa Lehtonen; Jyrki Korkeila; Mika Gissler

9:18 a.m. - 9:36 a.m.PRENATAL TOBACCO AND MARIJUANA EXPOSURE AND ADULT USE OF ALTERNATE TOBACCO PRODUCTS AND BLUNTSNatacha M De Genna, PhD*; Lidush Goldschmidt, PhD; Nancy L Day, PhD; Marie D Cornelius, PhD

9:36 a.m. - 9:54 a.m.PRENATAL TOBACCO EXPOSURE AND ADULT ELECTRONIC CIGARETTE USENatacha M De Genna, PhD*; Lidush Goldschmidt, PhD; Nancy L Day, PhD; Marie D Cornelius, PhD

9:54 a.m. - 10:12 a.m.PHYSIOLOGICAL REGULATION DURING THE FIRST YEAR OF LIFE AMONG INFANTS PRENATALLY EXPOSED TO CIGARETTES AND MARIJUANAPamela Schuetze, PhD*; Rina D Eiden, PhD; Marilyn A Huestis

10:12 a.m. - 10:30 a.m.PRENATAL TOBACCO AND CANNABIS EXPOSURE AND TODDLER EMOTION REGULATION: MEDIATING ROLE OF AUTONOMIC REGULATION IN INFANCYRina D Eiden, PhD*; Pamela Schuetze, PhD; Shannon Shisler, MA; Marilyn A Huestis, PhD

9:00 a.m.-10:30 a.m.Affari (4th Floor)Podium Presentation 5Paper Session 13Endgame Strategies For Tobacco UseChair: Raydel Valdes-Saldago, PhD, Mexico


9:00 a.m. - 9:15 a.m.CAN ENDGAME INTERVENTIONS ACHIEVE A TOBACCO-FREE WORLD BY 2040? AND WITH WHAT QALY GAINS AND COST SAVINGS?Frederieke Sanne van der Deen*; Nick Wilson, MPH; Christine L Cleghorn, PhD; Giorgi Kvizhinadze, PhD; Linda J Cobiac, PhD; Tony Blakely, PhD

9:30 a.m. - 9:45 a.m.YOUNG ADULT SMOKERS’ PERCEPTIONS OF ENDGAME INTERVENTIONS: A QUALITATIVE ANALYSISJanet Hoek*; Jude Ball; Heather Gifford; El-Shadan Tautolo; Richard Edwards; Stephanie Erick; Teresa Taylor

9:45 a.m. - 10:00 a.m.COULD SOCIAL MOVEMENTS GALVANISE ENDGAME MOMENTUM?Janet Hoek*; Richard Edwards

9:00 a.m.-10:30 a.m.Affari (1st Floor) - Room 2Podium Presentation 5Paper Session 14Exposure to Tobacco and E-Cigarette AdvertisingChair: Derek Cheung, PhD, Hong Kong

Audience: PH/E, P, HD, I


Satu

rday

, Mar

ch 1

1, 2

017


83

9:00 a.m. - 9:15 a.m.CIGARETTE PACKAGING TECHNOLOGY GIMMICKS: HOW TOBACCO COMPANIES MARKET PRODUCT TECHNOLOGY AND INNOVATION IN 14 COUNTRIESCarmen C Washington, MPH*; Joanna Cohen, PhD; Kevin Welding, PhD; Katherine Smith, PhD

9:15 a.m. - 9:30 a.m.YOUNG ADULT PERCEPTIONS OF THE BRITISH AMERICAN TOBACCO NEW ZEALAND AGREE/DISAGREE PLAIN PACKAGING COUNTER-CAMPAIGNJudith P McCool, PhD, MPH*; Becky Freeman, PhD; Cecilia Wong-Cornell, MPH

9:30 a.m. - 9:45 a.m.RESIDENTIAL VENDOR PROXIMITY AND REGULAR ADOLESCENT TOBACCO USE: THE WALKABILITY FACTOR?Mary Ann Pentz, PhD, MA*; Robert Urman; Feifei Liu; Jessica Barrington-Trimis, PhD, MS, MA; Jimi Huh, PhD; Tess B. Cruz, PhD; John Wilson, PhD, MS; Rob S. McConnell, MD

10:00 a.m. - 10:15 a.m.EXPOSURE TO POINT-OF-SALE MARKETING AND PRODUCT DISPLAYS OF CIGARETTES AND E-CIGARETTES AS A PREDICTOR OF SMOKING CESSATIONDale S Mantey, MPA*; Keryn E Pasch, Phd, MPA; Alexandra Loukas, PhD; Cheryl L Perry, PhD

10:15 a.m. - 10:30 a.m.ELECTRONIC CIGARETTE TV ADVERTISING: AMOUNT AND CONTENT AND THEIR IMPACT ON E-CIGARETTE USEJidong Huang, PhD*; Glen Szczypka, MA; Steven Binns, MA; Frank Chaloupka, PhD; Sherry Emery, PhD

9:00 a.m.-10:30 a.m.Affari (1st Floor) - Room 1Podium Presentation 5Paper Session 15Smoking Cessation in Vulnerable PopulationsChair: Daniel Kotz, PhD, MsC, MPH, Germany

Audience: C, T, HD, I, LMIC

9:00 a.m. - 9:15 a.m.ARE MODEST FINANCIAL INCENTIVES FOR SMOKING CESSATION AND TREATMENT ENGAGEMENT IN ADULT LOW-INCOME MEDICAID MEMBERS EFFECTIVE: RESULTS OF A REAL WORLD STUDYDavid L Fraser, MS*; Michael C Fiore, MD, MPH, MBA; Kathleen Kobinsky, MS; Stevens S Smith, PhD; Timothy B Baker, PhD

9:15 a.m. - 9:30 a.m.PSYCHOLOGICAL AND BEHAVIORAL MEDIATORS OF A MULTILEVEL INTERVENTION TO REDUCE TOBACCO SMOKE EXPOSURE IN LOW-INCOME CHILDREN LIVING WITH A SMOKERStephen J. Lepore, PhD*; Bradley N. Collins, PhD; Donna L. Coffman, PhD

9:30 a.m. - 9:45 a.m.SEXUAL AND GENDER MINORITY DISCRIMINATION AND PERCEIVED SMOKER-RELATED STIGMA: ASSOCIATIONS WITH SMOKING BEHAVIORS AMONG SEXUAL AND GENDER MINORITY CURRENT OR FORMER SMOKERSSharon Lipperman-Kreda, PhD*; Tamar MJ Antin, DrPH


84

9:45 a.m. - 10:00 a.m.PROMOTING SMOKING CESSATION AMONG VIETNAMESE AMERICANS USING A FAMILY-BASED LAY HEALTH WORKER INTERVENTION: A CLUSTER RANDOMIZED CONTROLLED TRIALJanice Y Tsoh, PhD*; Nancy J Burke, PhD; Ginny Gildengorin, PhD; Khanh Le, MD, MPH; Ching Wong, BS; Jin Kim, PhD; Stephen J. McPhee, MD; Tung T Nguyen, MD

10:00 a.m. - 10:15 a.m.PREDICTORS OF SUCCESSFUL CESSATION FOR SMOKERS UNDER COMMUNITY CORRECTIONS SUPERVISION: THE IMPORTANCE OF MEDICATION ADHERENCEKaren L Cropsey, Psy.D.*; Brendan Clark, Ph.D.; Adrienne C Lahti, M.D.; Peter S Hendricks, Ph.D.

10:15 a.m. - 10:30 a.m.EXAMINING THE EFFECTS OF SUBSTANCE USE ON TOBACCO CESSATION OUTCOMES IN THE HELPING HAND 2 RANDOMIZED CONTROLLED TRIALJoanna M Streck, B.A.*; Yuchiao Chang; Susan Regan; Jen-nifer K Kelley; Nancy A Rigotti

10:30 a.m.- 11:00 a.m.Passi Perduti (Basement - Lowest Level)PDC Building Refreshment Break

10:30 a.m.-11:30 a.m.Villa Vittoria: Sala Onice – Ground Floor Meet-the-Editor

Renee Bittoun, Deputy Editor Journal of Smoking Cessation Journal

11:00 a.m.-12:30 p.m.Affari (1st Floor) - Room 1Podium Presentation 6Symposium 31ROLL YOUR OWN CIGARETTES: SHINING A LIGHT ON A NEGLECTED ASPECT OF THE SMOKING EPIDEMICChair: Richard Edwards, MPH MD, New ZealandDiscussant: Ron Borland, PhD

Audience: PH/E, HD, I, LMIC

SYM31A: SMOKING OF ROLL-YOUR-OWN CIGARETTES IN THE UNITED STATES - LABORATORY STUDIESPresenters: Wallace Pickworth, PhD; Gillian Schauer, PhD; Erica Peters, PhD

SYM31B: ROLL-YOUR-OWN CIGARETTES IN IRELAND: KEY PATTERNS AND TRENDSPresenters: David S Evans, PhD; Anne O’Farrell, PhD; Paul Hickey, MA

SYM31C: PATTERNS OF ROLL-YOUR-OWN TOBACCO USE AMONG ADOLESCENTS AND YOUNG ADULTS IN NEW ZEALANDPresenters: Richard Edwards, MPH MD; Ben Healey, PhD; Janet Hoek, PhD

SYM31D: HOW DO YOUNG ADULT ROLL-YOUR-OWN SMOKERS MANAGE NEGATIVE STEREOTYPES?Presenters: Janet Hoek, PhD; Shelagh Ferguson, PhD; Erin Court, BA; Karine Gallopel-Morvan, PhD


Satu

rday

, Mar

ch 1

1, 2

017


85

11:00 a.m.-12:30 p.m.Affari (1st Floor) - Room 2Podium Presentation 6Symposium 32ATTITUDES AND PERCEPTIONS TOWARD A REDUCED NICOTINE PRODUCT STANDARD FOR CIGARETTESChair: Jennifer W Tidey, PhD, USACo-Chair: Melissa Mercincavage, PhD, USADiscussant: Dorothy K Hatsukami, PhD

Audience: PC, PH/E, P, I

SYM32A: PERCEIVED NICOTINE CONTENT OF REDUCED NICOTINE CONTENT CIGARETTES AND MENTHOL STATUS AS CORRELATES OF PERCEIVED HEALTH RISKSPresenters: Lauren R Pacek, PhD; F. Joseph McClernon, PhD; Rachel L Denlinger-Apte, MPH; Melissa Mercincavage, PhD; Andrew A Strasser, PhD; Ryan Vandrey, PhD; Tracy T Smith, PhD; Natalie Nardone, PhD; Dorothy K Hatsukami, PhD; Joseph S Koopmeiners, PhD; Rachel V Kozink, MS; Eric C Donny, PhD

SYM32B: EFFECTS OF NICOTINE DOSE IN CIGARETTES ON PERCEIVED HEALTH RISK AND SUBJECTIVE RESPONSE IN ADOLESCENT SMOKERSPresenters: Rachel N Cassidy, PhD; Rachel L Denlinger-Apte, MPH; Suzanne M Colby, PhD; Jennifer W Tidey, PhD; Kristina Jackson, PhD; Patricia A Cioe, PhD; Suchitra Krishnan-Sarin, PhD; Dorothy K Hatsukami, PhD

SYM32C: IDENTIFYING THEMES OF RISK PERCEPTION IN SMOKERS WHO HAVE NEVER USED REDUCED NICOTINE CIGARETTESPresenters: Melissa Mercincavage, PhD; Megan L Saddleson, PhD; Kirsten Lochbuehler, PhD; Andrew A Strasser, PhD

SYM32D: ACCEPTABILITY OF A REDUCED NICOTINE PRODUCT STANDARD FOR CIGARETTES AMONG SMOKERS PROVIDED WITH REDUCED NICOTINE CIGARETTES FOR SIX-WEEKSPresenters: Rachel L Denlinger-Apte, MPH; Jennifer W Tidey, PhD; Joseph S Koopmeiners, PhD; Dorothy K Hatsukami, PhD; Eric C Donny, PhD

11:00 a.m.-12:30 p.m.Affari (2nd Floor)Podium Presentation 6Symposium 33NICOTINE ADDICTION AND WITHDRAWAL: INTEGRATING GENETIC, PHENOTYPIC, AND PHARMACOLOGIC FINDINGSChair: Henry R. Kranzler, MD, USADiscussant: Caryn Lerman, PhD

Audience: BS, PC, C, T, I

SYM33A: GENETICS OF NICOTINE WITHDRAWAL SYMPTOMSPresenters: Joel Gelernter, MD

SYM33B: GENOMEWIDE ASSOCIATION ANALYSIS FOR FTND SCORE SHOWS CHR. 14 SIGNAL IS ATTRIBUTABLE TO TIME TO FIRST MORNING CIGARETTEPresenters: Henry R Kranzler, MD

SYM33C: CHRNA5 CRITICALLY REGULATES NICOTINE’S INFLUENCE OVER THE DOPAMINERGIC SYSTEMPresenters: Mariella De Biasi, PhD


86

SYM33D: IDENTIFICATION OF NOVEL GENETIC FACTORS ASSOCIATED WITH CYP2A6, NICOTINE METABOLITE RATIO AND SMOKING CESSATION OUTCOMES IN AFRICAN AND CAUCASIAN AMERICAN SMOKERSPresenters: Rachel Tyndale, PhD

11:00 a.m.-12:30 p.m.Palazzo dei Congressi: VerdePodium Presentation 6Symposium 34EMERGING METHODS FOR CHARACTERIZATION OF NEW AND MANIPULATED TOBACCO PRODUCTSChair: Pamela I Clark, PhD, USADiscussant: Mirjana Djordjevic, PhD

Audience: BS, PC, I

SYM34A: THE CIGARETTE MICROBIOTA IS INFLUENCED BY BRAND, MENTHOLATION AND STORAGE CONDITIONS: IMPLICATIONS FOR POTENTAIL EXPOSURE TO TOBACCO-SPECIFIC NITORSAMINES AND BACTERIAL PATHOGENSPresenters: Emmanuel F Mongodin, PhD; Amy R Sapkota, PhD

SYM34B: EMERGING ELECTROENCEPHALOGRAPHIC/EVENT-RELATED POTENTIAL METHODS: POTENTIAL FOR EVALUATING NEW AND MANIPULATED TOBACCO PRODUCTSPresenters: Edward Bernat, PhD

SYM34C: USING NOVEL TECHNIQUES TO IDENTIFY HARMFUL EXPOSURES FROM TOBACCO PRODUCTSPresenters: Marielle C Brinkman, BS

SYM34D: SWEET FLAVORS IN ELECTRONIC CIGARETTESPresenters: Hyoshin Kim, PhD

11:00 a.m.-12:30 p.m.Affari (2nd Floor) - Auda 2Podium Presentation 6Symposium 35INNOVATIVE BRAIN STIMULATION TECHNIQUES FOR TREATING TOBACCO DEPENDENCEChair: Christine E Sheffer, PhD, USADiscussant: Warren K Bickel, PhD

Audience: PC, C, T

SYM35A: CAN TRANSCRANIAL MAGNETIC STIMULATION BE USED TO ENHANCE COGNITIVE BEHANVIORAL THERAPY FOR SMOKING CESSATION?Presenters: Andreas J Fallgatter, MD; Alica Dieler; Thomas Dresler; Ann-Christine Ehlis; Florian Haeussing; Agnes Kroc-zek; Martin Herrmann

SYM35B: THE FEASIBILITY OF ENHANCING SMOKING RELAPSE PREVENTION WITH TRANSCRANIAL MAGNETIC STIMULATIONPresenters: Christine E Sheffer, PhD; Warren K Bickel, PhD; Thomas H Brandon, PhD; Christopher T Franck, PhD; Luana Panissidi, MA; Syed A Abdali, MS; Sara E Lunden, MPH; Neelam Prashad, BA; Antonio Mantovani, MD, PhD

SYM35C: TRANSCRANIAL MAGNETIC STIMULATION FOR SMOKING CESSATION: A DOUBLE-BLIND, SHAM-CONTROLLED, RANDOMIZED TRIALPresenters: Xingbao Li, MD; Mark S George, MD; Kathleen T Brady, MD, PhD; Karen J Hartwell, MD; Scott Henderson, BS


Satu

rday

, Mar

ch 1

1, 2

017


87

SYM35D: TRANSLATING BASIC SCIENCE KNOWLEDGE OF NEURAL CIRCUITS TO TREATMENT OPTIONS FOR TOBACCO DEPENDENCEPresenters: Collen A Hanlon, PhD

SYM35E: CONTINUOUS THETA BURST TMS AS A TOOL TO CHANGE DECISION-MAKING IN SMOKERSPresenters: Sarah E Snider, PhD; Colleen A Hanlon, PhD; Jeff S Stein, PhD; Warren K Bickel, PhD

11:00 a.m.-12:30 p.m.Affari (1st Floor) - Auda 1Podium Presentation 6Symposium 36UNDERSTANDING AND INTERVENING ON ALCOHOL USE IN SMOKERS WHO DRINK HEAVILYChair: Christopher W. Kahler, PhD, USADiscussant: Peter Selby, MD

Audience: PC, PH/E, HD, I

SYM36A: DAILY FLUCTUATIONS IN SMOKING TEMPTATION AND THE IMPACT OF ALCOHOL USE ON THE TEMPTATION-SMOKING CONNECTION IN HEAVY DRINKING SMOKERS: RESULTS FROM AN IVR STUDYPresenters: Amy Cohn, PhD; Hoda Elmasry, MPH; Stephen Armeli, PhD; Sarah Ehlke, MS, MA; Thomas Brandon, PhD

SYM36B: AN INTEGRATED BEHAVIORAL INTERVENTION FOR HEAVY-DRINKING SMOKERS: RESULTS FROM A RANDOMIZED PILOT STUDYPresenters: Lisa M. Fucito, PhD; Tess Hanrahan; Kathleen Carroll; Srinivas Muvvala; Stephanie O’Malley

SYM36C: A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL OF ORAL NALTREXONE FOR HEAVY DRINKING SMOKERS SEEKING SMOKING CESSATION TREATMENTPresenters: Christopher W. Kahler, PhD; Patricia Cioe, PhD; Golfo Tzilos; Nichea Spillane; Lorenzo Leggio; Susan Ramsey; Richard Brown; Stephanie O’Malley

SYM36D: VARENICLINE EFFECTS ON ALCOHOL DRINKING, SMOKING, AND EXPLICIT AND IMPLICIT COGNITIVE-MOTIVATION PROCESSES IN ALCOHOL DEPENDENT SMOKERS SEEKING ALCOHOL TREATMENTPresenters: Stephanie S. O’Malley, PhD; Alan Zweben; Lisa Fucito; Ralitza Gueorguieva; Srinivas Muvvala; Janna Cousijn; Reinout Wiers

11:00 a.m.-12:30 p.m.Affari (4th Floor)Podium Presentation 6Symposium 37PSYCHO-SOCIAL INTERVENTIONS FOR SMOKING CESSATION IN PREGNANCY: AN SRNT-EUROPE SYMPOSIUMChair: Linda C Bauld, BA (Hons), PhD, UKDiscussant: Michael Ussher, BSc, MSc, PhD

Audience: Waiting on this per the chair - TBD?

SYM37A: SMOKING CESSATION INTERVENTIONS IN PREGNANCY AND POST-PARTUM: HOW INTERESTED ARE WOMEN IN ACCESSING SUPPORT AND USING SERVICES?Presenters: Sophie Orton; Laura Vanderbloemen; Katherine Bowker; Tim Coleman; Jo Leonardi-Bee; Sue Cooper; Ste-phen Sutton; Michael Ussher; Felix Naughton


88

SYM37B: BARRIERS AND FACILITATORS TO SMOKING CESSATION DURING PREGNANCY AND ACCESSING PSYCHO-SOCIAL INTERVENTIONS: THE VIEWS OF PREGNANT WOMEN, THEIR PARTNERS AND HEALTH PROFESSIONALS IN THE UKPresenters: Lesley Sinclair; Kathryn Angus; Jennifer McKell; Allison Ford; Linda Bauld; Felix Naughton

SYM37C: WILLINGNESS TO ACCEPT FINANCIAL INCENTIVES FOR SMOKING CESSATION IN PREGNANCY: A COMPARISON FRANCE-UNITED KINGDOMPresenters: Noémi Berlin; Leontine Goldzahl; Pat Hoddinott; Linda Bauld; Ivan Berlin

SYM37D: SMOKING CESSATION SUPPORT FOR PREGNANT WOMEN: A SURVEY OF ENGLISH STOP SMOKING SERVICESPresenters: Sue Cooper; Sophie Orton; Naomi Coleman-Haynes; Sarah Lewis; Katherine Bowker; Tim Coleman; Andy McEwen

11:00 a.m.-12:30 p.m.Auditorium-General Session RoomPDC BuildingPodium Presentation 6Paper Session 16Trends in Tobacco Product UseChair: Geofrey Fong, PhD, Canada

Audience: PH/E, I, LMIC

11:00 a.m. - 11:15 a.m.COUNTRY-SPECIFIC PROFILES AND GLOBAL PATTERNS OF THE TOBACCO EPIDEMIC. IMPLICATIONS OF CURRENT PROFILES OF SMOKING AND POPULATIONS AGE STRUCTURE FOR TOBACCO-RELATED HEALTH OUTCOMES IN THE FUTURERaydel Valdes Salgado, PhD, MPH, MS*

11:15 a.m. - 11:30 a.m.DIFFERENTIAL CIGARETTE CONSUMPTION TRAJECTORIES FROM YOUNG ADULTHOOD TO MID-LIFE BY RACE AND GENDERKelvin Choi, PhD, MPH*; Melanie Sabado, PhD

11:30 a.m. - 11:45 a.m.LONGITUDINAL RELATIONSHOPS BETWEEN E-CIGARETTE USE AND SMOKING INITIATION IN UK ADOLESCENTSSally J Haw, *; Catherine Best; Farhana Haseen; Dorothy Cur-rie; Gozde Ozacinki

12:00 noon - 12:15 p.m.DO NEVER-SMOKERS MAKE UP AN INCREASING SHARE OF SNUS USERS AS CIGARETTE SMOKING DECLINES? THE NORWEGIAN EXPERIMENTKarl Erik Lund, PhD*; Tord F Vedoy, PhD; Linda Bauld, PhD

12:15 p.m. - 12:30 p.m.DAILY CANNABIS USE AMONG CIGARETTE SMOKERS IN THE UNITED STATES, 2002-2014: IMPLICATIONS FOR THE FUTURE OF TOBACCO CONTROL?Renee D Goodwin, PhD, MPH*; Lauren Pacek, PhD; Jan Copeland, PhD; Scott Moeller, PhD; Lisa Dierker, PhD; Andrea Weinberger, PhD; Michael Zvolensky, PhD; Misato Gbedemah, MPH; Melanie Wall, PhD; Deborah Hasin, PhD


Satu

rday

, Mar

ch 1

1, 2

017


89

11:00 a.m.-12:30 p.m.Affari (Ground Floor)Podium Presentation 6Paper Session 17Toxicity of Tobacco ProductsChair: Maciej L. Goniewicz, PharmD, PhD, USA

Audience: BS, PC, C, I

11:00 a.m. - 11:15 a.m.ALDEHYDE EMISSIONS FROM ELECTRONIC CIGARETTES: RELATION TO ATOMIZER AGE, PRODUCT MANUFACTURING VARIABILITY, AND INTRA-PUFF PARTICLE GENERATION INTERMITTENCYAlan Shihadeh, ScD*; Mohamad Baassiri, ME; Rola Salman, BS; Soha Talih, PhD; Nareg Karaoghlanian, BE

11:15 a.m. - 11:30 a.m.COMPENSATORY PUFFING BEHAVIOR WITH LOWER NICOTINE STRENGTH E-LIQUID CAN INCREASE CARBONYL EXPOSURELynne E Dawkins, PhD*; Catherine F Kimber, BSc; Leon Kosmider, PhD; Jolanta Kurek, MSc; Mira Doig, PhD; Colin Feyerabend, PhD; Olivia Corcoran, PhD

11:30 a.m. - 11:45 a.m.PRESENCE OF THE ORAL AND ESOPHAGEAL CARCINOGEN N’-NITROSONORNICOTINE IN SALIVA OF E-CIGARETTE USERSIrina Stepanov, PhD*; Gabriela Bustamante; Galina Yakovlev; Katrina Yershova; Bin Ma, PhD; Joni Jensen, MPH; Dorothy Hatsukami, PhD

11:45 a.m. - 12:00 noonELECTRONIC CIGARETTE AEROSOL EXTRACTS INDUCE SIGNIFICANT DNA DAMAGE IN NORMAL AND CANCER CELLSLurdes Queimado, MD, PhD*; Jimmy Manyanga, BS; Lacy Brame, MS; Dehra McGuire, BS; David Rubenstein, PhD; Theodore Wagener, PhD; Ilangovan Ramachandran, PhD; Vengatesh Ganapathy, PhD

12:00 noon - 12:15 p.m.SMOKING-ASSOCIATED DNA HYPOMETHYLATION IN BLOOD AS A SURROGATE FOR DNA HYPOMETHYLATION AND GENE DEREGULATION IN SMOKERS’ LUNGIte A Laird-Offringa, PhD*; Theresa Ryan Stueve, PhD; Wen-Qing Li, PhD; Jianxin Shi, PhD; Crystal N Marconett, PhD; Tongwu Zhang, PhD; Chenchen Yang, BS; Daniel Mullen, BS; William Wheeler, PhD; Xing Hua, PhD; Zea Borok, MD PhD; Neil E Caporaso, MD; Angela C Pesatori

12:15 p.m. - 12:30 p.m.HIGH LEVELS OF ORAL NITROSAMINE-DERIVED DNA ADDUCTS IN SMOKERS WHO DEVELOP ORAL/HEAD AND NECK CANCERSamir S Khariwala, MD MS*; Bin Ma, PhD; Chris Ruszczak, PhD; Steven Carmella, M.S.; Stephen Hecht, PhD; Irina Stepanov, PhD

12:30 p.m.-1:30 p.m.Villa Vittoria: Sala Onice – Ground FloorMeet-the-Editor

Adam Leventhal, Associate Editor for Nicotine and Tobacco Drug and Alcohol Dependence Journal

12:30 p.m.-2:00 p.m.Passi PerdutiPDC BuildingPoster Session 5

90



91

92



93

INDEX-AUTHOR

94


95


A

Abdali, Syed A . . . . . . . . . . . . . . . .86Abrams, David . . . . . . . . . . . . . . . .53Ackerman, Chris . . . . . . . . . . . . . . .62Adams, Lynn . . . . . . . . . . . . . . . . . .48Addicott, Merideth A . . . . . . . . . . . .45Addy, Nii A . . . . . . . . . . . . . . . . . . .51Adruino, Roberto C . . . . . . . . . . . . .54Afifi, Rima . . . . . . . . . . . . . . . . . . . .31Aguirre, Claudia . . . . . . . . . . . . . . .70Ahluwalia, Jasjit S . . . . . . . . . . .69, 70Alain, Anne-Emilie . . . . . . . . . . . . .50Alexander, Tesfa . . . . . . . . . . . .44, 81Allen, Alicia M . . . . . . . . . . . . . . . . .66Allen, Sharon . . . . . . . . . . . . . . . . .66Althabe, Fernando . . . . . . . . . . . . .48Ambrose, Bridget . . . . . . . . . . . . . .32Amos, Amanda . . . . . . . . . . . . . . . .48Ampelas, Anna-Eva . . . . . . . . . . . .34Angus, Kathryn . . . . . . . . . . . . . . . .88Anthenelli, Robert . . . . . . . . . . . . . .47Antin, Tamar MJ . . . . . . . . . . . . . . .83Aranda, Sanchia . . . . . . . . . . . . . . .68Arheart, Kristopher . . . . . . . . . . . . .48Aribo, Oceane . . . . . . . . . . . . . . . . .50Armeli, Stephen . . . . . . . . . . . . . . .87Arnott, Deborah . . . . . . . . .34, 48, 73Aronowitz, Catherine . . . . . . . . . . .72Arora, Monika . . . . . . . . . . . . . . . . .50Arrieta, Alejandro . . . . . . . . . . . . . .67Asfar, Taghrid . . . . . . . . . . . . . .31, 48Ashari, Dien . . . . . . . . . . . . . . . . . .64Ashley, David L . . . . . . . . . . . . . . . .32Aubin, Lisa St . . . . . . . . . . . . . . . . .47Audrain-McGovern, Janet . . . . . . . .79Auty, Samantha . . . . . . . . . . . . . . .45Aveyard, Paul . . . . . . . . . . . . . . . . .69

B

Baassiri, Mohamad . . . . . . . . . . . . .89Backinger, Cathy L . . . . . . . . . .32, 45Baker, Amanda . . . . . . . . . .31, 53, 67Baker, Timothy B . . . . . . . . . . . . . .83Balakrishna, Shrilatha . . . . . . . . . . .65Bali, Fatma . . . . . . . . . . . . . . . . . . .48Ball, Jude . . . . . . . . . . . . . . . . . . . .82Barrington-Trimis, Jessica L . . 48, 79,

83Barry, Rachel A . . . . . . . . . . . . .44, 45Bartlett, Christopher . . . . . . . . . . . .45Bar-Zeev, Yael . . . . . . . . . . . . .66, 68Bauld, Linda C . . . . . . . 32, 63, 67, 68,

88, 87, 113Beach, Evan S . . . . . . . . . . . . . . . .46Beguinot, Emmanuelle . . . . . . . . . .64Belizan, Jose . . . . . . . . . . . . . . . . .48Bell, David . . . . . . . . . . . . . . . . . . .81Bell, Spencer . . . . . . . . . . . . . . . . .71Bell, Stephanie . . . . . . . . . . . . . . . .53Bello, Mariel S . . . . . . . . . . . . . . . . .70Bennett, Morgane A . . . . . . . . . . . .48Benowitz, Neal L . . . . . 31, 37, 47, 48,

51, 52, 70, 80, 107

Berg, Carla . . . . . . . . . . . . . . . .35, 50Berlin, Ivan . . . . . . . . . . . . . . . .80, 88Berlin, Noémi . . . . . . . . . . . . . . . . .88Bernat, Edward . . . . . . . . . . . . . . . .86Berrueta, Mabel . . . . . . . . . . . . . . .48Bertrand, Sandrine S . . . . . . . . . . .50Best, Catherine . . . . . . . . . . . . . . . .88Bhasin, Shikha . . . . . . . . . . . . . . . .50Bhatnagar, Prashasti . . . . . . . . . . .66Bhattacharya, Arpita . . . . . . . . . . . .52Biasi, Mariella De . . . . . . . . . . .46, 85Bickel, Warren K . . . . . . . . . . . .86, 87Binns, Steven . . . . . . . . . . . . . . . . .83Bittoun, Renee . . . . . . . . . 80, 84, 115Blaga, Oana M . . . . . . . . . . . . . . . .66Blakely, Tony . . . . . . . . . . . . . . . . . .82Blecher, Evan . . . . . . . . . . . . . . . . .46Blendy, Julie A . . . . . . . . . . . . . . . .64Boatman, Jeffery A . . . . . . . . . . . . .51Boatright, Amy . . . . . . . . . . . . . . . .47Bock, Beth C . . . . . . . . . . . . . . . . . .47Bonevski, Billie . . . . . . . . . . . . .53, 68Bonner, Pamela E . . . . . . . . . . .46, 65Borek, Nicolette . . . . . . . . . . . . . . .69Borland, Ron . . . . . 34, 37, 50, 53, 71,

84, 107Borok, Zea . . . . . . . . . . . . . . . . . . .89Bowker, Katherine . . . . . . . . . .87, 88Bowman, Jenny A . . . . . . . . . . . . . .54Boyd, Mark . . . . . . . . . . . . . . . . . . .53Brady, Kathleen T . . . . . . . . . . . . . .86Brame, Lacy . . . . . . . . . . . . . . . . . .89Brandon, Thomas H . . . . . .45, 86, 87Branston, Robert . . . . . . . . . . . . . .55Braymiller, Jessica L . . . . . . . . . . . .52Brewer, Judson A . . . . . . . . . . . . . .52Brewer, Noel T . . . . . . . . . . . . . . . .71Breysse, Patrick . . . . . . . . . . . . . . .72Brinkman, Marielle C . . . . . . . . . . .86Brinzaniuc, Alexandra . . . . . . . . . . .66Brose, Leonie S . . . . . . . . . . . .48, 73Brown, Elizabeth . . . . . . . . . . . . . . .55Brown, Jennifer L . . . . . . . . . . . . . .66Brown, Richard . . . . . . . . . . . . . . . .87Brunette, Mary F . . . . . . . . . . . . . . .45Bublitz, Margaret . . . . . . . . . . . . . .63Buczynski, Matthew W . . . . . . .49, 50Budney, Alan J . . . . . . . . . . . . . . . .45Bullen, Chris . . . . . . . . . . . . . . . . . .53Bunn, Janice Y . . . . . . . . . . . . . . . .66Burhoo, Premduth . . . . . . . . . . . . .65Burke, Nancy J . . . . . . . . . . . . . . . .84Bustamante, Gabriela . . . . . . . . . . .89

C

Cador, Martine . . . . . . . . . . . . . . . .50Caillé-Garnier, Stéphanie . . . . . . . .50Cantrell, Jennifer . . . . . . . .48, 50, 81Cao, Dingcai . . . . . . . . . . . . . . . . . .80Caporaso, Neil E . . . . . . . . . . . . . .89Carlson, Samantha . . . . . . . . . . . . .66Carmella, Steven . . . . . . . . . . . . . .89Carpenter, Matthew J . . . . . . . . . . .47Carreras, Giulia . . . . . . . . . . . . . . .72

96

SRNT 2107 · Author Index

Carroll, Kathleen . . . . . . . . . . . . . . .87Cassel, Kevin D . . . . . . . . . . . . . . .72Cassidy, Rachel N . . . . . . . . . .51, 85Castaldelli-Maia, João Mauricio . . .65Cavallo, Dana . . . . . . . . . . . . . . . . .80Cepeda-Benito, Antonio . . . . . . . . .66Chaloupka, Frank J . . . .46, 54, 73, 83Chan, Sophia Siu Chee . . . . . . . . .54Chang, Yuchiao . . . . . . . . . . . .47, 84Chee, Siu . . . . . . . . . . . . . . . . . . . .54Cheeseman, Hazel . . . . . . . . . . . . .73Chellian*, Ranjithkumar . . . . . . . . .65Chellini, Elisabetta . . . . . . . . . . . . .72Chen, Ii-Lun . . . . . . . . . . . . . . . . . .32Chen, Ning . . . . . . . . . . . . . . . . . . .52Chereches, Razvan M . . . . . . . . . .66Cherukupalli, Rajeev . . . . . . . . . . .54Cheslack-Postava, Keely . . . . . . . .66Cheung, Derek . . . . . . . . . . . . . . . .82Cheung, Ho . . . . . . . . . . . . . . . . . .54Cheung, Yannes Tsz-Yan . . . . . . . .54Choi, Kelvin . . . . . . . . . . . . . . . . . .88Chon, Sandy . . . . . . . . . . . . . . . . . .53Cinciripini, Paul . . . . . . . . . . . . . . . .52Cioe, Patricia A . . . . . . . . . . . . .85, 87Clark, Brendan . . . . . . . . . . . . . . . .84Clark, Pamela I . . . . . . . . . . . . . . . .86Cleghorn, Christine L . . . . . . . . . . .82Cleland, Charles M . . . . . . . . . . . . .68Cobiac, Linda J . . . . . . . . . . . . . . . .82Coffman, Donna L . . . . . . . . . . .72, 83Cohen, Joanna E . . . . . 32, 37, 49, 50,

62, 65, 66, 72, 83, 107, 109Cohn, Amy . . . . . . . . . . . . . . . .61, 87Cohn, Amy C . . . . . . . . . . . . . . . . .63Cohn, Amy M . . . . . . . . . . . . . . . . . .33Colby, Suzanne M . . . . . . . . . . .33, 85Cole, Rob . . . . . . . . . . . . . . . . . . . .65Coleman, Tim . . . . . . . . . . . . . .87, 88Coleman-Haynes, Naomi . . . . . . . .88Collins, Bradley N . . . . . . . . . . .72, 83Collins, Lauren . . . . . . . . . . . . . . . .61Collins, Linda M . . . . . . . . . . . . . . . .32Conway, Kevin . . . . . . . . . . . . . . . .69Cooper, Maria R . . . . . . . . . . . . . . .49Cooper, Sue . . . . . . . . . . . . . . .87, 88Copeland, Jan . . . . . . . . . . . . . . . .88Corcoran, Olivia . . . . . . . . . . . . . . .89Cornacchione, Jennifer . . . . . . . . . .44Cornelius, Marie D . . . . . . . . . . . . .82Cortini, Barbara . . . . . . . . . . . . . . .72Court, Erin . . . . . . . . . . . . . . . . . . .84Courtney, Ryan . . . . . . . . . . . . . . . .63Cousijn, Janna . . . . . . . . . . . . . . . .87Cox, Alison . . . . . . . . . . . . . . . . . . .32Cox, Lisa Sanderson . . . . . . . .69, 70Cox, Shanna . . . . . . . . . . . . . . . . . .81Cravatt, Benjamin F . . . . . . . . . . . .50Creamer, MeLisa . . . . . . . .49, 62, 79Crook, Brittani . . . . . . . . . . . . . . . . .49Cropsey, Karen L . . . . . . . . . . . . . .84Cruz, Tess B . . . . . . . . . . . . . . . . . .83Cruz, Tess Boley . . . . . . . . . . . . . . .79Cummings, Michael K . . . . .34, 47, 53Cunningham, Mary C . . . . . . . . . . . .61Currie, Dorothy . . . . . . . . . . . . . . . .88

Curry, Sue . . . . . . . . . . . . . . . . . . . .47Curry, Susan J . . . . . . . . . . . . . . . . .32

D

D’Este, Catherine . . . . . . . . . . .53, 68D’Silva, Joanne . . . . . . . . . . . . . . . .70Dadich, Ann . . . . . . . . . . . . . . . . . .68Dar, Reuven . . . . . . . . . . . . . . . . . .52Davis, Kevin . . . . . . . . . . . . . . . . . .81Dawkins, Lynne E . . . . . . . . . . . . . .89Day, Fiona . . . . . . . . . . . . . . . . . . .68Day, Nancy L . . . . . . . . . . . . . . . . .82Dean, Judith . . . . . . . . . . . . . . . . . .53DeAtley, Teresa E . . . . . . . . . . . . . .71DeBiasi, Mariella . . . . . . . . . . . . . . .64Deen, Frederieke Sanne van der . .82Degree, Kaylah . . . . . . . . . . . . . . . .72Delahanty, Janine . . . . . . . . . . . . . .81Delk, Joanne E . . . . . . . . . . . . . . . .79Dempsey, Delia . . . . . . . . . . . . . . .48Denlinger, Rachel L . . . . . . . . .51, 63Denlinger-Apte, Rachel L . . . . . . . .85Der-Avakian, Andre . . . . . . . . . . . .45Dermody, Sarah S . . . . . . . . . . . . .51deWinter, Tamara . . . . . . . . . . . . . .46Dezfuli, Ghazaul . . . . . . . . . . . . . . .64Dieler, Alica . . . . . . . . . . . . . . . . . . .86Dierker, Lisa . . . . . . . . . . . . . . .52, 88DiPalma, Devon . . . . . . . . . . . . . . .65Djordjevic, Mirjana . . . . . . . . . . . . .86Dogar, Omara . . . . . . . . . . . . . . . . .63Doig, Mira . . . . . . . . . . . . . . . . . . . .89Donny, Eric C . . . . . . . .31, 45, 51, 85Doogan, Nathan J . . . . . . . . . . . . . .66Dowty, Rachel M . . . . . . . . . . . . . . .67Dresler, Carolyn . . . . . . . . . . . . . . .45Dresler, Thomas . . . . . . . . . . . . . . .86Driezen, Pete . . . . . . . . . . . . . . . . .50Drobes, David J . . . . . . . . . . . . . . .45Drope, Jeffrey . . . . . . . . . . . . . . . . .66Duke, Jennifer . . . . . . . . . . . . . . . .81Dunbar, Zachary . . . . . . . . . . . . . . .48Duncan, Dustin T . . . . . . . . . . . . . . .55Dunlop, Adrian . . . . . . . . . . . . .53, 68Dunsiger, Shira . . . . . . . . . . . . . . . .47Duong, Thomas B . . . . . . . . . . . . . .68Dusen, Duncan Van . . . . . . . . . . . .49Duwve, Joan . . . . . . . . . . . . . . . . . .67

E

Edwards, Richard . . . . . . . .81, 82, 84Eggers, Matthew . . . . . . . . . . . . . . .55Ehlis, Ann-Christine . . . . . . . . . . . .86Ehlke, Sarah . . . . . . . . . . . . . . . . . .87Eichberg, Christie . . . . . . . . . . . . . .71Eiden, Rina D . . . . . . . . . . . . . . . . .82Eisen, Tim . . . . . . . . . . . . . . . . . . . .46Eissenberg, Thomas . . . . . . . . . . . .72Ekblad, Mikael . . . . . . . . . . . . . . . .82Eker, Figen . . . . . . . . . . . . . . . . . . .64Elf, Jessica L . . . . . . . . . . . . . . . . .72

97


Ellerbeck, Edward F . . . . . . . . . . . . .70Elmasry, Hoda . . . . . . . . . . . . . . . .87Emery, Sherry . . . . . . . . . . . . . .33, 83Erick, Stephanie . . . . . . . . . . . . . . .82Eriksen, Michael P . . . . . . . . . . . . . .44Etter, Jean-Francois . . . . . . . . . . . .45Evans, David E . . . . . . . . . . . . . . . .45Evans, David S . . . . . . . . . . . . . . . .84

F

Fagan, Pebbles . . . . . . . . . . . . . . .72Fagerstrom, Karl . . . . . . . . . . . . . . .31Fagerstrom, Karl-Olov . . . . . . . . . .80Fairchild, Victoria . . . . . . . . . . . . . .72Falk, Emily B . . . . . . . . . . . . . . . . . .81Faller, Rachel Williams . . . . . . . . . .45Fallgatter, Andreas J . . . . . . . . . . . .86Fan, Lu . . . . . . . . . . . . . . . . . . . . . .65Farrell, Michael . . . . . . . . . . . . .53, 68Farrelly, Matthew . . . . . . . . . . . . . .81Felicitas-Perkins, Jamie Q . . . . . . .72Ferguson, Shelagh . . . . . . . . . . . . .84Ferguson, Stuart G . . . . . . . . . . . . .69Feyerabend, Colin . . . . . . . . . . . . .89Fiore, Michael C . . . . . . . . . . . . . . .83Fisher, Miranda . . . . . . . . . . . . . . . .71Fleischer, Nancy L . . . . . . . . . . . . .54Foll, Bernard Le . . . . . . . . . . . .47, 50Fong, Geoffrey T . . .32, 46, 50, 53, 65Fong, Geofrey . . . . . . . . . . . . . . . . .88Ford, Allison . . . . . . . . . . . . . . . . . .88Ford, Pauline . . . . . . . . . . . . . . . . .53Fouad, Fouad . . . . . . . . . . . . . . . . .31Foulds, Jonathan . . . . . . . . . . . . . .50Fournier, Marie-Line . . . . . . . . . . . .50Fowler, Christie D . . . . . . . . . . .46, 49Franck, Christopher T . . . . . . . . . . .86Franco, Armani Del . . . . . . . . . . . . .64Frank, Summer . . . . . . . . . . . . . . . .54Fraser, David L . . . . . . . . . . . . . . . .83Freeman, Becky . . . . . . . . . . . . . . .83Freund, Megan . . . . . . . . . . . . . . . .68Froeliger, Brett . . . . . . . . . . . . .47, 71Fucito, Lisa M . . . . . . . . . . . . . .31, 87

G

Gaalema, Diann E . . . . . . . . . . . . . .66Gaffey, Allison . . . . . . . . . . . . . . . . .63Gallopel-Morvan, Karine . . . . . .64, 84Gammon, Doris . . . . . . . . . . . . . . .55Gan, Quan . . . . . . . . . . . . . . . . . . .34Ganapathy, Vengatesh . . . . . . . . . .89Garcia, Raul . . . . . . . . . . . . . . . . . .64Garrison, Kathleen A . . . . . . . . . . . .52Gartner, Coral . . . . . . . . . . . . . . . . .53Gbedemah, Misato . . . . . . . . . . . . .88Gelernter, Joel . . . . . . . . . . . . . . . .85Genna, Natacha M De . . . . . . . . . .82George, Mark S . . . . . . . . . . . . . . .86George, Tony P . . . . . . . . . . . . .44, 52Getz, Kayla R . . . . . . . . . . . . . . . . .72

Ghandhi, Shashank . . . . . . . . . . . .48Gibbons, Luz . . . . . . . . . . . . . . . . .48Gibson, Laura A . . . . . . . . . . . . . . . .44Gifford, Heather . . . . . . . . .33, 70, 82Gilbert, David G . . . . . . . . . . . . . . .45Gildengorin, Ginny . . . . . . . . . . . . .84Gilks, Charles F . . . . . . . . . . . . . . .53Gilmore, Anna B . . . . . . . . . . . . . . .55Giovino, Gary . . . . . . . . . . . . . .50, 69Gipson, Cassandra D . . . . . . . . . . .64Gissler, Mika . . . . . . . . . . . . . . . . . .82Gitik, Miri . . . . . . . . . . . . . . . . . . . . .71Glasser, Allison M . . . . . . . . . . .32, 61Glover, Marewa . . . . . . . . . . . .66, 68Glover-Kudon, Rebecca . . . . . . . . .81Glynn, Thomas J . . . . . . . . . . . . . . .32Goenaga, Julianna . . . . . . . . . . . . .64Goldenson, Nicolas I . . . . . . . . . . . .70Goldman, David . . . . . . . . . . . . . . .71Goldschmidt, Lidush . . . . . . . . . . . .82Goldzahl, Leontine . . . . . . . . . . . . .88Golub, Jonathan E . . . . . . . . . .53, 72Goma, Fastone . . . . . . . . . . . . . . . .65Goniewicz, Maciej L . . . . . . 34, 36, 37,

45, 48, 51, 80, 89Goodwin, Renee D . . . . . . . . . .66, 88Gordon, Terry . . . . . . . . . . . . . . . . .48Gorini, Giuseppe . . . . . . . . . . . . . . .72Gould, Cheryl . . . . . . . . . . . . . . . . .33Gould, Gillian S . . . . . . . . . .33, 66, 68Gould, Thomas J . . . . . . . . . . .65, 71Grainger-Gasser, Alice . . . . . . . . . .50Grana, Rachel . . . . . . . . . . . . . . . .48Grant, Ashley . . . . . . . . . . . . . . . . .66Gray, Kevin M . . . . . . . . . . . . . .47, 71Grayless, Megan M . . . . . . . . . . . .49Green, Annika C . . . . . . . . . . . . . . .65Gritz, Ellen R . . . . . . . . . . . . . . . . .54Gueorguieva, Ralitza . . . . . . . .80, 87Guignard, Romain . . . . . . . . . . . . .64Guillaumier, Ashleigh . . . . . . . .53, 68Gupta, Amita . . . . . . . . . . . . . . . . . .72Gupta, Seema . . . . . . . . . . . . . . . .71Gupte, Nikhil . . . . . . . . . . . . . . .53, 72Guy, Mignonne C . . . . . . . . . . . . . .72

H

Haeussing, Florian . . . . . . . . . . . . .86Haghpanahan, Houra . . . . . . . . . . .81Hair, Elizabeth C . . . . . . . . . . . .48, 81Hajek, Peter . . . . . . . . . . . . . . . . . .69Halenar, Michael J . . . . . . . . . . . . .81Hall, Brandon J . . . . . . . . . . . . . . . .65Hamamura, Faith . . . . . . . . . . . . . .72Hammond, David . .61, 63, 64, 71, 72Hanlon, Colleen A . . . . . . . . . . . . . .87Hanrahan, Tess . . . . . . . . . . . . . . .87Hardin, James W . . . . . . . . . . . . . .71Harrell, Melissa B . . . . . . . .49, 62, 79Hartmann-Boyce, Jamie . . . . . . . . .32Hartwell, Karen J . . . . . . . . . . . . . .86Haseen, Farhana . . . . . . . . . . . . . .88Hasin, Deborah . . . . . . . . . . . . .66, 88

98


Hatsukami, Dorothy K . 31, 32, 51, 79, 85, 89

Haw, Sally J . . . . . . . . . . . . . . .81, 88Hawk Jr ., Larry W . . . . . . . . . . .52, 69Hays, Taylor . . . . . . . . . . . . . . . . . .47Healey, Ben . . . . . . . . . . . . . . . . . .84Healton, Cheryl . . . . . . . . . . . . . . . .32Hecht, Stephen . . . . . . . . . . . . . . . .89Heckman, Bryan W . . . . . . . . . . . . .47Henderson, Patricia N . . . . . . . . . .70Henderson, Patricia Nez . . . . . . . . .33Henderson, Scott . . . . . . . . . . . . . .86Henderson, Tracey . . . . . . . . . . . . .48Hendricks, Peter S . . . . . . . . . . . . .84Hennigfield, Jack E. . . . . . . . . . . . .80Henningfield, Jack E . . . . . . . . . . . .79Herman, Melissa A . . . . . . . . . . . . .50Hernandez, Carol . . . . . . . . . . . . . .70Herrmann, Martin . . . . . . . . . . . . . .86Herzog, Thaddeus A . . . . . . . . . . . .72Hickey, Paul . . . . . . . . . . . . . . . . . .84Higgins, Stephen T . . . . . . .36, 51, 66Hiscock, Rosemary . . . . . . . . . . . . .55Hitchman, Sara C . . . . . . . . . . .55, 71Hoddinott, Pat . . . . . . . . . . . . . . . . .88Hoek, Janet . . . . . . . . . . . . . . .82, 84Hoffman, Allison C . . . . . . . . . . . . .45Holiday, Erica . . . . . . . . . . . . . . . . .71Holter, Michael C . . . . . . . . . . . . . .64Hong, Zhang . . . . . . . . . . . . . . . . . .48Hopp, Craig . . . . . . . . . . . . . . . . . .63Hornik, Robert C . . . . . . . . . . . . . . .44Howe, Megan . . . . . . . . . . . . . . . . .80Hsu, Ku-Lung . . . . . . . . . . . . . . . . .50Hua, Xing . . . . . . . . . . . . . . . . . . . .89Huang, Jidong . . . . . . . . . . . . . . . .83Huang, Susan . . . . . . . . . . . . . . . . .68Huestis, Marilyn A . . . . . . . . . . . . . .82Hughes, John R . . . . . . . . . . . . . . .45Huh, Jimi . . . . . . . . . . . . . . . . . . . . .83Hyland, Andrew . . . . . . . . . . . . . . .32

I

Islam, Farahnaz . . . . . . . . . . . .71, 72Islami, Farah . . . . . . . . . . . . . . . . . .64

J

Jabba, Sairam V . . . . . . . . . . . .46, 65Jackson, Christian D . . . . . . . . . . . .79Jackson, Kristina . . . . . . . . . . . . . .85Jacob, Peyton . . . . . . . . . . . . . . . . .48Jain, Shonul . . . . . . . . . . . . . . . . . .48Jay, Stephen J . . . . . . . . . . . . . . . .67Jennings, Ernestine . . . . . . . . . . . .47Jensen, Eric . . . . . . . . . . . . . . . . . .48Jensen, Joni . . . . . . . . . . . . . . . . . .89Jeong, SooHee . . . . . . . . . . . . . . . .63Jibril, Abdi . . . . . . . . . . . . . . . . . . . .66Johnson, Amanda . . . . . . . . . . . . . .61Jordt, Sven-Eric . . . . . . . . . . . .46, 65Jorgensen, Dorothy . . . . . . . . . . . .72

K

Kaai, Susan C . . . . . . . . . . . . . . . . .65Kahler, Christopher W . . . . . . . . . . .87Kalkhoran, Sara M . . . . . . . . . . . . .47Kalousova, Lucie . . . . . . . . . . . . . .54Kaprio, Jaakko . . . . . . . . . . . . . . . .34Karaoghlanian, Nareg . . . . . . . . . . .89Keith, Diana R . . . . . . . . . . . . . . . .66Kelder, Steven H . . . . . . . . . . . .49, 62Kellar, Kenneth J . . . . . . . . . . . . . .64Kelley, Jennifer H . . . . . . . . . . . . . .47Kelley, Jennifer K . . . . . . . . . . . . . .84Kelly, Pete . . . . . . . . . . . . . . . . . . . .68Kennedy, Ryan D . . . . . . . .32, 50, 62Kevin, Luk Tzu Tsun . . . . . . . . . . . .47Khadse, Sandhya . . . . . . . . . . . . . .72Khariwala, Samir S . . . . . . . . . . . . .89Kientz, Julie . . . . . . . . . . . . . . . . . .52Kim, Hyoshin . . . . . . . . . . . . . . . . .86Kim, Jin . . . . . . . . . . . . . . . . . . . . . .84Kimber, Catherine F . . . . . . . . . . . .89King, Andrea . . . . . . . . . . . . . . . . . .80King, Brian A . . . . . . . . . . . . . . . . . .62Kinikar, Aarti . . . . . . . . . . . . . . . . . .72Kiparoglou, Vasiliki . . . . . . . . . . . . .55Kira, Anette . . . . . . . . . . . . . . . . . . .66Kirchner, Thomas R . . . . . . . . . 67, 112Kirkpatrick, Matthew G . . . . . . . . . .70Kittner, Deirdre L . . . . . . . . . . . . . . .71Kobinsky, Kathleen . . . . . . . . . . . . .83Kong, Grace . . . . . . . . . . . .33, 79, 80Koopmeiners, Joseph S . . . . . .51, 85Korhonen, Tellervo . . . . . . . . . . . . .34Korkeila, Jyrki . . . . . . . . . . . . . . . . .82Koru-Sengul, Tulay . . . . . . . . . . . . .48Kosmider, Leon . . . . . . . . . . . . .81, 89Kotz, Daniel . . . . . . . . . . . .47, 54, 83Koval, Robin . . . . . . . . . . . . . . . . . .61Kozink, Rachel V . . . . . . . . . . . . . .85Kranzler, Elissa C . . . . . . . . . . . . . .81Kranzler, Henry R . . . . . . . . . . . . . .85Krishnan-Sarin, Suchitra . . 45, 79, 80,

85Kroczek, Agnes . . . . . . . . . . . . . . . .86Kurek, Jolanta . . . . . . . . . . . . . . . . .89Kurti, Allison N . . . . . . . . . . . . . . . .66Kutlu, Munir Gunes . . . . . . . . . .65, 71Kvizhinadze, Giorgi . . . . . . . . . . . . .82

L

Labib, Kareem . . . . . . . . . . . . . . . .68Lagasse, Lisa P . . . . . . . . . . . . . . .50Lahti, Adrienne C . . . . . . . . . . . . . .84Laird-Offringa, Ite A . . . . . . . . . . . . .89Lam, Hy . . . . . . . . . . . . . . . . . . . . .68Lam, Tai-Hing . . . . . . . . . . . . . . . . .54Lando, Harry . . . . . . . . . . . . . . . . . .31Langleben, Daniel . . . . . . . . . . . . . .72Langley, Tessa . . . . . . . . . . . . . . . .81Lantz, Paula M . . . . . . . . . . . . . . . .54Lanza, Stephanie T . . . . . . . . . . . .52Lassi, Glenda . . . . . . . . . . . . . . . . .46Lazard, Allison . . . . . . . . . . . . . . . .44

99


Le, Khanh . . . . . . . . . . . . . . . . . . . .84Lebina, Limakatso . . . . . . . . . . . . .53Lee, David . . . . . . . . . . . . . . . . . . .48Lee, Dustin C . . . . . . . . . . . . . . . . .45Lee, Lily . . . . . . . . . . . . . . . . . .48, 55Lee, Stella . . . . . . . . . . . . . . . . . . . .44Leggio, Lorenzo . . . . . . . . . . . . . . .87Lehtonen, Liisa . . . . . . . . . . . . . . . .82Leischow, Scott . . . . . . . . . 31, 73, 114Lencucha, Raphael . . . . . . . . . . . . .66Leonardi-Bee, Jo . . . . . . . . . . . . . .87Lepore, Stephen J . . . . . . . . . . .72, 83Lerman, Caryn . . . . . . . . . .52, 70, 85Leventhal, Adam M . . . . . . 45, 70, 79,

89, 116Levin, Edward D . . . . . . . . . . . .64, 65Levy, David T . . . . . . . . . . . . . . . . .54Lewis, M . Jane . . . . . . . . . . . . . . . .62Lewis, Sarah . . . . . . . . . . . . . . . . . .88Li, Lin . . . . . . . . . . . . . . . . . . . . . . .71Li, Wen-Qing . . . . . . . . . . . . . . . . . .89Li, William Ho-Cheung . . . . . . . . . .54Li, Xingbao . . . . . . . . . . . . . . . . . . .86Liautaud, Madalyn M . . . . . . . . . . . .70Ling, Pamela M . . . . . . . . . . . . . . . .44Lipperman-Kreda, Sharon . . . . . . .83Liu, Feifei . . . . . . . . . . . . . . . . . . . .83Liu, Jiaying . . . . . . . . . . . . . . . . . . .44Lochbuehler, Kirsten . . . . . . . . . . . .85Lopez, Alexa A . . . . . . . . . . . . . . . . .66Loukas, Alexandra . . . . . . . . . .49, 83Lounsbury, David . . . . . . . . . . . . . .68Louviere, Jordan . . . . . . . . . . . . . . .72Lovett, Ray . . . . . . . . . . . . . . . . . . .33Lucas, Annelies . . . . . . . . . . . . . . .47Lund, Ingeborg . . . . . . . . . . . . . . . .64Lund, Karl Erik . . . . . . . . . . . . . . . .88Lunden, Sara E . . . . . . . . . . . . . . . .86Luo, Xianghua . . . . . . . . . . . . . . . .51Ly, Christina . . . . . . . . . . . . . . . . . .49Lynch, Tania . . . . . . . . . . . . . . . . . .72Lyttle, Susan . . . . . . . . . . . . . . . . . .48

M

Ma, Bin . . . . . . . . . . . . . . . . . . . . . .89Mackay, Daniel . . . . . . . . . . . . . . . .81MacMonegle, Anna . . . . . . . . . . . . .81Macy, Jonathan T . . . . . . . . . . . . . .67Maddox, Raglan . . . . . . . . . . . .33, 70Maloney, Sarah . . . . . . . . . . . . . . . .72Mantey, Dale S . . . . . . . . . . . . . . . .83Mantovani, Antonio . . . . . . . . . . . . .86Manyanga, Jimmy . . . . . . . . . . . . .89Marconett, Crystal N . . . . . . . . . . . .89Marcus, Bess H . . . . . . . . . . . . . . .47Marr, Brain . . . . . . . . . . . . . . . . . . .52Marti, C . Nathan . . . . . . . . . . . . . . .49Martinez, Jaime L . . . . . . . . . . . . . .70Martinson, Neil . . . . . . . . . . . . . . . .53Maruyama, Tracey A Richers . . . . .44Matter, Chris M . . . . . . . . . . . . . . . .70Mave, Vidya . . . . . . . . . . . . . . . . . .72Mayer, Margaret . . . . . . . . . . . . . . .79Mayo, Ashley . . . . . . . . . . . . . . . . .63

Mayo, Matthew S . . . . . . . . . . . . . . .70Maziak, Wasim . . . . . . . . . . . . . . . .31Mbulo, Lazarous . . . . . . . . . . . . . . .50McAfee, Tim . . . . . . . . . . . . . . . . . .81McClernon, F . Joseph . . . . .51, 71, 85McClernon, Francis J . . . . . . . . . . .45McClure, Erin A . . . . . . . . . . . . .33, 44McConnell, Rob S . . . . . . . .48, 79, 83McCool, Judith P . . . . . . . . . . . . . .83McCrae, Tarsha . . . . . . . . . . . . . . .55McDonald, Emily A . . . . . . . . . . . . .44McEwen, Andy . . . . . . . . . . . . . . . .88McGuire, Dehra . . . . . . . . . . . . . . .89McKell, Jennifer . . . . . . . . . . . . . . .88Mcnamara, Patrick . . . . . . . . . . . . .80McNeill, Ann . . .31, 35, 48, 53, 55, 73McPhee, Stephen J . . . . . . . . . . . . .84McRae, Thomas . . . . . . . . . . . . . . .47McRobbie, Hayden . . . . . . . . . . . . .62Mead, Erin . . . . . . . . . . . . . . . . . . .68Meghea, Cristian I . . . . . . . . . . . . .66Meiser, Bettina . . . . . . . . . . . . . . . .68Melis, Miriam . . . . . . . . . . . . . . . . .50Meng, Gang . . . . . . . . . . . . . . . . . .65Mercincavage, Melissa . . . . . . . . . .85Mermelstein, Robin J . . . . . . . .33, 79Meurk, Carla . . . . . . . . . . . . . . . . . .53Meza, Rafael . . . . . . . . . . . . . . . . .54Miao, Shida . . . . . . . . . . . . . . . . . . .46Middlestadt, Susan E . . . . . . . . . . .67Miller, Mollie E . . . . . . . . . . . . . . . .63Ming, Leung . . . . . . . . . . . . . . . . . .71Moeller, Scott . . . . . . . . . . . . . . . . .88Mohamed, Zahurin . . . . . . . . . . . . .65Mongodin, Emmanuel F . . . . . . . . .86Moodie, Crawford . . . . . . . . . . . . . .64Morales, Mark . . . . . . . . . . . . . . . . .52Moran, Meghan B . . . . . . . . . . .61, 62Morello, Paola . . . . . . . . . . . . . . . . .48Morgan, Jennifer C . . . . . . . . . . . . .71Motlhaoleng, Katlego . . . . . . . . . . .53Mukhopadhyay, Bhavna B . . . . . . .71Muleta, Hemen . . . . . . . . . . . . . . . .66Mullen, Daniel . . . . . . . . . . . . . . . . .89Munafò, Marcus R . . . . . . 46, 55, 110Muvvala, Srinivas . . . . . . . . . . . . . .87Myers, Matt . . . . . . . . . . . . . . . . . . .32

N

Nadas, Arthur . . . . . . . . . . . . . . . . .48Nagib, Ahmed . . . . . . . . . . . . . . . . .68Nair, Saritha . . . . . . . . . . . . . . . . . .68Nardone, Natalie . . . . . . . . .48, 51, 85Nargis, Nigar . . . . . . . . . . . . . . . . . .50Naughton, Felix . . . . . . . . . . . .87, 88Neisewander, Janet L . . . . . . . . . . .64Nelson, Deborah . . . . . . . . . . . . . . .66Newcombe, David . . . . . . . . . . . . .63Newcomer, John W . . . . . . . . . . . .45Newell, Luke . . . . . . . . . . . . . . . . . .80Ng, Hanna . . . . . . . . . . . . . . . . . . .63Nguyen, Linh Thi . . . . . . . . . . . . . .68Nguyen, Nam Truong . . . . . . . . . . .68Nguyen, Trang Thi . . . . . . . . . . . . .68

100


Pickworth, Wallace . . . . . . . . . . . . .84Pierce, John P . . . . . . . . . . . . . . . .61Pipe, Andrew . . . . . . . . . . . . . . . . .47Piper, Megan E . . . . . . . . . . . . .31, 52Pistis, Marco . . . . . . . . . . . . . . . . . .50Pokhrel, Pallav . . . . . . . . . . . . . . . .72Polis, Ilham Y . . . . . . . . . . . . . . . . .50Popova, Lucy . . . . . . . . . . . . . . . . .44Powell, Gregory L . . . . . . . . . . . . . .64Prashad, Neelam . . . . . . . . . . . . . .86Prochaska, Judith J . . . . . . . . .37, 107

Q

Qiaoping, Yuan . . . . . . . . . . . . . . . .71Quach, Thu . . . . . . . . . . . . . . . . . . .68Quah, Anne C .K . . . . . . . . . . . . . . .65Queimado, Lurdes . . . . . . . . . . . . .89

R

Rabin, Rachel A . . . . . . . . . . . . . . .44Raichur, Priyanka . . . . . . . . . . . . . .72Ramachandran, Ilangovan . . . . . . .89Ramsey, Susan . . . . . . . . . . . . . . .87Rao, Pamela . . . . . . . . . . . . . . . . . .81Rath, Jessica M . . . . . . . . . . . .48, 81Ray, Lara A . . . . . . . . . . . . . . . . . . .70Reboussin, Beth A . . . . . . . . . . . . . .44Redner, Ryan . . . . . . . . . . . . . . . . .66Rees, Vaughan W . . . . . . . . . . . . . .72Regan, Susan . . . . . . . . . . . . . .47, 84Rezvani, Amir H . . . . . . . . . . . . . . .65Ribisl, Kurt M . . . . . . . . . . . . . . . . .71Richter, Kimber P . . . . . . . . . . . . . .44Richter, Patricia . . . . . . . . . . . . . . .80Ridgeway, William . . . . . . . . . . . . .81Ries, Richard . . . . . . . . . . . . . . . . .52Rigotti, Nancy A . . .31, 36, 47, 62, 84Rizo, Javier . . . . . . . . . . . . . . . . . . .52Roberto, Marisa . . . . . . . . . . . . . . .50Roberts, Megan E . . . . . . . . . . . . . .66Rogers, Todd . . . . . . . . . . . . . . . . .55Rose, Jennifer S . . . . . . . . . . . . . . .52Rose, Shyanika W . . . . . . . . . . .61, 63Rosen, Rochelle . . . . . . . . . . . . . . .47Rosenberry, Zachary R . . . . . . . . . .44Ross, Hana . . . . . . . . . . . . . . . . . . .46Rossem, Carolien van . . . . . . . . . .47Rubenstein, David . . . . . . . . . . . . .89Rupprecht, Laura E . . . . . . . . . . . .51Russell, Michael A . . . . . . . . . . . . .52Ruszczak, Chris . . . . . . . . . . . . . . .89

S

Sabado, Melanie . . . . . . . . . . . . . . .88Saddleson, Megan L . . . . . . . . . . . .85Sakuma, Kari-Lyn K . . . . . . . . . . . .72Salgado, Raydel Valdes . . . . . .45, 88Salloum, Ramzi G . . . . . . . .31, 64, 72Salman, Rola . . . . . . . . . . . . . . . . .89

Nguyen, Tung T . . . . . . . . . . . .68, 84Nguyen-Thanh, Viet . . . . . . . . . . . .64Niaura, Ray . . . . . . . . . . . . . . . . . . .53Niaura, Raymond . . . . . . . .32, 61, 63Noar, Seth M . . . . . . . . . . . . . . .44, 71Nollen, Nikka L . . . . . . . . . . . . . . . .52Nollen, Nikki L . . . . . . . . . . . . . . . . .70Nonnemaker, James . . . . . . . . .55, 81Norman, Leslie . . . . . . . . . . . . . . . .62Nunes, Eric J . . . . . . . . . . . . . . . . .51

O

O’Connor, Richard J . . . . . . . . . . . .72O’Donnell, Matthew B . . . . . . . . . . .81O’Donnell, Rachel . . . . . . . . . . . . . .48O’Farrell, Anne . . . . . . . . . . . . . . . .84O’Malley, Stephanie S . . . . .52, 80, 87Oldmeadow, Christopher . . . . .54, 68Oliver, Jason A . . . . . . . . . . . . . . . .45Oncken, Cheryl . . . . . . . . . . . . .68, 81Ong’ang’o, Jane . . . . . . . . . . . . . . .65Orlan, Elizabeth . . . . . . . . . . . . . . .44Orleans, Tracy . . . . . . . . . . . . . . . .32Orton, Sophie . . . . . . . . . . . . . .87, 88Ozacinki, Gozde . . . . . . . . . . . . . . .88

P

Pacek, Lauren R . . . . . . . . . . . .85, 88Pal, Prasanta . . . . . . . . . . . . . . . . .52Palafox, Sherilyn . . . . . . . . . . . . . . .72Palipudi, Krishna . . . . . . . . . . . . . . .50Pandy, Vijayapandi . . . . . . . . . . . . .65Pang, Raina D . . . . . . . . . . . . . . . . .70Panissidi, Luana . . . . . . . . . . . . . . .86Parascandola, Mark . . . . . . . . . . . .46Parikh, Vinay . . . . . . . . . . . . . . . . .65Park, Elyse R . . . . . . . . . . . . . . . . .47Park, Emily (Sa Nan) . . . . . . . . . . .68Park, Jinwoo . . . . . . . . . . . . . . . . . .51Park, Su Hyun . . . . . . . . . . . . .48, 55Parsons, Loren H . . . . . . . . . . . . . .50Partos, Timea . . . . . . . . . . . . . . . . .55Pasch, Keryn E . . . . . . . . . . . . .49, 83Passey, Megan . . . . . . . . . . . . . . . .36Patel, Deesha . . . . . . . . . . . . . . . . .81Paterson, Keriata . . . . . . . . . . . . . .66Paul, Chris . . . . . . . . . . . . . . . . . . .53Paul, Christine L . . . . . . . . . . . .67, 68Pearson, Jennifer L . . . .32, 48, 61, 63Pei, Rui . . . . . . . . . . . . . . . . . . . . . .81Pell, Jill . . . . . . . . . . . . . . . . . . . . . .81Peltier, Richard . . . . . . . . . . . . . . . .48Peng, Annie R . . . . . . . . . . . . . .52, 70Pentz, Mary Ann . . . . . . . . . . . . . . .83Pergadia, Michele L . . . . . . . . . . . .45Perry, Cheryl L . . . . . . . .49, 62, 79, 83Pesatori, Angela C . . . . . . . . . . . . .89Pester, Mollie S . . . . . . . . . . . . . . . .70Peters, Erica N . . . . . . . . . .33, 44, 84Petronio, Maria Grazia . . . . . . . . . .72Picciotto, Marina R . . . . . . . . . .64, 65

101


Samet, Jonathan M . . . . . . . . . . . .62Sangalang, Angeline . . . . . . . . . . . .44Sapkota, Amy R . . . . . . . . . . . . . . .86Sargent, James D . . . . . . . . . . . . . .61Savin, Micah J . . . . . . . . . . . . . . . .54Schauer, Gillian L . . . . . . . . . . .44, 84Schayck, Onno C .P . van . . . . . .47, 54Scheffels, Janne . . . . . . . . . . . . . . .64Schensul, Jean J . . . . . . . . . . . . . .68Scheuermann, Taneisha S . . . . . . .70Schillo, Barbara A . . . . . . . . . . . . . .70Schmaelzle, Ralf . . . . . . . . . . . . . . .81Schnoll, Robert . . . . . . . . . . . . . . . .52Schuetze, Pamela . . . . . . . . . . . . .82Schwartz, Rob . . . . . . . . . . . . . . . .33Scott, Sheryl . . . . . . . . . . . . . . . . . .70Searles, Andrew . . . . . . . . . . . . . . .68Sebrie, Ernesto M . . . . . . . . . . . . . .71Selby, Peter . . . . . . . . .31, 47, 53, 87Selya, Arielle S . . . . . . . . . . . . . . . .52Semple, Sean . . . . . . . . . . . . . . . . .48Sestini, Piersante . . . . . . . . . . . . . .72Shafer, Paul . . . . . . . . . . . . . . . . . .81Shah, Vandana . . . . . . . . . . . . . . . .71Shahawy, Omar El . . . . . . . . . .55, 68Shakeshaft, Anthony . . . . . . . . .53, 68Sharma, Ratika . . . . . . . . . . . . . . . .53Shaw, Tim . . . . . . . . . . . . . . . . . . . .68Shearston, Jenni A . . . . . . . . . .48, 55Sheffer, Christine E . . . . . . . . . . . . .86Sheikh, Abdullahi . . . . . . . . . . . . . .66Sheikh, Aziz . . . . . . . . . . . . . . . . . .54Shelley, Donna . . . . . . . . . . . . . . . .68Sheon, Nicolas M . . . . . . . . . . . . . .44Sheridan, Janie . . . . . . . . . . . . . . . .63Sherman, Scott E . . . . .31, 48, 55, 68Sherwood, Emma . . . . . . . . . . . . . .68Shi, Jianxin . . . . . . . . . . . . . . . . . . .89Shi, Zhenhao . . . . . . . . . . . . . . . . .72Shiffman, Saul M . . . . . . . .35, 52, 80Shihadeh, Alan . . . . . . . . . . . . .31, 89Shisler, Shannon . . . . . . . . . . . . . .82Shoaib, Mohammed . . . . . . . . . . . .65Shurtleff, David . . . . . . . . . . . . . . . .63Siddiqi, Kamran . . . . . . . . .31, 63, 66Sidhu, Sohrab . . . . . . . . . . . . . . . . .44Silva, Phillip R . . . . . . . . . . . . . . . . .51Siman, Nina . . . . . . . . . . . . . . . . . .68Simonavicius, Erikas . . . . . . . . . . .48Simpson, Colin . . . . . . . . . . . . . . . .54Simpson, Sean . . . . . . . . . . . . . . . .81Sinclair, Lesley . . . . . . . . . . . . . . . .88Singer, Daniel E . . . . . . . . . . . . . . .47Skelton, Eliza . . . . . . . . . . . . . . . . .53Slade, Susan . . . . . . . . . . . . . . . . .65Smith, Katherine C . . . . . . .62, 65, 83Smith, Philip . . . . . . . . . . . . . . . . . .66Smith, Stevens S . . . . . . . . . . . . . .83Smith, Tracy T . . . . . . .31, 50, 51, 85Snider, Sarah E . . . . . . . . . . . . . . .87Sommer, Toby J . . . . . . . . . . . . . . .46Soule, Eric K . . . . . . . . . . . . . . . . . .32Spigt, Mark . . . . . . . . . . . . . . . . . . .47Spillane, Nichea . . . . . . . . . . . . . . .87St .Helen, Gideon . . . . . . . . . . . . . .80Stanger, Catherine . . . . . . . . . . . . .45

Stanton, Cassandra A . . . . . . . .61, 66Stein, Jeff S . . . . . . . . . . . . . . . . . .87Stepanov, Irina . . . . . . . . . .79, 80, 89Stockings, Emily A . . . . . . . . . . . . .54Stone, Matthew D . . . . . . . . . . . . . .70Strasser, Andrew A . . . . . . . . . . . . .85Streck, Joanna M . . . . . . . . . . . . . .84Stroud, Laura R . . . . . . . . . . . . . . .63Stueve, Theresa Ryan . . . . . . . . . .89Suen, Yi Nam . . . . . . . . . . . . . . . . .47Suerken, Cynthia . . . . . . . . . . . . . .44Sullivan, Nicolette . . . . . . . . . . . . . .45Suryavanshi, Nishi . . . . . . . . . . . . .72Sutfin, Erin L. . . . . . . . . . . . . . . . . .44Sutton, Stephen . . . . . . . . . . . . . . .87Sved, Alan F . . . . . . . . . . . . . . . . . .51Swayampakala, Kamala . . . . . . . . .71Szczypka, Glen . . . . . . . . . . . . . . . .83

T

Talbot, Eugene . . . . . . . . . . . . . . . .62Talhout, Reinskje . . . . . . . . . . . . . .80Talih, Soha . . . . . . . . . . . . . . . . . . .89Tamplin, Stephen A . . . . . . . . . . . . .50Tamura, Kosuke . . . . . . . . . . . . . . .55Tarcea, Monica . . . . . . . . . . . . . . . .72Tauras, John A . . . . . . . . . . . . . . . .73Tautolo, El-Shadan . . . . . . .33, 70, 82Taylor, Natalie . . . . . . . . . . . . . . . . .68Taylor, Seth R . . . . . . . . . . . . . . . . .65Taylor, Teresa . . . . . . . . . . . . . . . . .82Team, The PATH Study . . . . . . . . .69Teplitskaya, Lyubov . . . . . . . . . . . .48Thomas, David . . . . . . . . . . . . .33, 70Thomas, Janet . . . . . . . . . . . . . . . .66Thompson, Mary . . . . . . . . . . . . . . .50Thrasher, James F . . . .54, 64, 71, 72Thrasher, Jim . . . . . . . . . . . . . .50, 65Tidey, Jennifer W . . . . . . . .51, 63, 85Tindle, Hilary A . . . . . . . . . . . . . . . .47Tingle, Malcolm . . . . . . . . . . . . . . .63Tiwari, Cheenu . . . . . . . . . . . . . . . .46Toll, Ben . . . . . . . . . . . . . . . . . . . . .31Tonstad, Serena . . . . . . . . . . . 61, 111Tosun, Nicole . . . . . . . . . . . . . . . . .66Travers, Mark . . . . . . . . . . . . . . . . .48Trigo, Jose M . . . . . . . . . . . . . . . . .50Trinidad, Dennis R . . . . . . . . . . . . .72Tsoh, Janice Y . . . . . . . . . . . . .68, 84Tumolo, Jessica M . . . . . . . . . . . . .65Turner, Jill R . . . . . . . . . . . . . . .64, 71Turner, Steve . . . . . . . . . . . . . . . . .48Twyman, Laura . . . . . . . . . . . . . . . .68Tyndale, Rachel F . . . . . . . .52, 70, 86Tzelepis, Flora . . . . . . . . . . . . .53, 68Tzilos, Golfo . . . . . . . . . . . . . . . . . .87

U

Urman, Robert . . . . . . . . . . . . .48, 83Ussher, Michael . . . . . . . . . . . . . . .87

102


V

Valdes-Saldago, Raydel . . . . . . . . .82Vallone, Donna M . . . . . . . . . . .48, 81Vanderbloemen, Laura . . . . . . . . . .87VanDevanter, Nancy . . . . . . . . . . . .68Vandrey, Ryan . . . . . . . . . . . . . . . .85Vandry, Ryan . . . . . . . . . . . . . . . . .51Vannan, Annika . . . . . . . . . . . . . . . .64Variava, Ebrahim . . . . . . . . . . . . . .53Varlow, Megan . . . . . . . . . . . . . . . .68Vasilenko, Sara A . . . . . . . . . . . . . .52Vedoy, Tord F . . . . . . . . . . . . . . . . .88Verdi, Simona . . . . . . . . . . . . . . . . .72Vergara-Lopez, Chrystal . . . . . . . . .63Vidrine, Damon J . . . . . . . . . . . . . .54Viechtbauer, Wolfgang . . . . . . .47, 54Vilardaga, Roger . . . . . . . . . . . . . . .52Vilcassim, MJ Ruzmyn . . . . . . . . . .48Villaluz, Nicole . . . . . . . . . . . . . . . .70Villanti, Andrea C . . . . .32, 46, 61, 63Vink, Jacqueline . . . . . . . . . . .49, 109Vock, David M . . . . . . . . . . . . . . . . .51Vogl, Lisa M . . . . . . . . . . . . . . . . . .48Volinsky, Allyson C . . . . . . . . . . . . . .44

W

Waa, Andrew M . . . . . . . . . . . .33, 70Wagener, Theodore . . . . . . . . . . . .89Wahlquist, Amy E . . . . . . . . . . . . . .47Walker, Denise D . . . . . . . . . . . . . .45Walker, Matthew W . . . . . . . . . . . . .44Walker, Natalie . . . . . . .31, 34, 53, 63Wall, Melanie M . . . . . . . . . . . .66, 88Walsberger, Scott . . . . . . . . . . . . . .68Walter, Karoline . . . . . . . . . . . . . . .71Wang, An-Li . . . . . . . . . . . . . . . . . .72Ward, Kenneth D . . . . . . . . . . . . . . .31Washington, Carmen C . . . . . . . . .83Watson, Christina . . . . . . . . . . . . . .80Watson, Clifford . . . . . . . . . . . . . . .80Weaver, Scott R . . . . . . . . . . . . . . . .44Weiger, Caitlin . . . . . . . . . . . . .61, 66Weinberger, Andrea . . . . . . . . . . . .88Weitzman, Michael . . . . . . . . . .48, 55Welding, Kevin . . . . . . . . . .62, 65, 83Wells, Corinne . . . . . . . . . . . . . . . .65West, Robert . . . . . 31, 37, 47, 54, 67,

107, 112Wheeler, William . . . . . . . . . . . . . . .89Wickham, Robert J . . . . . . . . . . . . .51

Wiers, Reinout . . . . . . . . . . . . . . . .87Wiggers, John H . . . . . . . . . . . . . . .54Wigginton, Britta . . . . . . . . . . . . . . .53Wileyto, E . Paul . . . . . . . . . . . . . . .52Willette, Blair . . . . . . . . . . . . . . . . . .65Wilson, John . . . . . . . . . . . . . . . . . .83Wilson, Nick . . . . . . . . . . . . . . . . . .82Wiseman, Kimberly D . . . . . . . . . . .44Wolfe, Gary W . . . . . . . . . . . . . . . .63Wolfson, Mark . . . . . . . . . . . . . . . . .44Wong, Ching . . . . . . . . . . . . . . .68, 84Wong-Cornell, Cecilia . . . . . . . . . . .83Wye, Paula M . . . . . . . . . . . . . . . . .54

X

Xiao, Haijun . . . . . . . . . . . . . . . . . .81Xu, Xin . . . . . . . . . . . . . . . . . . . . . .81

Y

Yadav, Amit . . . . . . . . . . . . . . . . . . .50Yakovlev, Galina . . . . . . . . . . . . . . .89Yan, Tsz . . . . . . . . . . . . . . . . . . . . .54Yang, Chenchen . . . . . . . . . . . . . . .89Yang, Qinghua . . . . . . . . . . . . . . . .44Yershova, Katrina . . . . . . . . . . . . . .89Ylioja, Thomas . . . . . . . . . . . . . . . .47Yohn, Nicole . . . . . . . . . . . . . . . . . .64Yong, Hua . . . . . . . . . . . . . . . . . . . .71Yong, Hua-Hie . . . . . . . . . . . . .50, 53Yurekli, Ayda . . . . . . . . . . . . . . . . . .46Yusufali, Afzal Hussein . . . . . . . . . .48

Z

Zaveri, Nurulain T . . . . . . . . . . . . . .46Zawertailo, Laurie . . . . . . . . . . . . . .47Zeller, Mitchell . . . . . . . . . . . . . . . . .32Zeng, Emily Y . . . . . . . . . . . . . . . . .52Zhang, Helena . . . . . . . . . . . . . . . .47Zhang, Tongwu . . . . . . . . . . . . . . . .89Zhao, Xiaoquan . . . . . . . . . . . . . . .81Zhu, Andy ZX . . . . . . . . . . . . . . . . . .70Zimmerman, Julie B . . . . . . . . . . . .46Zimmerman, Mia . . . . . . . . . . . . . . .62Zvolensky, Michael . . . . . . . . . . . . .88Zweben, Alan . . . . . . . . . . . . . . . . .87

103


104


105


106



Sche

dule

-at-

a-G

lanc

e

107

SCHEDULE- AT-A-GLANCE

108




Sche

dule

-at-

a-G

lanc

e

109

TUESDAY, MARCH 7, 2017

3:00 p.m.-5:00 p.m.Piazza Adua Reception AreaRegistration

WEDNESDAY, MARCH 8, 2017

7:30 a.m.-5:00 p.m.Piazza Adua Reception AreaRegistration

9:00 a.m.-12:00 noonSala Auda 1 – Primo Piano (1st Floor)PDA Building (Palazzo Degli Affari Building)Pre-Conference Workshop #1Novel Approaches to Implementing Tobacco Treatment Within Health Systems

9:00 a.m.-12:00 noonSala Affari: Room 2 – Primo Piano (1st Floor)PDA BuildingPre-Conference Workshop #2Is Nicotine Reduction Really a Viable Policy Option for Tobacco Control?

9:00 a.m.-12:00 noonSala Affari: Room 1 – Secondo Piano (2nd Floor)PDA BuildingPre-Conference Workshop #3Developing Evidence-Based Control Policies Targeting Waterpipe Tobacco Smoking: Time for Action.

9:00 a.m.-12:00 noonSala Affari: Piano Terra (Ground Floor)PDA BuildingPre-Conference Workshop #4Working Globally to Support Rapid Learning for E-Cigarette Policy, Surveillance and Policy Research

9:00 a.m.-12:00 noonSala Affari: Room 2 – Secondo Piano (2nd Floor) PDA BuildingPre-Conference Workshop #5Introduction to the Multiphase Optimization Strategy (MOST) for Building More Effective, Efficient, Economical, and Scalable Behavioral and Biobehavioral Interventions

8:30 a.m.-12:00 noonAuditorium-General Session RoomPDC BuildingPre-Conference Workshop #6FDA’s Population Health Standard: Balancing the Risks and Benefits in Regulatory Decision-making

9:00 a.m.-12:00 noonSala Affari: Room 1 – Primo Piano (1st Floor)PDA BuildingPre-Conference Workshop #7Tobacco and Marijunana Co-use in Adolescents and Young Adults

SRNT 2017 · Schedule-at-a-Glance

110

8:30 a.m.-12:00 noonSala Affari: Auda 2 – Secondo Piano (2nd Floor)PDA BuildingPre-Conference Workshop #8Reducing The Impacts of Commercial Tobacco on Indigenous Peoples: Best Practices For Engaging with Indigenous Peoples in Research

9:00 a.m.-12:00 noonSala Affari: Quarto Piano – Top Floor (4th Floor)PDA BuildingPre-Conference Workshop #9What does our Tobacco Work Mean to Us? Translating Knowledge through Art in Florence

8:30 a.m.-12:00 noonVilla Vittoria: Sala Verde(2nd Floor) PDC BuildingSRNT-E Satellite Symposium: Comparing Regulations on Tobacco and Nicotine ProductsSponsored by SRNT-Europe

1:00 p.m.-6:30 p.m.Retropresidenza (Passi Perduti - Lowest Level)PDC BuildingSpeaker Ready Room

1:00 p.m.-3:15 p.m.Network MeetingsPlan to join your colleagues and attend the Network meeting of interest.

1:00 p.m.-2:00 p.m.Adolescent Network Meeting: Villa Vittoria: Sala 101 - Primo Piano (1st Floor) Genetics Network Meeting: Villa Vittoria: Sala Onice - Terra Piano (Ground Floor)Global Health Network Meeting: Villa Vittoria: Sala 9 - Terra Piano (Ground Floor)Health Disparities Network Meeting: Villa Vittoria: Sala Verde – Secondo Piano (2nd Floor)

2:15 p.m.-3:15 p.m.Basic Science Network Meeting: Villa Vittoria: Sala Onice - Terra Piano (Ground Floor)Public Health Policy Network Meeting: Villa Vittoria: Sala 4 - Terra Piano (Ground Floor)Treatment Network Meeting: Villa Vittoria: Sala Verde – Secondo Piano (2nd Floor)

3:30 p.m.-4:45 p.m.Transdisciplinary Topical Discussions #1-#7 are held concurrently(These roundtable sessions are held concurrently, and have been selected to address a diverse array of pressing questions in our field.)

TTD #1Sala Affari: Room 1 – Primo Piano (1st Floor) PDA Building E-health Smoking Cessation Interventions: Do They Really Work?Moderator(s): Saul Shiffman, PhD

TTD #2Sala Auda 1 – Primo Piano (1st Floor) PDA Building NRT Bought Over the Counter: Are Gums and Patches Possibly Not Effective in the Real World? Moderator(s): Ann McNeill, PhD



Sche

dule

-at-

a-G

lanc

e

111

TTD #3Sala Affari: Auda 2 – Secondo Piano (2nd Floor) PDA Building Polysubstance Abuse: How to Treat Tobacco Alongside Other Addictions? Moderator(s): Carla Berg, PhD

TTD #4Sala Affari: Room 2–Primo Piano (1st Floor) PDA BuildingFinancial Incentives for Quitting Tobacco: An Effective and Ethical Approach?Moderator(s): Stephen Higgins, PhD

TTD #5Sala Affari: Room 1 –Secondo Piano (2nd Floor) PDA BuildingMaking the Delivery of Tobacco Cessation Treatment Routine in Health Care Systems: What are the Challenges? Moderator(s): Nancy Rigotti, PhD

TTD #6Sala Affari: Piano Terra (Ground Floor) PDA Building Vape Shops: Just Another Tobacco Product Retailer or a Smoking Cessation Service?Moderator(s): Maciej L. Goniewicz, PhD, Pharm D

TTD #7Sala Affari: Quarto Piano–Top Floor (4th Floor) PDA Building How Do We Reduce Children’s Exposure to Second-Hand Tobacco Smoke Globally?Moderator(s): Megan Passey, PhD

5:00 p.m.-6:00 p.m.Auditorium-General Session RoomPDC BuildingKeynote Presidential Symposium (Opening Session)Nicotine + Other Addictive Behaviors: Addressing the Added Complexities Across the Translational ContinuumNeal L. Benowitz, MD, Chief, Division of Clinical Pharmacology, University of California San Francisco, USA;Ron Borland PhD, FASSA, Nigel Gray Distinguished Fellow in Cancer Prevention, The Cancer Council Victoria, Melbourne, Australia;Joanna E. Cohen, PhD, Director, Institute for Global Tobacco Control, Johns Hopkins Bloomberg School of Public, Baltimore, USA;Judith J. Prochaska, PhD, MPH, Associate Professor of Medi-cine, Department of Medicine, Stanford University, USA;Robert West, PhD, Professor of Health Psychology, University College London, UK

6:00 p.m.-7:30 p.m.Passi Perduti (Basement - Lowest Level)PDC Building Opening Reception(All attendees are welcome! Cash bar and hors d’oeuvres)

THURSDAY, MARCH 9, 2017




112


9:00 a.m.-10:30 a.m.Auditorium-General Session RoomPDC BuildingWelcome/Awards/Plenary

9:00 a.m. Welcome & Opening Remarks by the Presidents of SRNT-E & SRNT

Ivan Berlin, PhDDeborah Ossip, PhD

9:10 a.m. Awards

Tom Glynn, PhD

9:30 a.m. Plenary

Epidemiology and Public Health Themed Lecture and 2017 Doll-Wynder Award Winner“How to Think - Not Feel - About Tobacco Harm Reduction”Kenneth E. Warner; Avedis Donabedian Distinguished University Professor

10:30 a.m.-11:00 a.m.Salone Club (Lower level)PDC BuildingExhibitor TimeRefreshment Break

11:00 a.m.-12:30 p.m.Affari (2nd Floor) - Auda 2Podium Presentation 1: Symposium 1Health Communication for Non-Cigarette Tobacco ProductsAudience: P, I, LMIC

11:00 a.m.-12:30 p.m.Affari (1st Floor) - Room 1Podium Presentation 1: Symposium 2Exploring Marijuana and Tobacco Co-Use: A Problematic Rela-tionship That Can No Longer Be IgnoredAudience: PH/E, PC, HD, I

11:00 a.m.-12:30 p.m.Affari (1st Floor) - Room 2Podium Presentation 1: Symposium 3In Memory of Athina Markou: A Legacy of Transitional Science on Nicotine Withdrawal and RewardAudience: BS, PC, T

1:00 a.m.-12:30 p.m.Affari (2nd Floor)Podium Presentation 1: Symposium 4Exploring Dimensions of Flavors: Toxicity, Preference, and UseAudience: BS, PC, PH/E, I

11:00 a.m.-12:30 p.m.VerdePDC BuildingPodium Presentation 1: Symposium 5The Economics of Tobacco Control: Key Findings From the NCI & WHO Tobacco Control MonographAudience: P, I, LMIC



Sche

dule

-at-

a-G

lanc

e

113

11:00 a.m.-12:30 p.m.Affari (4th Floor)Podium Presentation 1: Symposium 6The CHRNA5-A3-B4 Gene Cluster: From Discovery to Causality, Mechanism, and TherapeuticsAudience: BS, PC, I

11:00 a.m.-12:30 p.m.Auditorium-General Session RoomPDC BuildingPodium Presentation 1: Paper Session 1Novel Findings From Clinical TrialsAudience: C, T, I

11:00 a.m.-12:30 p.m.Affari (1st Floor) - Auda 1Podium Presentation 1: Paper Session 2Secondhand Exposure AssessmentAudience: PC, PH/E, I, LMIC

11:00 a.m.-12:30 p.m.Affari (Ground Floor)Podium Presentation 1: Paper Session 3Correlates of Novel Product UseAudience: PH/E, P, HD, I, LMIC

12:30 p.m.-2:00 p.m.Passi PerdutiPDC BuildingPoster Session 1: Clinical

12:30 p.m.-2:00 p.m.Passi Perduti (Basement - Lowest Level)Lunch BreakPick up your complimentary boxed lunch, starting at 12:15 p.m.

12:45 p.m.-2:00 p.m.Villa Vittoria: Sala 101 - Primo Piano (1st Floor)Past Presidents Luncheon(by invitation only)

12:45 p.m.-1:45 p.m.Villa Vittoria: Sala 4 – Terra Piano (Ground Floor) Meet-the-EditorJoanna Cohen, Deputy Editor Tobacco Control Journal

2:00 p.m.- 3:00 p.m.Auditorium-General Session RoomPDC BuildingPre-Clinical/Basic Science Plenary Themed LectureGenetic Overlap Between Cigarette Smoking and Other Sub-stance UseJacqueline Vink, Professor, Behavioral Science Institute, Rad-boud University, Nijmegen, The Netherlands

3:00 p.m.- 3:30 p.m.Salone Club (Lower level)PDC BuildingExhibitor TimeRefreshment Break

3:30 p.m.-5:00 p.m.Affari (4th Floor)Podium Presentation 2: Symposium 7Endocannabinoid Modulation of Nicotine Dependence: Sympo-sium in Memoriam of Dr. Larry ParsonsAudience: BS, PC, I


114

3:30 p.m.-5:00 p.m.Affari (1st Floor) - Room 2Podium Presentation 2: Symposium 8Global Tobacco Control Disparities: Where Are We? Where Are We Going?Audience: P, HD, I, LMIC

3:30 p.m.-5:00 p.m.Affari (2nd Floor)Podium Presentation 2: Symposium 9Contributions of Basic Science to Public PolicyAudience: BS, P, I

3:30 p.m.-5:00 p.m.Affari (Ground Floor)Podium Presentation 2: Symposium 10Understanding Non-Adherence to Smoking Interventions: Detec-tion, Reasons, Individual Differences, and ConsequencesAudience: C, T, I

3:30 p.m.-5:00 p.m.Affari (1st Floor) - Auda 1Podium Presentation 2: Symposium 11Development and Testing of Smartphone Apps for Smoking CessationAudience: PC, C, T, I

3:30 p.m.-5:00 p.m.Affari (1st Floor) - Room 1Podium Presentation 2: Symposium 12Time-Varying Effect Modeling to Shed New Light on the Develop-mental Course of Nicotine Product Use in the USAudience: PH/E, P

3:30 p.m.-5:00 p.m.Auditorium- General Session RoomPDC BuildingPodium Presentation 2: Symposium 13The Potential of Electronic Cigarettes for Reducing the Harm of Tobacco in Priority Populations: People, Places, Policies, Promo-tion, and PracticesAudience: PH/E, P, HD, I, LMIC

3:30 p.m.-5:00 p.m.VerdePDC BuildingPodium Presentation 2: Paper Session 4Treatment in Smokers With ComorbiditiesAudience: C, HD, I, T

3:30 p.m.-5:00 p.m.Affari (2nd Floor) - Auda 2Podium Presentation 2: Paper Session 5Tax and Price PolicyAudience: PH/E, P, HD, I

5:00 p.m.-6:00 p.m.Villa Vittoria: Sala Onice – Terra Piano (Ground Floor) Meet-the-EditorMarcus Munafo, Deputy Editor Nicotine and Tobacco Research Journal

5:00 p.m.-6:00 p.m.Passi PerdutiPDC BuildingPoster Session 2: Policy, Pre-Clinical



Sche

dule

-at-

a-G

lanc

e

115

FRIDAY, MARCH 10, 2017



8:15 a.m.-8:45 a.m.Villa Vittoria: Sala Verde – Secondo Piano (2nd Floor)PDC BuildingSRNT-Europe Members Meeting (All members are welcome to attend.)

9:00 a.m.-10:00 a.m.Auditorium-General Session RoomPDC BuildingClinical Plenary Themed LectureTreatment of Patients With Tobacco Addiction: Improving Current Practice and Future PerspectivesSerena Tonstad, MD, MPH, PhD, Head Physician, Preventive Cardiology section, Department of Endocrinology, Obesity and Preventive Medicine at Oslo University Hospital, Oslo, Norway and a Professor, School of Public Health, Loma Linda University, Loma Linda, California


10:00 a.m.- 10:30 a.m.Salone Club (Lower level)PDC BuildingExhibitor TimeRefreshment Break

10:30 a.m.-12:00 noonAffari (2nd Floor) - Auda 2Podium Presentation 3: Symposium 14Natural, Organic, Additive-Free, and Eco-Friendly Themes in Cigarette Packaging and Advertising: The New “Light,” “Low,” and “Mild”?Audience: PH/E, P, I

10:30 a.m.-12:00 noonAuditorium-General Session RoomPDC BuildingPodium Presentation 3: Symposium 15E-Cigarette Use Among Youth and Young Adults: Findings From the US Surgeon General’s ReportAudience: PH/E, P, I

10:30 a.m.-12:00 noonAffari (Ground Floor)Podium Presentation 3: Symposium 16Cytisine Update: Moving Research Forward Toward a Globally Affordable Tobacco Cessation MedicationAudience: C, T, I


116

10:30 a.m.-12:00 noonAffari (1st Floor) - Room 1Podium Presentation 3: Symposium 17Examining Links Between Menthol Use and Smoking Persis-tence in Vulnerable PopulationsAudience: PC, PH/E, HD, I, LMIC

10:30 a.m.-12:00 noonAffari (1st Floor) - Room 2Podium Presentation 3: Symposium 18Beyond Plain Packaging: Pack Inserts and Dissuasive CigarettesAudience: P, PC, I, LMIC

10:30 a.m.-12:00 noonVerdePDC BuildingPodium Presentation 3: Symposium 19The Brighter Side of Nicotine: Beyond Nicotine Addiction and Towards Development of Beneficial Nicotinic DrugsAudience: PC, C, T, I

10:30 a.m.-12:00 noonAffari (4th Floor)Podium Presentation 3: Paper Session 6Nicotine and Animal ModelsAudience: BS, PC

10:30 a.m.-12:00 noonAffari (1st Floor) - Auda 1Podium Presentation 3: Paper Session 7Smoking in Low and Medium Income CountriesAudience: PH/E, P, LMIC

10:30 a.m.-12:00 noonAffari (2nd Floor)Podium Presentation 3: Paper Session 8Smoking and E-Cigarette Use in PregnancyAudience: PH/E, C, HD, I

12:00 noon-1:30 p.m.Passi PerdutiPDC BuildingPoster Session 3: Public Health

12:00 noon-1:30 p.m.Passi Perduti (Basement - Lowest Level)Lunch BreakPick up your complimentary boxed lunch, starting at 11:45 a.m.

12:00 noon-1:30 p.m.Villa Vittoria: Sala 9 - Terra Piano (Ground Floor)PDC BuildingTrainee Network Senior Investigator Roundtables

12:15 p.m.-1:15 p.m.Villa Vittoria: Sala 101 – Primo Piano (1st Floor)Meet-the-EditorRobert West, Deputy Editor Addiction Journal

1:30 p.m.-2:00 p.m.Auditorium-General Session RoomPDC BuildingJarvik-Russell New Investigator Awards Paper SessionEcological Momentary Tobacco ControlThomas R. Kirchner, PhD, Clinical Associate Professor of Public Health, Medicine, and Urban Science at NYU College of Global Public Health, USA



Sche

dule

-at-

a-G

lanc

e

117

2:00 p.m.- 3:00 p.m.

Policy Theme Plenary LecturePopulation Level Policies to Prevent Chronic Disease: Applying Lessons From Nicotine and Tobacco ResearchLinda Bauld, Professor of Health Policy, University of Stirling and Chair in Behavioural Research for Cancer Prevention, Cancer Research UK. President-elect of SRNT-Europe

3:00 p.m.-3:30 p.m.Salone Club (Lower level)PDC BuildingExhibitor Time (Last time to visit)Refreshment Break

3:30 p.m.-5:00 p.m.Affari (1st Floor) - Room 2Podium Presentation 4: Symposium 20Increasing Reach Within and Beyond Health Care Settings to Im-prove Access to Tobacco use Treatment: Leveraging Community and Treatment Settings in Asia, Australia and the United StatesAudience: C, T, I

3:30 p.m.-5:00 p.m.Affari (2nd Floor)Podium Presentation 4: Symposium 21E-Cigarettes and Other Global Tobacco Exposures During PregnancyAudience: PH/E, HD, I

3:30 p.m.-5:00 p.m.Auditorium-General Session RoomPDC BuildingPodium Presentation 4: Symposium 22Tobacco Use Transitions Among Youth and Adults: Descriptive Longitudinal Data From Waves 1 and 2 of the Path StudyAudience: PH/E

3:30 p.m.-5:00 p.m.Affari (Ground Floor)Podium Presentation 4: Symposium 23Nicotine Preloading: Effectiveness and MechanismsAudience: C, T, I

3:30 p.m.-5:00 p.m.Affari (4th Floor)Podium Presentation 4: Symposium 24Advances in Understanding Nicotine Dependence in African American Smokers: A Transdisciplinary PerspectiveAudience: PC, C, HD, I, LMIC

3:30 p.m.-5:00 p.m.Affari (1st Floor) - Auda 1Podium Presentation 4: Symposium 25The Role of Research in Meeting FCTC Commitments to Indig-neous Peoples: What Progress Have We Made?Audience: PH/E, P, HD, I, LMIC

3:30 p.m.-5:00 p.m.Affari (2nd Floor) - Auda 2Podium Presentation 4: Symposium 26New Mechanistic and Translational Views of the Hippocampus in Nicotine Dependence and Relapse: Evidence Bridging Mouse and HumanAudience: BS, PC, T


118

3:30 p.m.-5:00 p.m.Affari (1st Floor) - Room 1Podium Presentation 4: Paper Session 9Tobacco Product Health WarningsAudience: PC, P, I, LMIC

3:30 p.m.-5:00 p.m.VerdePDC BuildingPodium Presentation 4: Paper Session 10Attitudes Towards Secondhand Exposure PoliciesAudience: OH/E, P, I, LMIC

5:00 p.m.-6:00 p.m.Villa Vittoria: Sala Onice – Ground FloorMeet-the-EditorScott Leischow, Editor-in-Chief Tobacco Regulatory Science Journal

5:00 p.m.-6:00 p.m.Passi PerdutiPDC BuildingPoster Session 4: Public Health

7:30 p.m.-10:30 p.m.

SRNT-E Gala Dinner(RSVP and additional fee required)

SATURDAY, MARCH 11, 2017

8:00 a.m.-11:00 a.m.Piazza Adua (Reception Area) Registration

8:00 a.m.-11:00 a.m.Retropresidenza (Passi Perduti - Lowest Level)PDC BuildingSpeaker Ready Room

8:15 a.m.- 8:45 a.m.Villa Vittoria: Sala Verde – Secondo Piano (2nd Floor)PDC BuildingSRNT Members Meeting

9:00 a.m.-10:30 a.m.Affari (2nd Floor)-Auda 2PDC BuildingPodium Presentation 5: Symposium 27Understanding Diverse Patterns of Poly-Tobacco and Cannabis Product Use Among Youth and Young Adults: Longitudinal Data From Four Tobacco Centers for Regulatory ScienceAudience: PH/E, HD

9:00 a.m.-10:30 a.m.Affari (1st Floor) - Auda 1Podium Presentation 5: Symposium 28Product Standards for Cigarettes: Models to Achieve Maximum Public Health BenefitAudience: PC, P, I

9:00 a.m.-10:30 a.m.Auditorium- General Session RoomPDC BuildingPodium Presentation 5: Symposium 29E-Cigarettes and E-Liquids: Evaluating the Effects of Constitu-entsAudience: PC, P, I



Sche

dule

-at-

a-G

lanc

e

119

9:00 a.m.-10:30 a.m.Affari (2nd Floor)Podium Presentation 5: Symposium 30Is Smoking Cessation Clinical Practice Hampered by Outdated Regulation of Pharmacotherapies?Audience: C, T, P, I

9:00 a.m.-10:30 a.m.VerdePDC BuildingPodium Presentation 5: Paper Session 11Public Education CampaignsAudience: PH/E, P, HD, I

9:00 a.m.-10:30 a.m.Affari (Ground Floor)Podium Presentation 5: Paper Session 12Prenatal Exposure to Tobacco, E-Cigarettes, and MarijuanaAudience: BS, PC, HD

9:00 a.m.-10:30 a.m.Affari (4th Floor)Podium Presentation 5: Paper Session 13Endgame Strategies for Tobacco UseAudience: P, I, LMIC

9:00 a.m.-10:30 a.m.Affari (1st Floor) - Room 2Podium Presentation 5: Paper Session 14Exposure to Tobacco and E-Cigarette AdvertisingAudience: PH/E, P, HD, I

9:00 a.m.-10:30 a.m.Affari (1st Floor) - Room 1Podium Presentation 5: Paper Session 15Smoking Cessation in Vulnerable PopulationsAudience: C, T, HD, I, LMIC

10:30 a.m.- 11:00 a.m.Passi Perduti (Basement - Lowest Level)PDC Building Refreshment Break

10:30 a.m.-11:30 a.m.Villa Vittoria: Sala Onice – Ground Floor Meet-the-EditorRenee Bittoun, Deputy Editor Journal of Smoking Cessation Journal

11:00 a.m.-12:30 p.m.Affari (1st Floor) - Room 1Podium Presentation 6: Symposium 31Roll Your Own Cigarettes: Shining a Light on a Neglected Aspect of the Smoking EpidemicAudience: PH/E, HD, I, LMIC

11:00 a.m.-12:30 p.m.Affari (1st Floor) - Room 2Podium Presentation 6: Symposium 32Attitudes and Perceptions Toward a Reduced Nicotine Product Standard for CigarettesAudience: PC, PH/E, P, I

11:00 a.m.-12:30 p.m.Affari (2nd Floor)Podium Presentation 6: Symposium 33Nicotine Addiction and Withdrawal: Integrating Genetic, Pheno-typic, and Pharmacologic FindingsAudience: BS, PC, C, T, I


120

11:00 a.m.-12:30 p.m.VerdePDC BuildingPodium Presentation 6: Symposium 34Emerging Methods for Characterization of New and Manipulated Tobacco ProductsAudience: BS, PC, I

11:00 a.m.-12:30 p.m.Affari (2nd Floor) - Auda 2Podium Presentation 6: Symposium 35Innovative Brain Stimulation Techniques for Treating TobaccoDependenceAudience: PC, C, T

11:00 a.m.-12:30 p.m.Affari (1st Floor) - Auda 1Podium Presentation 6: Symposium 36Understanding and Intervening on Alcohol Use in Smokers Who Drink HeavilyAudience: PC, PH/E, HD, I

11:00 a.m.-12:30 p.m.Affari (4th Floor)Podium Presentation 6: Symposium 37Psycho-Social Interventions for Smoking Cessation in Pregnancy An SRNT-Europe SymposiumAudience: C, HD, I, T

11:00 a.m.-12:30 p.m.Auditorium- General Session RoomPDC BuildingPodium Presentation 6: Paper Session 16Trends in Tobacco Product UseAudience: PH/E, I, LMIC

11:00 a.m.-12:30 p.m.Affari (Ground Floor)Podium Presentation 6: Paper Session 17Toxicity of Tobacco ProductsAudience: BS, PC, C, I

12:30 p.m.-1:30 p.m.Villa Vittoria: Sala Onice – Ground FloorMeet-the-EditorAdam Leventhal, Associate Editor for Nicotine and Tobacco Drug and Alcohol Dependence Journal

12:30 p.m.-2:00 p.m.Passi PerdutiPDC BuildingPoster Session 5


121


122


123


124

fiera c & e c f , i m 8-11, 2017 program .srnt. · message from the program chair dear...

Documents